Allergic Diseases (and Differential Diagnoses)

doi:10.1007/3-540-26584-8_5

. 2005:76–217. doi: 10.1007/3-540-26584-8_5

Allergic Diseases (and Differential Diagnoses)

PMCID: PMC7120921

The content is available as a PDF (3.6 MB).

References

1.Bachert C., Hauser U., Prem B., Rudack C., Ganzer U. Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol. 1995;1([Suppl]):44–49. doi: 10.1007/BF02484434. [DOI] [PubMed] [Google Scholar]
2.Bachmann W., Bachert C. Quantitative evaluation of rhinomanometric curves. A new simple method. Laryngol Rhinol Otol. 1984;63:58–61. doi: 10.1055/s-2007-1008242. [DOI] [PubMed] [Google Scholar]
3.Bousquet J., Vignola A.M., Campbell A.M., Michel F.B. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol. 1996;110:207–218. doi: 10.1159/000237289. [DOI] [PubMed] [Google Scholar]
4.Busse W.W., Holgate S.T. Asthma and rhinitis. Oxford: Blackwell; 1995. [Google Scholar]
5.Canonica G.W., Ciprandi G., Pesce G.P., Buscaglia S., Paolieri F., Bagnasco M. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol. 1995;107:99–102. doi: 10.1159/000236943. [DOI] [PubMed] [Google Scholar]
6.Durham S.R. Mechanisms of mucosal inflammation in the nose and lungs. Clin Exp Allergy. 1998;28([Suppl 2]):15–16. [PubMed] [Google Scholar]
7.Ellegard E., Karlsson G. Nasal congestion during pregnancy. Clin Otolaryngol. 1999;24:307–311. doi: 10.1046/j.1365-2273.1999.00264.x. [DOI] [PubMed] [Google Scholar]
8.Heppt W. Zytologie der Nasenschleimhaut. Berlin Heidelberg New York: Springer; 1998. [Google Scholar]
9.Malm L., van-Wijk R.G., Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. Rhinology. 1999;37:133–135. [PubMed] [Google Scholar]
10.Mygind N., Dahl R., Pedersen S., Thestrup-Pedersen K. Essential Allergy. Oxford: Blackwell Science; 1996. [Google Scholar]
11.Mygind N., Laussen L.C., Dahl M. Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy. 2000;55:11–15. doi: 10.1034/j.1398-9995.2000.00108.x. [DOI] [PubMed] [Google Scholar]
12.Naclerio R.M. Pathophysiology of perennial allergic rhinitis. Allergy. 1997;52:41–44. doi: 10.1111/j.1398-9995.1997.tb04816.x. [DOI] [PubMed] [Google Scholar]
13.Nolte D., Renovanz H.D., Schumann K. Obere und untere Luftwege als funktionelle Einheit. Munich: Dustri; 1982. Nase und Respirationstrakt. [Google Scholar]
14.Passalacqua G., Bachert C., Davies R.J., Durham S.R., et al. Inhaled and nasal corticosteroids: safety aspects. Allergy. 2000;55:16–33. doi: 10.1034/j.1398-9995.2000.00370.x. [DOI] [PubMed] [Google Scholar]
15.Simons F.E. Learning impairment and allergic rhinitis. Allergy Asthma Proc. 1996;17:185–189. doi: 10.2500/108854196778996895. [DOI] [PubMed] [Google Scholar]
16.Simons F.E. Allergic rhinobronchitis: The asthma-allergic rhinitis link. J Allergy Clin Immunol. 1999;104:534–540. doi: 10.1016/S0091-6749(99)70320-9. [DOI] [PubMed] [Google Scholar]
17.van Cauwenberge P., Bachert C., Passalacqua G., Bousquet J., Canonica G.W., Durham S.R., Fokkens W.J., Howarth P.H., Lund V., Malling H.J., Mygind N., Passali D., Scadding G.K., Wang D.Y. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55:116–134. doi: 10.1034/j.1398-9995.2000.00526.x. [DOI] [PubMed] [Google Scholar]
18.Tas E., Bircher A.J. Therapie der Rhinitis allergica. Ther Umsch. 2001;58:309–314. doi: 10.1024/0040-5930.58.5.309. [DOI] [PubMed] [Google Scholar]
19.van Wijk R.G., de Graaf-in’tVeld C., Garrelds I.M. Nasal hyperreactivity. Rhinology. 1999;37:50–55. [PubMed] [Google Scholar]
20.World Health Organization (2004) Allergic rhinitis and its impact on asthma (ARIA). In: Bousquet J, et al. (eds) Executive summary. WHO (in press)
21.Wüthrich B., Schindler C., Leuenberger P., Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol. 1995;106:149–156. doi: 10.1159/000236836. [DOI] [PubMed] [Google Scholar]

References

1.National Institutes of Health . Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. Bethesda: NIH; 1997. [Google Scholar]
2.American Thoracic Society Guidelines for methacholine challenge and exercise challenge testing. Am J Respir Crit Care Med. 2000;161:309–329. doi: 10.1164/ajrccm.161.1.ats11-99. [DOI] [PubMed] [Google Scholar]
3.Bachert C. Asthma and rhinitis: management implications. Eur Respir J. 1997;7:294–295. [Google Scholar]
4.Barnes P.J., Chung F., Page C.P. Inflammatory mediators of asthma. Pharmacol Rev. 1998;50:515–596. [PubMed] [Google Scholar]
5.Baur X. Charakterisierung ursächlicher Allergene. Berlin Heidelberg New York: Springer; 1986. Asthma, alveolitis, aspergillose. [Google Scholar]
6.Bernstein D.J. Allergic reactions to workplace allergens. JAMA. 1997;278:1907–1913. doi: 10.1001/jama.278.22.1907. [DOI] [PubMed] [Google Scholar]
7.Borelli S., Düngemann H., editors. Fortschritte der Allergologie und Dermatologie. Basel: IMP-Verlag; 1981. [Google Scholar]
8.Busse W.W., Elias J., Sheppard D., et al. Airway remodeling and repair. Am J Respir Crit Care Med. 1999;160:1035–1042. doi: 10.1164/ajrccm.160.3.9902064. [DOI] [PubMed] [Google Scholar]
9.Crapo R.O. Pulmonary function testing. N Engl J Med. 1994;331:25–30. doi: 10.1056/NEJM199407073310107. [DOI] [PubMed] [Google Scholar]
10.Debelic M., editor. Bronchitis im Kindes-und Jugendlichenalter. Munich: Dustri; 1986. [Google Scholar]
11.Doerschug K.C., Peterson M.W., Dayton C.S., et al. Asthma guidelines. An assessment of physician understanding and practice. Am J Respir Crit Care Med. 1999;159:1735–1741. doi: 10.1164/ajrccm.159.6.9809051. [DOI] [PubMed] [Google Scholar]
12.Düngemann H (1978) Karenz-Expositionsprophylaxe. Atemwegs Lungenkrankh 4
13.Dykewicz MS, Fineman S. Diagnosis and management of rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998;81:478–518. doi: 10.1016/s1081-1206(10)63155-9. [DOI] [PubMed] [Google Scholar]
14.Fischer A., McGregor G.P., Saria A., Philipp B., Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest. 1996;98:2284–2291. doi: 10.1172/JCI119039. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Fruhmann G. Sonstige Berufskrankheiten: Obstruktive Atemwegserkrankungen. In: Ferlinz R., editor. Pneumologie. Stuttgart: Thieme; 1994. [Google Scholar]
16.Fuchs E. Gewerbliche Allergene als Ursache obstruktiver Lungenerkrankungen. Früherkennung und Abklärung. Schweiz Med Wochenschr. 1982;112:185. [PubMed] [Google Scholar]
17.Fuchs E., Schultze-Werninghaus G. Themen der Medizin. Nürnberg: Wander; 1986. Asthma bronchiale. [Google Scholar]
18.Gonsior E., Henzgen M., Jörres R.F., Kroidl R.F., Merget R., Riffelmann F.W., Wallenstein G.W. Leitlinie für die Durchführung bronchialer Provokationstests mit Allergenen. Deutsche Ges für Allergologie und klinische Immunologie. Allergo J. 2001;10:193–199. doi: 10.1055/s-2002-20553. [DOI] [PubMed] [Google Scholar]
19.Hansen K. Bronchialasthma (Bronchiolenasthma) und verwandte Störungen. In: Hansen K., editor. Allergie. Stuttgart: Thieme; 1957. [Google Scholar]
20.Hansel TT, Bauer PJ (eds) (2001) New drugs for asthma, allergy and COPD. Progress in respiration research, vol 31. Karger, Basel
21.Henderson W.R., Shelhamer J.H., Reingold D.B., Smith L.J., Evans R., Kaliner M. Alpha-adrenergic hyper-responsiveness in asthma. N Engl J Med. 1979;300:642–647. doi: 10.1056/NEJM197903223001203. [DOI] [PubMed] [Google Scholar]
22.Holgate S.T., Davies D.E., Lackie P.M., Wilson S.Y., Puddicombe S.L., Lordan J.L. Epitheliolmesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 2000;105:193–204. doi: 10.1016/S0091-6749(00)90066-6. [DOI] [PubMed] [Google Scholar]
23.Kay AB, Austen KF, Lichtenstein LM (eds) (1984) Asthma. Physiology, immunopharmacology and treatment. Academic Press, London
24.Kerschensteiner M., Gallmeier E., Behrens L., Vargas Leal V., Misgeld T., Klinkert W.E.F., Kohlbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neutrophic factor in vitro and in inflammatory brain lesions: A neutroprotective role of inflammation? J Exp Med. 1999;189:865–870. doi: 10.1084/jem.189.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Kjellmann N-IM (1976) Immunoglobulin E and atopic allergy in childhood. Linköping University Medicine Dissertation No. 36
26.König P. Therapie des Status asthmaticus. Internist. 1985;26:208. [PubMed] [Google Scholar]
27.Kunkel G. Neurogene Aspekte der allergischen Entzündungsreaktion. In: Ring J., Darsow V., editors. Allergie 2000: Probleme, Strategien und praktische Konsequenzen. Munich: Dustri; 2001. pp. 179–181. [Google Scholar]
28.Kroegel C., editor. Moderne Therapie des Asthma bronchiale. Stuttgart: Thieme; 1997. [Google Scholar]
29.Lebowitz M.D., Barbee R., Burrows B. Family concordance of IgE, atopy, and disease. J Allergy Clin Immunol. 1984;73:259–264. doi: 10.1016/S0091-6749(84)80017-2. [DOI] [PubMed] [Google Scholar]
30.Magnussen H. Überempfindlichkeit der Atemwege. Dtsch med Wochenschr. 1990;115:1604–1610. doi: 10.1055/s-2008-1065199. [DOI] [PubMed] [Google Scholar]
31.Middleton E. Jr, et al., editors. Allergy: principles and practice. 5th edn. St. Louis: Mosby; 1998. pp. 544–558. [Google Scholar]
32.Milgrom H., Fick R.B., Su J.Q., et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med. 1999;341:1966–1973. doi: 10.1056/NEJM199912233412603. [DOI] [PubMed] [Google Scholar]
33.Nadel J.A., editor. Physiology and pharmacology of the airways. New York: Marcel Dekker; 1980. [Google Scholar]
34.Niggemann B., Illi S., Madloch C. Histamine challenges discriminate between symptomatic and asymptomatic children. Eur Resp J. 2001;17:246–253. doi: 10.1183/09031936.01.17202460. [DOI] [PubMed] [Google Scholar]
35.Nolte D. Asthma: Das Krankheitsbild, der Asthmapatient, die Therapie. 6th edn. Munich: Urban & Schwarzenberg; 1996. [Google Scholar]
36.Reinhardt D., editor. Asthma bronchiale im Kindesalter. Berlin Heidelberg New York: Springer; 1996. [Google Scholar]
37.Schultze-Werninghaus G (ed) (1999) Deutsche Atemwegsliga: Empfehlungen zur Allergiediagnostik bei Atemwegserkrankungen in der Praxis. Pneumologie 48:300–304 [PubMed]
38.Schultze-Werninghaus G. Die Immuntherapie (allergenspezifische Hyposensibilisierung) bei Asthma bronchiale. Atemw Lungenkrh. 1997;23:701–707. [Google Scholar]
39.Slavin RG, Reisman RE (eds) Expert guide to allergy and immunology. American College of Physicians, Philadelphia, pp 23–40
40.Szepanski R., Lecheler J. Standard-und Qualitätssicherung der Asthmaschulung im Kindes-und Jugendalter. Präv Rehab. 1995;7:1–41. [Google Scholar]
41.Tiffeneau R., Beauvallet M. Production exclusive d’effets pulmonaires locaux par inhalation d’aerosol d’acetylcholine. Son utilisation comme test d’insufficance respiratoire. Sem Hop. 1945;21:154–166. [Google Scholar]
42.Townsley R.G. IgE levels and methacholine inhalation responses in monozygous and dizygous twins. J Allergy Clin Immunol. 1976;57:227. [Google Scholar]
43.Virchow J.C., Kroegel C., Walker C., Matthyss H. Cellular and immunological markers of allergic and intrinsic bronchial asthma. Lung. 1994;172:313–334. doi: 10.1007/BF00172846. [DOI] [PubMed] [Google Scholar]
44.Virchow J.C., Prasse A., Naya I., Summertin A., Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;62:578–585. doi: 10.1164/ajrccm.162.2.9905041. [DOI] [PubMed] [Google Scholar]
45.Wahn U., Seger S., Wahn V., editors. Pädiatrische Allergologie und Immunologie. 3rd edn. Munich: Urban und Fischer; 1999. [Google Scholar]
46.Wettengel R., Berdel D., Cegla U., et al. Empfehlungen der Deutschen Atemwegsliga zum Asthmamanagement bei Erwachsenen und Kindern. Med Klin. 1994;89:57–67. [PubMed] [Google Scholar]
47.Worth H., Meyer A., Folgering H., Kirsten D., Lecheler J., Magnussen H., Pleyer K., Schmidt S., Schmitz M., Taube K., Wettengel R. Empfehlungen der Deutschen Atemwegsliga zum Sport und körperlichen Training bei Patienten mit obstruktiven Atemwegserkrankungen. Pneumologie. 2000;54:61–67. doi: 10.1055/s-2000-9066. [DOI] [PubMed] [Google Scholar]
48.Wüthrich B. Zum Allergenkatalog beruflicher Inhalationsallergien. Berufsdermatosen. 1976;24:123. [Google Scholar]

References

1.Abeck D., Thomsen S., Plötz S., Ring J. Die Biologische Urtikaria-Therapie. Acta Biol. 1999;38:3–23. [Google Scholar]
2.Beissert S., Stauder H., Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42:1030–1032. doi: 10.1016/S0190-9622(00)90299-8. [DOI] [PubMed] [Google Scholar]
3.Bork K., Witzke G. Long-term prophylaxis with C1-inhibitor (C1INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J Allergy Clin Immunol. 1989;83:677. doi: 10.1016/0091-6749(89)90082-1. [DOI] [PubMed] [Google Scholar]
4.Braun-Falco O. Entwicklungen in der Dermatologie. In: Braun-Falco O., Marghescu S., editors. Fortschritte der praktischen Dermatologie und Venerologie. Berlin Heidelberg New York: Springer; 1976. p. 417. [Google Scholar]
5.Champion R.H. Urticaria then and now. Br J Dermatol. 1988;119:427–436. doi: 10.1111/j.1365-2133.1988.tb03246.x. [DOI] [PubMed] [Google Scholar]
6.Doeglas H.M.G. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol. 1975;93:135. doi: 10.1159/000144504. [DOI] [PubMed] [Google Scholar]
7.Ellis M.H. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol. 1998;102:876–877. doi: 10.1016/S0091-6749(98)70032-6. [DOI] [PubMed] [Google Scholar]
8.Fiebiger E., Hammerschmid F., Stingl G., Maurer D. Anti-FcεRIα autoantibodies in autoimmune-mediated disorders. J Clin Invest. 1998;101:243–251. doi: 10.1172/JCI511. [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664–671. doi: 10.1067/mai.2000.105706. [DOI] [PubMed] [Google Scholar]
10.Haas N., et al. Vergleichende Studie zur Häufigkeit, Diagnostik und Therapie der Urtikaria in einer Hautpoliklinik. Allergologie. 1995;18:110–113. [Google Scholar]
11.Henz B.M. Das Spektrum der Urtikaria. In: Henz B.M., Zuberbier T., Grabbe J., editors. Urtikaria. Klinik, Diagnostik, Therapie. Berlin Heidelberg New York: Springer; 1996. pp. 1–17. [Google Scholar]
12.Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599–1604. doi: 10.1056/NEJM199306033282204. [DOI] [PubMed] [Google Scholar]
13.Illig L., Paul E. Die Stellung der Antihistaminika in der Urtikaria-Therapie. Hautarzt. 1978;29:407. [PubMed] [Google Scholar]
14.Juhlin L. Modem approaches to treatment of chronic urticaria. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. p. 279. [Google Scholar]
15.Kaplan A.P. The pathogenic basic of urticaria and angioedema: Recent advances. Am J Med. 1981;70:755–757. doi: 10.1016/0002-9343(81)90528-3. [DOI] [PubMed] [Google Scholar]
16.Kumar S.A., Martin B.L. Urticaria and angioedema: diagnostic and treatment considerations. J Am Osteopath Assoc. 1999;99([Suppl]):1–4. [PubMed] [Google Scholar]
17.Leznoff A., Sussmann G.L. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: A study of 90 patients. J Allergy Clin Immunol. 1989;84:66. doi: 10.1016/0091-6749(89)90180-2. [DOI] [PubMed] [Google Scholar]
18.Leznoff A. Chronic urticaria. Can Fam Physician. 1998;44:2170–2176. [PMC free article] [PubMed] [Google Scholar]
19.Maibach H.I., Johnson H.L. Contact urticaria syndrome. Contact urticaria to diethyltoluamide. Arch Dermatol. 1975;111:720–730. doi: 10.1001/archderm.111.6.720. [DOI] [PubMed] [Google Scholar]
20.Merk H. Urticaria und Rhinitis allergica. In: Hornbostel H., Kaufmann W., Siegenthaler W., editors. Innere Medizin in Praxis und Klinik. 4th edn. Stuttgart: Thieme; 1992. pp. 3281–3293. [Google Scholar]
21.Meurer M. Urticaria vasculitis. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 148–151. [Google Scholar]
22.Müller J., Vieluf D., Ring J. Schilddrüsenhormone als Amplifikatoren der Histamin-Freisetzung unter Insektengift-Hyposensibilisierung. Allergo J. 1993;2([Suppl 2]):77–8. [Google Scholar]
23.Ollert M., Ring J. Urtikaria und Angioödem. In: Przybilla B., Bergmann K., Ring J., editors. Praktische allergologische Diagnostik. Darmstadt: Stein-kopff; 2000. pp. 328–334. [Google Scholar]
24.Opferkuch W., Kövary P.M., Jaeger U., Echternacht-Happle K., Gronemeyer W., Hammar C., Niemczyk H., Rieger C. Clinical aspects and therapy of hereditary angioneurotic edema. In: Ring J., Burg G., editors. New trends in Allergy. Berlin Heidelberg New York: Springer; 1981. p. 272. [Google Scholar]
25.Paul E., Bödeker R.-H. Behandlung der chronischen Urticaria mit Terfenadin und Ranitidin. Allergologie. 1987;10:113. [Google Scholar]
26.Ring J., Brockow K., Ollert M., Engst R. Antihistamines in urticaria. Clin Exp Allergy. 1999;29([Suppl 1]):31–37. doi: 10.1046/j.1365-2222.1999.00006.x. [DOI] [PubMed] [Google Scholar]
27.Ring J., Przybilla B. Diagnostik der chronischen Urtikaria. Med Welt. 1987;38:256–259. [Google Scholar]
28.Sabroe R.A., Grattan C.E., Francis D.M., Barr R.M., Kobza B. A., Greaves M.W. The autologous serum skin test: A screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999;140:446–452. doi: 10.1046/j.1365-2133.1999.02707.x. [DOI] [PubMed] [Google Scholar]
29.Schäfer T., Ring J., et al. Epidemiology adverse food reactions due to allergy and other forms of hypersensitivity. In: Eisenbrand G., et al., editors. Food allergies and intolerances. VCH Weinheim: DFG; 1996. pp. 40–54. [Google Scholar]
30.Schmutzler W. Histamin als Mediator allergischer Reaktionen. Allergologie. 1997;20:536–542. [Google Scholar]
31.Skrebova N., Takiwaki H., Miyaoka Y., Arase S. Localized heat urticaria: a clinical study using laser Doppler flowmetry. J Dermatol Sci. 2001;26:112–118. doi: 10.1016/S0923-1811(00)00162-6. [DOI] [PubMed] [Google Scholar]
32.Schrallhammer-Baenkler S., Ring J., Landthaler M. Localized heat urticaria. Arch Dermatol Res. 1985;277:406. doi: 10.1007/BF00509243. [DOI] [Google Scholar]
33.Toubi E., Blant A., Kessel A., Golan T.D. Low dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy. 1997;52:312–316. doi: 10.1111/j.1398-9995.1997.tb00996.x. [DOI] [PubMed] [Google Scholar]
34.Warin R.P., Champion R.H. Urticaria. London: Saunders; 1974. [Google Scholar]
35.Wüthrich B. Therapie der akuten und chronischen Urtikaria und des Quincke-Ödems. Schweiz Rundschau Med. 1989;78:576–581. [PubMed] [Google Scholar]
36.Zuberbier T., Henz B.M. Diagnostik der Urtikaria. In: Henz B.M., Zuberbier T., Grabbe J., editors. Urtikaria. Klinik, Diagnostik, Therapie. Berlin Heidelberg New York: Springer; 1996. pp. 137–156. [Google Scholar]
37.Zuberbier T, Aberer W, Grabbe J, Hartmann K, Merk H, Ollert M, Rueff F, Wedi B, Wenning J (2004) Diagnostik und Therapie der Urtikaria. Leitlinie der DDG und DGAI. Allergo J (in press) [DOI] [PubMed]

References

1.Barnard J.H. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259–264. doi: 10.1016/0091-6749(73)90044-4. [DOI] [PubMed] [Google Scholar]
2.Bochner B.S., Lichtenstein L.M. Anaphylaxis. N Engl J Med. 1991;324:81–88. doi: 10.1056/NEJM199106203242506. [DOI] [PubMed] [Google Scholar]
3.Brockow K., Kiehn M., Riehtmüller C., Vieluf D., Berger J., Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera venom immunotherapy: a prospective randomized placebo-controlled trial. J Allergy Clin Immunol. 1997;100:458–463. doi: 10.1016/S0091-6749(97)70135-0. [DOI] [PubMed] [Google Scholar]
4.Brown M.J., Brown D.C., Murphy M.B. Hypokalemia from beta-2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309:1414–1419. doi: 10.1056/NEJM198312083092303. [DOI] [PubMed] [Google Scholar]
5.Capurro N., Levi R. The heart as target organ in systemic allergic reactions. Circ Res. 1975;36:520–528. doi: 10.1161/01.res.36.4.520. [DOI] [PubMed] [Google Scholar]
6.Delage C., Irey H.C. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forens Sci. 1972;17:525. [PubMed] [Google Scholar]
7.De Soto H., Turk P. Cimetidine in anaphylactic shock refractory to standard therapy. Anesth Analg. 1989;69:264–265. doi: 10.1213/00000539-198908000-00029. [DOI] [PubMed] [Google Scholar]
8.Eisenberg M.S., Mengest T.J. Cardiac resuscitation. N Engl J Med. 2001;344:1304–1313. doi: 10.1056/NEJM200104263441707. [DOI] [PubMed] [Google Scholar]
9.Endrich B., Ring J., Intaglietta M. Effects of radiopaque contrast media on the microcirculation of the rabbit omentum. Radiology. 1979;132:331–339. doi: 10.1148/132.2.331. [DOI] [PubMed] [Google Scholar]
10.Fisher M.M.D. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anesth Intensive Care. 1986;17:17–21. doi: 10.1177/0310057X8601400105. [DOI] [PubMed] [Google Scholar]
11.Fuchs E., Ferlinz R. Allergische Krankheiten. In: v Wolff H.R., Weihrauch T.R., editors. Internistische Therapie. 6th edn. Munich: Urban und Schwarzenberg; 1986. pp. 275–288. [Google Scholar]
12.Gronemeyer W. Noradrenalin statt Adrenalin beim anaphylaktischen Schock. Dtsch Med Wochenschr. 1980;102:101. [PubMed] [Google Scholar]
13.Hannaway P.J., Hoppler G.D.K. Severe anaphylaxis and drug induced beta-blockage. N Engl J Med. 1983;308:1536. [PubMed] [Google Scholar]
14.Hermann K., Ring J. The renin-angiotensin system in patients with repeated anaphylactic reactions during Hymenoptera venom hyposensitization and sting challenge. Int Arch Allergy Immunol. 1997;11:251–156. doi: 10.1159/000237462. [DOI] [PubMed] [Google Scholar]
15.Johansson S.G.O., Hourihane J.O.B., Bousquet J., Bruijnzeel-Koomen, Dreborg S., Haahtela T., Kowalski M.L., Mygind N., Ring J., van Cauwenberge P., van Hage-Hamsten M., Wüthrich B. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813–824. doi: 10.1034/j.1398-9995.2001.t01-1-00001.x. [DOI] [PubMed] [Google Scholar]
16.Kleinhans D. Anstrengungs-induzierte Urtikaria und Anaphylaxie. Med Klein. 1987;82:103–104. [PubMed] [Google Scholar]
17.Laubenthal H. Ergebnisse einer multizentrischen Studie. Berlin Heidelberg New York: Springer; 1986. Dextrananaphylaxie, Pathomechanismus und Prophylaxe. [Google Scholar]
18.Lockey R.F., Benedict L.M., Turkeltaub T.B., Bukantz S.C. Fatalities from immunotherapy (IT) and skin testing (ST) J Allergy Clin Immunol. 1987;79:666–677. doi: 10.1016/S0091-6749(87)80164-1. [DOI] [PubMed] [Google Scholar]
19.Lorenz W., Doenicke A., Dittmann I., Hug P., Schwarz B. Anaphylaktoide Reaktionen nach Applikation von Blutersatzmitteln beim Menschen. Verhinderung dieser Nebenwirkung von Haemaccel durch Praemedikation mit H1 und H2-Antagonisten. Anaesthesist. 1977;26:644. [PubMed] [Google Scholar]
20.Marone G., Patelle V., de Crescanzo A., Genovese M. Human heart mast cells in anaphylaxis and cardiovascular disease. Int Arch Allergy Immunol. 1995;107:72–75. doi: 10.1159/000236935. [DOI] [PubMed] [Google Scholar]
21.Maulitz R.M., Pratt D.S., Schocket A.L. Exercise-induced anaphylactic reaction to shellfish. J Allergy Clin Immunol. 1979;63:433. doi: 10.1016/0091-6749(79)90218-5. [DOI] [PubMed] [Google Scholar]
22.Meßmer K. Plasma substitutes and indications for their use. In: Tinker J., Rapin M., editors. Care of the critically ill patient. Berlin Heidelberg New York: Springer; 1983. pp. 569–575. [Google Scholar]
23.Müller U. Spätkomplikationen bei Anaphylaxie. In: Ring J., Darsow U., editors. Allergie 2000: Probleme, Strategien und praktische Kon-sequenzen. Munich: Dustri; 2001. pp. 249–252. [Google Scholar]
24.Pavek K., Wegmann A., Nordström L., Schwander D. Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Klin Wochenschr. 1982;60:941–947. doi: 10.1007/BF01716952. [DOI] [PubMed] [Google Scholar]
25.Przybilla B., Ring J. Anaphylaxis to ethanol and sensitization to acetic acid. Lancet. 1983;1:483. doi: 10.1016/S0140-6736(83)91487-3. [DOI] [PubMed] [Google Scholar]
26.Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144–1150. doi: 10.1046/j.1365-2222.2000.00864.x. [DOI] [PubMed] [Google Scholar]
27.Reimers A., Müller U. Behandlung des anaphylaktischen Schocks. Ther Umschau. 2000;58:325–328. doi: 10.1024/0040-5930.58.5.325. [DOI] [PubMed] [Google Scholar]
28.Richet C. De l’anaphylaxie ou sensibilite croissante des organismes a des doses successives de poison. Arch Fisiol. 1904;1:129. [Google Scholar]
29.Richter W., Hedin H., Ring J., Kraft D., Messmer K. Anaphylaktoide Reaktionen nach Dextran I. Immunologische Grundlagen und klinische Befunde. Allergologie. 1980;3:9. [Google Scholar]
30.Ring J., Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466–468. doi: 10.1016/S0140-6736(77)91953-5. [DOI] [PubMed] [Google Scholar]
31.Ring J. Anaphylaktoide Reaktionen nach Infusion naturlicher und künstlicher Kolloide. Berlin Heidelberg New York: Springer; 1978. [Google Scholar]
32.Ring J., Darsow U. Idiopathic anaphylaxis. Curr Allergy Asthma Rep. 2002;2:40–45. doi: 10.1007/s11882-002-0036-8. [DOI] [PubMed] [Google Scholar]
33.Ring J., Galosi A., Przybilla B. Contact anaphylaxis from emulgade F. Contact Dermatitis. 1986;15:49–40. doi: 10.1111/j.1600-0536.1986.tb01272.x. [DOI] [Google Scholar]
34.Ring J., Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol. 1999;17:387–399. doi: 10.1007/BF02737644. [DOI] [PubMed] [Google Scholar]
35.Rohrer C.L., Pichler W.J., Helbling A., et al. Anaphylaxie: Klinik, Ätiologie und Verlauf bei 118 Patienten. Schweiz Med Wochenschr. 1998;128:53–63. [PubMed] [Google Scholar]
36.Sheffer A.L., Austen K.F. Exercise-induced anaphylaxis. J Allergy Clin Immunol. 1980;66:106. doi: 10.1016/0091-6749(80)90056-1. [DOI] [PubMed] [Google Scholar]
37.Simons F.E., Gu X., Johnston L.M., Simons K.J. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics. 2000;106:1040–1044. doi: 10.1542/peds.106.5.1040. [DOI] [PubMed] [Google Scholar]
38.Smedegard G., Revenäs B., Arfors K.E. Anaphylaxis in the monkey: hemodynamics and blood flow distribution. Acta Physiol Scand. 1979;106:191. doi: 10.1111/j.1748-1716.1979.tb06389.x. [DOI] [PubMed] [Google Scholar]
39.Smith P.L., Kagey-Sobotka A., Blecker E.R., Traystman R., Kaplan A.P., Gralink H., Valentine M.D., Permut S., Lichtenstein L.M. Physiologic manifestations of human anaphylaxis. J Clin Invest. 1980;60:1072. doi: 10.1172/JCI109936. [DOI] [PMC free article] [PubMed] [Google Scholar]
40.Sullivan T.J. Cardiac disorders in penicillin-induced anaphylaxis: association with intravenous epinephrine therapy. J Am Med Assoc. 1982;248:2161. doi: 10.1001/jama.248.17.2161. [DOI] [PubMed] [Google Scholar]
41.Stark B.J., Sullivan T.J. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78:76–83. doi: 10.1016/0091-6749(86)90117-X. [DOI] [PubMed] [Google Scholar]
42.Tryba M., Ahnefeld F.W., Barth J., Dick W., Doenicke A., Fuchs T., Gervais H., Laubenthal H., Löllgen H., Lorenz W., Mehrkens H.H., Meuret G.H., Möllmann H., Piepenbrock S., Przybilla B., Ring J., Schmutzler W., Schultze-Werninghaus G., Schüttler J., Schuster J.P., Sefrin P., Zander J., Zenz M. Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Allergo J. 1994;3:211–222. doi: 10.1007/s001010050050. [DOI] [PubMed] [Google Scholar]
43.Waldhausen E., Keser G., Marquardt B. Der anaphylaktische Schock. Anästhesist. 1987;36:150–158. [PubMed] [Google Scholar]
44.Wegmann A., Reuker H., Pavek K., Schwander D. Katecholamintherapie und Herzrhyth-musstörungen im anaphylaktischen und anaphylaktoiden Schock. Anaesthesist. 1983;32([Suppl]):320. [Google Scholar]
45.Wiggins C.A., Dykowicz M.S., Patterson R. Idiopathic anaphylaxis. Classification, evaluation and treatment of 123 patients. J Allergy Clin Immunol. 1988;82:849–855. doi: 10.1016/0091-6749(88)90089-9. [DOI] [PubMed] [Google Scholar]
46.Zaloga G.P., Delacey W., Holmboe E., Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med. 1986;105:65–66. doi: 10.7326/0003-4819-105-1-65. [DOI] [PubMed] [Google Scholar]

References

1.Aas K. The diagnosis of hypersensitivity to ingested foods. Reliability of skin prick testing and the radioallergosorbent test with different materials. Clin Allergy. 1978;8:39–50. doi: 10.1111/j.1365-2222.1978.tb00446.x. [DOI] [PubMed] [Google Scholar]
2.Andrée C. L’allergie digestive, concept ou realité? Presse Med. 1984;27:1667–1669. [PubMed] [Google Scholar]
3.Bauer C.P., Grübl A. Hypoallergene Babynahrung. In: Behr-Völtzer C., Hamm M., Vieluf D., Ring J., editors. Diät bei Nahrungsmittelallergien und-intoleranzen. 2nd edn. Munich: Urban & Vogel; 2002. pp. 105–111. [Google Scholar]
4.Ballmer-Weber B.K., Wüthrich B. Die Nahrungsmittelallergie und ihre diätetische Behandlung. Aktuell Ernähr Med. 2001;26:196–201. doi: 10.1055/s-2001-17723. [DOI] [Google Scholar]
5.Behr-Völtzer C., Hamm M., Vieluf D., Ring J., editors. Diät bei Nahrungsmittelallergien und-intoleranzen. 2nd edn. Munich: Urban & Vogel; 2002. [Google Scholar]
6.Balmer-Weber B, Bengtsson U, et al. (2004) Standardization of food challenges in patients with immediate reactions to foods. Position paper EAACI. Allergy (in press) [DOI] [PubMed]
7.Bischoff S.C., Mayer J., Wedemeyer J., et al. Colonoscopic allergen provocation (CO-LAP): a new diagnostic approach for gastrointestinal food allergy. Gut. 1997;40:745–753. doi: 10.1136/gut.40.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Bock S.A., Sampson H.A., Atkins F.M., Zeiger R.S., et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol. 1988;82:986–997. doi: 10.1016/0091-6749(88)91021-4. [DOI] [PubMed] [Google Scholar]
9.Brostoff J., Challacombe S.J., editors. Food allergy and intolerance. London: Bailliere Tindall; 1987. [Google Scholar]
10.Bruijnzeel-Koomen C., Ortolani C., Aas K., et al. Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy. 1995;50:623–635. doi: 10.1111/j.1398-9995.1995.tb02579.x. [DOI] [PubMed] [Google Scholar]
11.Deutsche Gesellschaft für Ernährung, editor. Richtig essen. Berlin: F+G Rollendruck; 1995. [Google Scholar]
12.Diätverband — Bundesverband der Hersteller von Lebensmitteln für besondere Ernährungszwecke, editor. Product & Diät. Hemmingen: Presto; 1998. [Google Scholar]
13.Ebner C., Hirschwehr R., Bauer L., et al. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin) J Allergy Clin Immunol. 1995;95:962–969. doi: 10.1016/S0091-6749(95)70096-X. [DOI] [PubMed] [Google Scholar]
14.Egger J., Carter C.M., Wilson J., Turner M.W., Soot-hill J.F. Is migraine food allergy? A double blind controlled trial of oligoantigenic diet treatment. Lancet. 1983;2:865–869. doi: 10.1016/S0140-6736(83)90866-8. [DOI] [PubMed] [Google Scholar]
15.Ehlers I., Henz B., Zuberbier T. Diagnose und Therapie pseudo-allergischer Reaktionen der Haut durch Nahrungsmittel. Allergologie. 1996;19:270–276. [Google Scholar]
16.Eisenbrand G., Aulepp H., Dayan A.D., et al. Food allergies and intolerances. Weinheim: VCH Verlagsge-sellschaft; 1996. [Google Scholar]
17.Eisenmann A., Ring J., von der Helm D., Meurer M., Braun-Falco O. Vasculitis allergica durch Nahrungsmittelallergie. Hautarzt. 1988;39:318–321. [PubMed] [Google Scholar]
18.Ewan P.W., Clark A.T. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet. 2001;357:111–115. doi: 10.1016/S0140-6736(00)03543-1. [DOI] [PubMed] [Google Scholar]
19.Feingold B. Why your child is hyperactive. New York: Random; 1975. [Google Scholar]
20.Franck P., Moneret V. D., Dousset B., et al. The allergenicity of soybean-based products is modified by food technologies. Int Arch Allergy Immunol. 2002;128:212–219. doi: 10.1159/000064254. [DOI] [PubMed] [Google Scholar]
21.Häberle M. Klinische und lebensmittelchemische Aspekte bei Unverträglichkeits-Reaktionen auf Salicylat-und Additiva-haltige Lebens-mittel. Zbl Haut. 1987;153:75–95. [Google Scholar]
22.Henzgen M., Schlenvoigt G., Diener C., Jäger L. Nahrungsmittelallergie bei Frühblüher-pollinose und deren Beeinflussung mittels Hyposensibilisierung. Allergologie. 1991;14:90–9. [Google Scholar]
23.Hjorth N., Roed-Petersen J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis. 1976;2:28–42. doi: 10.1111/j.1600-0536.1976.tb02975.x. [DOI] [PubMed] [Google Scholar]
24.Holt P.G. Mucosal immunity in relation to the development of tolerance/sensitization. Allergy. 1998;53:6–19. doi: 10.1111/j.1398-9995.1998.tb04932.x. [DOI] [PubMed] [Google Scholar]
25.Host A. Importance of the first meal on the development of cow’s milk allergy and intolerance. Allergy Proc. 1991;12:27–32. doi: 10.2500/108854191778879287. [DOI] [PubMed] [Google Scholar]
26.Hourihane J.O., Kilburn A., Dean P., Warner J.O. Clinical characteristics of peanut allergy. Clin Exp Allergy. 1997;27:634–639. doi: 10.1111/j.1365-2222.1997.tb01190.x. [DOI] [PubMed] [Google Scholar]
27.Isolauri E. Probiotics in the prevention and treatment of allergic disease. Pediatr Allergy Immunol. 2001;12([Suppl 14]):56–59. doi: 10.1034/j.1399-3038.2001.121413.x. [DOI] [PubMed] [Google Scholar]
28.Jäger L., Wüthrich B. Nahrungsmittelallergien und-intoleranzen. Ulm: Gustaf Fischer; 1998. [Google Scholar]
29.Jarisch R., Pirker C., Möslinger T., Götz M. The role of histamine in wine intolerance. J Allergy Clin Immunol. 1997;89:197. [Google Scholar]
30.Jorde W. Orale Desensibilisierung. In: Fillipp G., editor. Allergologie. Munich: Banaschewski; 1980. p. 53. [Google Scholar]
31.Kanny G., Hatahet R., Moneret-Vautrin A., Kohler C., Bellut A. Allergy and intolerance to flavouring agents in atopic dermatitis in young children. Allerg Immunol. 1994;6:204–210. [PubMed] [Google Scholar]
32.Klaschka F. Hämatogenes Kontaktekzem durch Nahrungsmittel. Allergologie. 1987;10:93–96. [Google Scholar]
33.Kurek M., Janowska E. Allergische und pseudoallergische Reaktionen auf Aromastoffe in der Nahrung. Z Hautkrankheiten H+G. 2001;76:699–703. [Google Scholar]
34.Mempel M., Rakoski J., Ring J., Ollert M. Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol. 2003;111:1406–1409. doi: 10.1067/mai.2003.1497. [DOI] [PubMed] [Google Scholar]
35.Möller C. Effect of pollen immunotherapy on food hypersensitivity in children with birch pollinosis. Ann Allergy. 1989;62:343–345. [PubMed] [Google Scholar]
36.Montes R.G., Perman J.A. Lactose intolerance: pinpointing the source of nonspecific gastrointestinal symptoms. Postgrad Med. 1991;89:175–178. doi: 10.1080/00325481.1991.11700961. [DOI] [PubMed] [Google Scholar]
37.Niggemann B., Reibel S., Roehr C.C., et al. Predictors of positive food challenge outcome in non-IgE-mediated reactions to food in children with atopic dermatitis. J Allergy Clin Immunol. 2001;106:1053–1058. doi: 10.1067/mai.2001.120192. [DOI] [PubMed] [Google Scholar]
38.Nordlee J.A., Taylor S.L., Townsend J.A., Thomas L.A., Bush R.K. Identification of a Brazilnut allergen in transgenic soybeans. N Engl J Med. 1996;334:688–692. doi: 10.1056/NEJM199603143341103. [DOI] [PubMed] [Google Scholar]
39.Ortolani C., Ballmer-Weber B.K., Hansen K.S., et al. Hazelnut allergy: a double-blind, placebo-controlled food challenge multicenter study. J Allergy Clin Immunol. 2000;105:577–581. doi: 10.1067/mai.2000.103052. [DOI] [PubMed] [Google Scholar]
40.Pichler W.J., Stich O. Nahrungsmittelallergien bei Pollensensibilisierungen, part II: Kreuzreaktionen bei Beifußpollen-Sensibilisierungen. Allergologie. 1993;16:494–501. [Google Scholar]
41.Pratschke E. Mediatoren der immunologischen Stimulation gastraler Funktionen: Experimentelle Untersuchungen am Beispiel der Gastrinfreisetzung. München: Habilitationsschrift; 1986. [Google Scholar]
42.Przybilla B., Ring J. Food allergy and atopic eczema. Semin Dermatol. 1990;9:220–225. [PubMed] [Google Scholar]
43.Reimann H.J., Ring J., Ultsch B., Wendt P. Intragastral provocation under endoscopic control (IPEC) in food allergy. Clin Allergy. 1985;15:195–202. doi: 10.1111/j.1365-2222.1985.tb02273.x. [DOI] [PubMed] [Google Scholar]
44.Ring J. Nahrungsmittelallergie und andere Unverträglichkeitsreaktionen durch Nahrungsmittel. Klin Wochenschr. 1984;62:795–802. doi: 10.1007/BF01711852. [DOI] [PubMed] [Google Scholar]
45.Ring J. Nahrungsmittel-Allergie und Gentechnik. In: Steinhart H., Tanner W., editors. Bayerische Akademie der Wissenschaften. Rundgespräche der Kommission für Ökologie, vol 16. Lebensmittel und Gentechnik. Munich: Dr. Friedrich Pfeil; 1999. pp. 61–72. [Google Scholar]
46.Ring J. Gentechnologie und Lebensmittelallergie (DGAI-Stellungnahme) Allergo J. 1997;6:214. [Google Scholar]
47.Ring J., Braun-Falco O. Allergie-Diät Verfahren zur Diagnostik und Therapie von Nahrungsmittel-Allergien und-Pseudo-Allergien. Hautarzt. 1987;38:198–205. [PubMed] [Google Scholar]
48.Roe D.A. Nutrition and the skin. New York: Liss; 1986. [Google Scholar]
49.Sampson H.A. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 2001;107:891–896. doi: 10.1067/mai.2001.114708. [DOI] [PubMed] [Google Scholar]
50.Schäfer T., Bohler E., Ruhdorfer S., et al. Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy. 2001;56:1172–1179. doi: 10.1034/j.1398-9995.2001.00196.x. [DOI] [PubMed] [Google Scholar]
51.Schauder P., Ollenschläger G. Prävention und Therapie. 2nd edn. Munich: Urban & Fischer; 2002. Ernährungsmedizin. [Google Scholar]
52.Schindler H., Bräckle J., Karch B. Kochbuch für Allergiker. Munich: Ehrenwirth; 1981. [Google Scholar]
53.Seifert J., Ring J., Brendel W. Prolongation of skin allografts after oral application of antilymphocyte serum in rats. Nature. 1975;249:776. doi: 10.1038/249776a0. [DOI] [PubMed] [Google Scholar]
54.Stefanini G.F., Saggioro A., Alvisi V., et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535–541. doi: 10.3109/00365529509089786. [DOI] [PubMed] [Google Scholar]
55.Stevenson D.D., Simon R.A. Sensitivity to ingested metabisulphites in asthmatic subjects. J Allergy Clin Immunol. 1981;68:26–32. doi: 10.1016/0091-6749(81)90119-6. [DOI] [PubMed] [Google Scholar]
56.Strobel S., Hourihane J.O. Gastrointestinal allergy: clinical symptoms and immunological mechanisms. Pediatr Allergy Immunol. 2001;12([Suppl 14]):43–46. doi: 10.1034/j.1399-3038.2001.121410.x. [DOI] [PubMed] [Google Scholar]
57.Thiel C.L., Fuchs E. Berichtsband. Berlin: Grosse; 1981. Über korrelative Beziehungen bei Kräuterpollen-und Gewürzallergenen, RAST 3; pp. 178–185. [Google Scholar]
58.Turjanmaa K. Atopy patch test, an additional new tool in the diagnosis of food allergy. Acta Dermatovenerol Croat. 2001;9:69–71. [Google Scholar]
59.Vieths S., Meyer A.H., Ehlers I., et al. Zur Deklaration “versteckter Allergene” in Lebensmitteln. Allergo J. 2001;10:130–136. [Google Scholar]
60.Wagner G., Ring J. Anaphylaktische Reaktionen bei Nuß-und Mohnallergie. Notfallmedizin. 1981;7:361. [Google Scholar]
61.Wahn U., Seger R., Wahn V. Pädiatrische Allergologie und Immunologie. 3rd edn. Munich: Urban & Fischer; 1999. [Google Scholar]
62.Warin R.P., Smith R.J. Challenge test battery in chronic urticaria. Br J Dermatol. 1975;94:401–406. doi: 10.1111/j.1365-2133.1976.tb06117.x. [DOI] [PubMed] [Google Scholar]
63.De Weck A.L., Griot-Wenk M., Schneider H., et al. Human allergogeneticists should listen to their dog’s barking. In: Ring J., Behrendt H., et al., editors. New trends in allergy V. Berlin Heidelberg New York: Springer; 2002. pp. 27–36. [Google Scholar]
64.Werfel T. Allergenspezifische T-Zell-Antwort bei Ekzemkrankheiten. München-Deisenhofen: Dustri; 2000. [Google Scholar]
65.Werfel T., Wedi B., Kleine-Tebbe J., et al. Vorgehen bei Verdacht auf eine pseudoallergische Reaktion auf Nahrungsmittelinhaltsstoffe. Allergo J. 1999;8:135–341. [Google Scholar]
66.Werner M. Krankheiten infolge peroraler Allergeninvasion. In: Hansen K., Werner M., editors. Lehrbuch der klinischen Allergie. Stuttgart: Thieme; 1967. p. 179. [Google Scholar]
67.Wüthrich B. Nahrungsmittelallergien. Internist. 1986;27:362–371. [PubMed] [Google Scholar]
68.Wüthrich B., Ballmer-Weber B.K. Food-induced anaphylaxis. Allergy. 2001;56([Suppl 67]):102–104. doi: 10.1034/j.1398-9995.2001.00930.x. [DOI] [PubMed] [Google Scholar]
69.Wüthrich B. Lethal or life-threatening allergic reactions to food. J Invest Allergol Clin Immunol. 2000;10:59–65. [PubMed] [Google Scholar]
70.Wüthrich B. Nahrungsmittel und Allergie. München-Deisenhofe: Dustri; 2002. [Google Scholar]

References

1.Albrecht I., Eichler G., Müller U., Hoigné R. On the significance of severe local reactions to hymenoptera stings. Clin Allergy. 1980;10:675. doi: 10.1111/j.1365-2222.1980.tb02151.x. [DOI] [PubMed] [Google Scholar]
2.Barnard J.H. Studies of 400 hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259. doi: 10.1016/0091-6749(73)90044-4. [DOI] [PubMed] [Google Scholar]
3.Bauer C.P. Stichprovokationen zur Diagnostik von Insektengift-Allergien? Allergologie. 1986;9:14. [Google Scholar]
4.Benson R., Semenov H. Allergy in its relation to bee sting. J Allergy. 1930;1:105. doi: 10.1016/S0021-8707(30)90149-9. [DOI] [Google Scholar]
5.Benton A.W., Morse R.A., Stewart J.D. Venom collection from honey bees. Science. 1963;142:228. doi: 10.1126/science.142.3589.228. [DOI] [PubMed] [Google Scholar]
6.Brehler R. Ultra-Rush-Hyposensibilisierung. Allergologie. 1999;22([Suppl 2]):570–571. [Google Scholar]
7.Brockow K., Kiehn M., Riethmüller C., et al. Efficacy of antihistamine treatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1997;100:458–463. doi: 10.1016/S0091-6749(97)70135-0. [DOI] [PubMed] [Google Scholar]
8.De Bandt M., Atassi-Dumont M., Kahn M.F., et al. Serum sickness after wasp venom immunotherapy: clinical and biological study. J Rheumatol. 1997;24:1195–1197. [PubMed] [Google Scholar]
9.Forck G., Kästner H., Kalveram C. Insect venom tolerance: IgG-“blocking” antibodies and sting provocation. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. p. 269. [Google Scholar]
10.Fuchs E. Allergie. Münch Med Wochenschr. 1959;100:1711. [Google Scholar]
11.Golden D.B.K., Valentine M.D., Kagey-Sobotka A., Lichtenstein M.L. Prevalence of hymenoptera venom allergy. J Allergy Clin Immunol. 1982;69:124. doi: 10.1016/S0091-6749(62)80408-4. [DOI] [Google Scholar]
12.Habermann E. Bee and wasp venoms. Science. 1972;177:314. doi: 10.1126/science.177.4046.314. [DOI] [PubMed] [Google Scholar]
13.Hemmer W., Focke M., Jarisch R. In-vitro-Doppelpositivität gegen Bienen-und Wespengift. Allergologie. 1999;22([Suppl 2]):63–64. [Google Scholar]
14.Hunt K.J., Valentine M.D., Sobotka A.K., Benton A.W., Amodio F.J., Lichtenstein L.M. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299:157. doi: 10.1056/NEJM197807272990401. [DOI] [PubMed] [Google Scholar]
15.Jarisch R. Die Bienengiftallergie (Modell einer IgE-mediierten Soforttypallergie) Wien Klin Wochenschr. 1980;92([Suppl 122]):3. [PubMed] [Google Scholar]
16.Jeßberger B., Habig J., Karl S., et al. Hymenopterengiftallergie: Hyposensibilisierungstherapie trotz vorhandener Kontraindikationen. Allergologie. 1994;17:255–260. [Google Scholar]
17.Kämmerer H. Fragekasten. Münch Med Wochenschr. 1941;88:939. [Google Scholar]
18.Kiehn M., Ring J. Hyposensibilisierung mit Insektengiftextrakten bei Patienten mit Hymenopterengift-Allergie im höheren Lebensalter. Allergo J. 1993;2([Suppl 2]):90–94. [Google Scholar]
19.King T.P., Lu G., Gonzalez M., Qian N., Soldatova L. Yellow jacket venom allergens, hyaluronidase and phospholipase: Sequence similarity and antigenic cross-reactivity with their hornet and wasp homologues and possible implications for clinical allergy. J Allergy Clin Immunol. 1996;98:588–600. doi: 10.1016/S0091-6749(96)70093-3. [DOI] [PubMed] [Google Scholar]
20.Lerch E., Müller U.R. Long-term protection after stopping venom immunotherapy: results of restings in 200 patients. J Allergy Clin Immunol. 1998;101:606–612. doi: 10.1016/S0091-6749(98)70167-8. [DOI] [PubMed] [Google Scholar]
21.Lessof M., Sobotka A.K., Lichtenstein L.M. Protection against anaphylaxis in hymenopterasensitive patients by passive immunization. J Allergy Clin Immunol. 1976;57:246. [PubMed] [Google Scholar]
22.Lichtenstein L.M., Valentine M.D., Sobotka A.K. A case for venom treatment in anaphylactic sensitivity to hymenoptera sting. N Engl J Med. 1974;290:1223. doi: 10.1056/NEJM197405302902204. [DOI] [PubMed] [Google Scholar]
23.Light W.V., Reismann R.E., Rosario N.A., Arbesman C.E. Comparison of the allergenic properties of bee venom and whole bee body extract. Clin Allergy. 1976;6:293. doi: 10.1111/j.1365-2222.1976.tb01909.x. [DOI] [PubMed] [Google Scholar]
24.Lockey R.F. Systemic reactions to stinging ants. J Allergy Clin Immunol. 1975;54:132. doi: 10.1016/0091-6749(74)90050-5. [DOI] [PubMed] [Google Scholar]
25.Lonsdorf G., Ring J., Burg G. Anaphylaktische Reaktionen nach Insektenstichen. Notfall Medizin. 1981;7:409. [Google Scholar]
26.Lotter G. Sensibilisierung für Bienengift durch Typhus-Antitoxin und Desensibilisierung mit Forapin. Münch Med Wochenschr. 1939;86:330–33. [Google Scholar]
27.Loveless M.H., Fackler W.R. Wasp venom allergy and immunity. Ann Allergy. 1956;14:347. [PubMed] [Google Scholar]
28.Mauss V. Einfluß von Lebensweise, Populationsdynamik und Abwehrverhalten aculeater Hymenopteren auf das Stichrisiko für den Menschen. Allergologie. 1999;22:542–545. [Google Scholar]
29.Mauss V., Treiber R. Betreuungsschlüssel für die Faltenwespen (Hymenoptera: Masarinae, Polistinae, Vespinae) der Bundesrepublik Deutschland. Hambu: Deutscher Jugendbund für Naturbeobachtung; 1994. [Google Scholar]
30.Mueller H.L., Schmid W.H., Rubinstein R. Stinging-insect hypersensitivity. A 20-year old study of immunologic treatment. Pediatrics. 1975;55:530. [PubMed] [Google Scholar]
31.Müller U.R. Klinik, Diagnostik und Therapie. Stuttgart: G. Fischer; 1988. Insektenstichallergie. [Google Scholar]
32.Müller U. New development in the diagnosis and treatment of hymenoptera venom allergy. Int Arch Allergy Immunol. 2001;124:447–499. doi: 10.1159/000053779. [DOI] [PubMed] [Google Scholar]
33.Müller U., Mosbech H. Position paper: Immunotherapy with hymenoptera venoms. Allergy. 1993;48([Suppl 2]):37–46. doi: 10.1111/j.1398-9995.1993.tb04755.x. [DOI] [Google Scholar]
34.Mumcuoglu Y., Rufli T. Dermatologische Entomologie. 12. Apidael Bienen. 13. Vespidae Wespen. Schweiz Rundsch Med. 1980;69:1317. [Google Scholar]
35.O’Connor R., Peck M.L. Handbook of experimental pharmacology. Berlin Heidelberg New York: Springer; 1978. Venoms of Apidae; p. 613. [Google Scholar]
36.Ollert M., Ring J. Prognostische Bedeutung von Immunoblot-Untersuchungen bei Hymenopterengift-Allergie. Allergologie. 1999;22([Suppl 2]):578–579. [Google Scholar]
37.Parrish H.M. Analysis of 460 fatalities from venomous animals in the United States. Am J Med Sci. 1963;245:129. doi: 10.1097/00000441-196302000-00001. [DOI] [PubMed] [Google Scholar]
38.Przybilla B., Ring J., Galosi A., Geursen R.G., Stickl H.A. Bee-venom immunoglobulin for prophylaxis of anaphylactic reactions during bee venom immunotherapy (rush hyposensitization) Immunol Allergy Practice. 1986;8:107–111. [Google Scholar]
39.Przybilla B. Pathophysiologische und klinische Aspekte der allergischen Reaktion vom Soforttyp und der Immunglobulin-E-Immunantwort: Untersuchungen unter besonderer Berücksichtigung der Bienen-und Wespengiftallergie. Munich: Habilitationsschrift; 1986. [Google Scholar]
40.Przybilla B., Ring J., Grießhammer B., Braun-Falco O. Schnellhyposensibilisierung mit Hymenopterengiften-Verträglichkeit und Therapieerfolg. Dtsch Med Wochenschr. 1987;112:416. doi: 10.1055/s-2008-1068068. [DOI] [PubMed] [Google Scholar]
41.Przybilla B., Ring J., Rieger B. Die Indikation zur Hymenopterengift-Hyposensibilisierung kann nicht anhand eines diagnostischen Parameters bewertenden Punkteschemas gestellt werden. Allergologie. 1992;13:114–119. [Google Scholar]
42.Rakoski J., von Mayenburg J. Das Ultra-Rush-Verfahreneine-eine neue Methode zur Über-prüfung der Aktualität von Insektengiftallergien. Allergologie. 1986;9:73–74. [Google Scholar]
43.Ring J., Lonsdorf G., Schury W., Burg G. Bienen-und Wespengift-Allergie. Klinik Prophylaxe und Therapie. Münch Med Wochenschr. 1982;124:587. [PubMed] [Google Scholar]
44.Ring J., Gottsmann M., Przybilla B., Eisenmenger W. Tod nach 1000 Bienenstichen. Münch Med Wochenschr. 1986;128:339. [Google Scholar]
45.Ring J., Przybilla B., Müller U. Insektengiftallergie: Aktuelles für die Praxis. Allergo J. 1997;6([Suppl 1]):571–57. [Google Scholar]
46.Rueff F., Reißig J., Przybilla B. Nebenwirkungen der Schnellhyposensibilisierung mit Hymenopterengift. Allergo J. 1997;6([Suppl 1]):659–664. [Google Scholar]
47.Rueff F., Przybilla B., Fuchs T., Gall H., Rakoski J., Stolz W., Vieluf D. Diagnose und Therapie der Bienen-und Wespengiftallergie. Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) Allergo J. 2000;9:458–472. [Google Scholar]
48.Rzany B., Przybilla B., Jarisch R., et al. Clinical characteristics of immunotherapy with Hymenoptera venoms. A retrospective study. Allergy. 1991;46:251–254. doi: 10.1111/j.1398-9995.1991.tb00582.x. [DOI] [PubMed] [Google Scholar]
49.Schäfer T., Przybilla B. IgE antibodies to hymenoptera venoms in the serum are common in the general population and are related to indications of atopy. Allergy. 1996;51:372–377. [PubMed] [Google Scholar]
50.Schumacher M.J., Tveten M.S., Egen N.B. Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol. 1994;93:831–835. doi: 10.1016/0091-6749(94)90373-5. [DOI] [PubMed] [Google Scholar]
51.Schuberth K.C., Golden D.B.K., Kagey-Sobotka A., Valentine M., Lichtenstein L.M. Evaluation and treatment of insect sting allergy. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. p. 260. [Google Scholar]
52.Settipane G.A., Newstead G.J., Boyd G.K. Frequency of hymenoptera allergy in an atopic and normal population. J Allergy Clin Immunol. 1972;50:176. doi: 10.1016/0091-6749(72)90045-0. [DOI] [PubMed] [Google Scholar]
53.Stibich A.S., Carbonaro P.A., Schwartz R.A. Insect bite reactions: an update. Dermatology. 2001;202:193–197. doi: 10.1159/000051635. [DOI] [PubMed] [Google Scholar]
54.Tokura Y. Lymphocyte populations associated with exaggerated insect bite reactions. J Am Acad Dermatol. 1994;31:298. doi: 10.1016/S0190-9622(08)81992-5. [DOI] [PubMed] [Google Scholar]
55.Tunget C.L., Clark R.F. Invasion of the “killer” bees. Separating fact from fiction. Postgrad Med. 1993;94:92–102. [PubMed] [Google Scholar]
56.Urbanek R. Neue Konzepte der Behandlung von Insektengiftallergien. Derm Beruf Umwelt. 1979;27:44. [PubMed] [Google Scholar]
57.Van der Zwan J.C., Flintermann J., Jankowski I.G., et al. Hyposensitisation to wasp venom in six hours. Br Med J. 1983;287:1329–1331. doi: 10.1136/bmj.287.6402.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Weed R.I. Exaggerated delayed hypersensitivity to mosquito bite in chronic lymphocyte leukemia. Blood. 1965;26:257–268. [PubMed] [Google Scholar]

References

1.Abelson M.B., Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol. 1993;38:115–132. doi: 10.1016/0039-6257(93)90036-7. [DOI] [PubMed] [Google Scholar]
2.Allansmith M.R. The eye and immunology. St. Louis: Mosby; 1982. [Google Scholar]
3.Allansmith M.R., Ross R.N. Ocular allergy and mast cell stabilizers. Surv Ophthalmol. 1986;30:229–244. doi: 10.1016/0039-6257(86)90119-0. [DOI] [PubMed] [Google Scholar]
4.Anderson D.F. The conjunctival late-phase reaction and allergen provocation in the eye. Clin Exp Allergy. 1996;26:1105–1107. doi: 10.1111/j.1365-2222.1996.tb00494.x. [DOI] [PubMed] [Google Scholar]
5.Bialasiewicz A.A. Augenheilkunde. In: Heppt W., Renz H., Röcken M., editors. Allergologie. Berlin Heidelberg New York: Springer; 1998. pp. 262–271. [Google Scholar]
6.Bielory L. Allergic and immunologic disorders of the eye, part II: ocular allergy. J Allergy Clin Immunol. 2000;106:1019–1032. doi: 10.1067/mai.2000.111029. [DOI] [PubMed] [Google Scholar]
7.Bonini S., Bucci M.G., et al. Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol. 1990;86/(6):869–876. doi: 10.1016/S0091-6749(05)80148-4. [DOI] [PubMed] [Google Scholar]
8.Bonini S., Bonini S., Lambiase A., et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology. 2000;107:1157–1163. doi: 10.1016/S0161-6420(00)00092-0. [DOI] [PubMed] [Google Scholar]
9.Foster C.S., Rice B.A., Dutt J.E. Immunopathology of atopic keratoconjuncitivitis. Ophthalmology. 1991;98:1190–1196. doi: 10.1016/s0161-6420(91)32154-7. [DOI] [PubMed] [Google Scholar]
10.Friedlaender M.H. Contact allergy and toxicity in the eye. Int Ophthalmol Clin. 1988;28/(4):317–320. doi: 10.1097/00004397-198802840-00012. [DOI] [PubMed] [Google Scholar]
11.Friedlaender M.H. Allergy and immunology of the eye. New York: Raven; 1993. [Google Scholar]
12.Fuchs E. Über sympathisierende Entzündung. Albrecht v. Graefes Arch Ophthal. 1905;61:365. doi: 10.1007/BF01969717. [DOI] [Google Scholar]
13.Hatinen A., Terasvirta M., Fakj J.E. Contact allergy to components in topical ophthalmologic preparations. Acta Ophthalmol. 1985;63:424–426. doi: 10.1111/j.1755-3768.1985.tb01557.x. [DOI] [PubMed] [Google Scholar]
14.Jay J.L. Clinical factors and diagnosis of atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthal. 1981;60:335–340. doi: 10.1136/bjo.65.5.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.McGill J. Conjunctival cytokines in ocular allergy. Clin Exp Allergy. 2000;30:1355–1357. doi: 10.1046/j.1365-2222.2000.00974.x. [DOI] [PubMed] [Google Scholar]
16.Montan P.G., Biberfeld P.J., Scheynius A. IgE, IgE receptors and other immunocytochemical markers in atopic and nonatopic patients with vernal keratoconjunctivitis. Ophthalmology. 1995;102:725–732. doi: 10.1016/s0161-6420(95)30962-1. [DOI] [PubMed] [Google Scholar]
17.Neuhann T. Papillomatös-hyperplastische Konjunktivitis durch Kontaktlinsen. Mbl Augenheilkunde. 1983;8:46–50. doi: 10.1055/s-2008-1054706. [DOI] [PubMed] [Google Scholar]
18.Ring I., Dechant W., Seifert J., Lund O.-E., Grette J.-H., Stefani F.H., Brendel W. Immunosuppression with antilymphocyte globulin (ALG) in the treatment of ophthalmic disorders. Ophthal Res. 1978;10:82–97. doi: 10.1159/000264940. [DOI] [Google Scholar]
19.Silverstein A.M., O’Connor G.R., editors. Immunology and immunopathology of the eye. New York: Masson; 1979. [Google Scholar]
20.Solomon A., Pe’er J., Levi-Schaffer F. Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies. Curr Opin Allergy Clin Immunol. 2001;1:477–482. doi: 10.1097/01.all.0000011063.28808.cc. [DOI] [PubMed] [Google Scholar]
21.Theodore F.H., Schlossmann A. Ocular allergy. Baltimore: Williams & Wilkins; 1958. [Google Scholar]
22.Trocme S.D., Aldave A.J. The eye and the eosinophil. Surv Ophthalmol. 1994;39:241–252. doi: 10.1016/0039-6257(94)90197-X. [DOI] [PubMed] [Google Scholar]

References

1.Ackroyd J.F. Sedormid purpura: An immunological study of drug hypersensitivity. Progr Allergy. 1952;3:531. [Google Scholar]
2.Aster R.H. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med. 1995;332:1374–1376. doi: 10.1056/NEJM199505183322011. [DOI] [PubMed] [Google Scholar]
3.Belongia E.A., Hedberg C.W., Gleich G.J. An investigation into the cause of the eosinophilia myalgia syndrome associated with tryptophan use. N Engl J Med. 1990;323:357–365. doi: 10.1056/NEJM199008093230601. [DOI] [PubMed] [Google Scholar]
4.Berg P.A., Becker E.W. The lymphocyte transformation test-a debated method for the evaluation of drug allergic hepatic injury. J Hepatol. 1995;22:115–118. doi: 10.1016/0168-8278(95)80270-3. [DOI] [PubMed] [Google Scholar]
5.Brendel W., Ring J. Transplantationsimmunologie. In: Filipp G., editor. Allergologie. Munich: Banaschewski; 1980. p. 436. [Google Scholar]
6.Dukes M.N.G. Drug-induced hepatic injury. Amsterdam: Elsevier; 1998. [Google Scholar]
7.Greinacher A., Potzsch B., Amiral J., Dummel V., Eichner A., Mueller-Eckhardt C. Heparin in associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994;71:247–251. [PubMed] [Google Scholar]
8.Jäger L., Merk H.F. Arzneimittel-Allergie. Jena: Gustav Fischer; 1996. [Google Scholar]
9.Kelton J.G., Huang A.T., Mold N. The use of in vitro techniques to study drug-induced pancytopenia. N Engl J Med. 1979;301:621. doi: 10.1056/NEJM197909203011201. [DOI] [PubMed] [Google Scholar]
10.Landsteiner K. Wien Klin Wochenschr. 1901;14:1132. [PubMed] [Google Scholar]
11.Manns M. Autoantibodies and antigens in liver diseases-updated. J Hepatol. 1989;9:272–280. doi: 10.1016/0168-8278(89)90063-9. [DOI] [PubMed] [Google Scholar]
12.Maria V.A.J., Pinto L., Victorino R.M.M. Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol. 1994;21:151–158. doi: 10.1016/S0168-8278(05)80388-5. [DOI] [PubMed] [Google Scholar]
13.Mueller-Eckhardt C. Ex vivo drug antigens. Are drug-induced immunoreactions such as immunohemolytic anemia related to genetic control? In: Estabrook R.W., Lindenlaub E., Oesch F., de Weck A.L., editors. Toxicological and immunological aspects of drug metabolism and environmental chemicals. Stuttgart: Schattauer; 1988. pp. 329–342. [Google Scholar]
14.Mueller-Eckhart C., Kuenzlen E., Thilo-Korner D., Pralle H. High-dose intravenous immunoglobulin for post transfusion purpura. N Engl J Med. 1983;308:287. doi: 10.1056/NEJM198302033080526. [DOI] [PubMed] [Google Scholar]
15.Mueller-Eckhardt C., Salama A. Immunhämolytische Anämien durch Medikamente. Dtsch Ärztebl. 1987;84:232–234. [Google Scholar]
16.Neftel K.A., Wälti M., Spengler H., von Felten A., Weitzmann S.A., Bürgi H., de Weck A.L. Neutropenia after penicillins: toxic or immune-mediated? Klin Wochenschr. 1981;59:877. doi: 10.1007/BF01721921. [DOI] [PubMed] [Google Scholar]
17.Pessayre D. Mecanisme de hepatites medi-camenteuses Gastroenterol. Clin Biol. 1995;19:47–56. [PubMed] [Google Scholar]
18.Pihusch R. Die Heparin-induzierte Thrombozytopenie. Phlebologie. 1998;27:111–116. [Google Scholar]
19.Plötz G, et al. Hypereosinophilie-Syndrom. Hautarzt
20.Raif W., Schubothe H. Durch körperfremde Substanzen induzierte immunhämatologische Erkrankungen. Allergologie. 1979;2:192. [Google Scholar]
21.Raskob G.E., George J.N. Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice. Ann Intern Med. 1997;127:839–841. doi: 10.7326/0003-4819-127-9-199711010-00012. [DOI] [PubMed] [Google Scholar]
22.Salama A., Mueller-Eckhardt C. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med. 1985;313:469–474. doi: 10.1056/NEJM198508223130803. [DOI] [PubMed] [Google Scholar]
23.Salama A., Mueller-Eckhardt C. Humanemediated blood cell dyscrasias related to drugs. Semin Hematol. 1992;29:54–63. [PubMed] [Google Scholar]
24.Schiele F., Vuillemenot A., Kramarz P., Kieffer Y., Anguenot T., Bernard Y., Bassand J.P. Use of recombinant hirudin as antithrombotic treatment in patients with heparin induced thrombocytopenia. Ann J Hematol. 1995;50:20–25. doi: 10.1002/ajh.2830500105. [DOI] [PubMed] [Google Scholar]
25.Shulman N.R., Aster R.H., Leitner A., Hiller M.C. Immunoreactions involving platelets. V. Posttransfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. J Clin Invest. 1961;40:1597. doi: 10.1172/JCI104383. [DOI] [PMC free article] [PubMed] [Google Scholar]
26.Shulman N.R. Immunologic reactions to drugs. N Engl J Med. 1972;286:508–512. doi: 10.1056/NEJM197208242870810. [DOI] [PubMed] [Google Scholar]
27.Varga J., Uitto J., Jimenez S.A. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Int Med. 1992;116:140–147. doi: 10.7326/0003-4819-116-2-140. [DOI] [PubMed] [Google Scholar]
28.Wanamaker W.M., Wanamaker S.J., Celesia G.G., et al. Thrombocytopenia associated with long-term levodopa therapy. J Am Med Assoc. 1976;235:2217. doi: 10.1001/jama.235.20.2217. [DOI] [PubMed] [Google Scholar]
29.Zweiman B., Patten E. Immunohematologic diseases. J Am Med Assoc. 1982;248:2677–2682. doi: 10.1001/jama.248.20.2677. [DOI] [PubMed] [Google Scholar]

References

1.Becker E.L., Austen K.F. Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homcytotropic antibody-mediated histamine release and the first component of rat complement. J Exp Med. 1966;124:379–395. doi: 10.1084/jem.124.3.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Brostoff J., Challacombe S.J., editors. Food allergy and intolerance. London: Tindall; 1987. [Google Scholar]
3.Bruckbauer H.R., Ollert M., Ring J. Vaskulitiden der Haut. Bay Int. 1997;17:166–179. [Google Scholar]
4.Burden A.D., Tillman D.M., Foley P., Holme E. IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol. 1996;35:411–415. doi: 10.1016/S0190-9622(96)90606-4. [DOI] [PubMed] [Google Scholar]
5.Cochrane C.G., Koftler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16:185. doi: 10.1016/S0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]
6.Dixon F.J., Vasquez J.J., Weigle W.O., Cochrane C.G. Pathogenesis of serum sickness. Arch Pathol. 1958;65:18. [PubMed] [Google Scholar]
7.Eisenmann A., Ring J., von der Helm D., Meurer M., Braun-Falco O. Vasculitis allergica durch Nahrungsmittelallergie. Hautarzt. 1988;39:318–321. [PubMed] [Google Scholar]
8.Fauci A.S. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979;301:235. doi: 10.1056/NEJM197908023010503. [DOI] [PubMed] [Google Scholar]
9.Gross W.L., Schmitt W.H., Lotti T. ANCA-assoziierte Vaskulitiden. Hautarzt. 1995;46:511–524. doi: 10.1007/s001050050292. [DOI] [PubMed] [Google Scholar]
10.Hunt H.J., Valentine M.D., Sobotha A.K., Junginger J.W., Lichtenstein L.M. Serum sickness associated with nonvenom protein in mixed hymenoptera whole body extract. J Allergy Clin Immunol. 1976;57:246–254. [Google Scholar]
11.Jenette C.J., Milling D.M., Falk R.J. Vasculitis affecting the skin. Arch Dermatol. 1994;130:899–906. doi: 10.1001/archderm.130.7.899. [DOI] [PubMed] [Google Scholar]
12.Kohler P.F. Immune complexes and allergic disease. In: Middleton E., Ellis E.F., Reed C.E., editors. Allergy, principles and practice. 2nd edn. St. Louis: Mosby; 1983. pp. 167–199. [Google Scholar]
13.Meurer M. Urticarial vasculitis. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 148–151. [Google Scholar]
14.Morgan A.C., Jr, Rossen R., Twomey J.J. Naturally occurring circulating immune complexes: normal serum contains idiotype-anti-idotype complexes dissociable by certain IgG antiglobulins. J Immunol. 1979;122:1672. [PubMed] [Google Scholar]
15.Ollert, deleted in production
16.v Pirquet C., Schick B. Die Serumkrankheit. Leipzig: Deutike; 1905. [Google Scholar]
17.Ravetch J.V. Fc receptors: Rubor redux. Cell. 1994;78:533–560. doi: 10.1016/0092-8674(94)90521-5. [DOI] [PubMed] [Google Scholar]
18.Ring J., Seifert J., Lob G., Coulin K., Angstwurm H., Frick E., Brass B., Mertin I., Backmund H., Brendel W. Intensive immunosuppression in the treatment of multiple sclerosis. Lancet. 1974;II:1093. doi: 10.1016/S0140-6736(74)90866-6. [DOI] [PubMed] [Google Scholar]
19.Ring J., Seifert J., Seiler F., Brendel W. Improved compatibility of ALG therapy by application of aggregate free globulin. Int Arch Allergy Appl Immunol. 1976;52:227–234. doi: 10.1159/000231686. [DOI] [PubMed] [Google Scholar]
20.Ring J. Anaphylaktoide Reaktionen nach Infusion natürlicher und künstlicher Kolloide. Berlin Heidelberg New Yor: Springer; 1978. [Google Scholar]
21.Ruzicka T., Burg G. Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeico-satetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol. 1987;88:120–123. doi: 10.1111/1523-1747.ep12525265. [DOI] [PubMed] [Google Scholar]
22.Sais G., Vidaller A., Jucgla A., Gallardo F., Peyri J. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol. 1995;131:1399–1402. doi: 10.1001/archderm.131.12.1399. [DOI] [PubMed] [Google Scholar]
23.Scherer R., Wolff H.H. Vasculitis allergica. Allergologie. 1979;2:62. [Google Scholar]
24.Sedlacek H.H. Pathophysiological aspects of immune complex diseases. Klin Wochenschr. 1980;58:543–593. doi: 10.1007/BF01477164. [DOI] [PubMed] [Google Scholar]
25.Seifert J., Land W., Ring J., Lob G., Brendel W. Antigen-Eliminationstechnik. Fortschr Med. 1978;96:695–697. [PubMed] [Google Scholar]
26.Smedegard G., Revenas B., Arfors K.E. Anaphylaxis in the monkey: hemodynamics and blood flow distribution. Acta Physiol Scand. 1979;106:191–198. doi: 10.1111/j.1748-1716.1979.tb06389.x. [DOI] [PubMed] [Google Scholar]
27.Soter N.A., Austen K.F., Gigli I. Urticaria and arthralgias as manifestations of necrotizing angiitis (vasculitis) J Invest Dermatol. 1974;63:485–490. doi: 10.1111/1523-1747.ep12680443. [DOI] [PubMed] [Google Scholar]
28.Sylvestre D.L., Ravetch J.V. Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science. 1994;265:1095–1098. doi: 10.1126/science.8066448. [DOI] [PubMed] [Google Scholar]
29.Theissen U., Luger T.A., Schwarz T. Erfolgreiche topische Anwendung von Cyclosporin A bei Pyoderma gangraenosum. Hautarzt. 1996;47:132–135. doi: 10.1007/s001050050390. [DOI] [PubMed] [Google Scholar]
30.Theofilopoulos A.N., Dixon F.J. Detection of immune complexes; techniques and implications. Hosp Pract. 1980;15:107. doi: 10.1080/21548331.1980.11946602. [DOI] [PubMed] [Google Scholar]
31.van Furth R., Cohn Z.A., Hirsch J.G., et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull Wld Hlth Org. 1972;46:845. [PMC free article] [PubMed] [Google Scholar]
32.Wolff H.H., Scherer R. Allergic vasculitis. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 140–147. [Google Scholar]
33.Zhang Y., Ramos B.F., Jakschik B.A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science. 1992;258:1957–1959. doi: 10.1126/science.1470922. [DOI] [PubMed] [Google Scholar]

References

1.Allen D.H., Basten A., Woolcock A.J. Studies of cell and humoral immunity in birdbreeders hypersensitivity pneumonitis. Am Rev Resp Dis. 1977;115:45. [Google Scholar]
2.Bäck O., Lindgren R., Wiman L.G. Nitrofurantoin induced pulmonary fibrosis and lupus syndrome. Lancet. 1974;I:930. doi: 10.1016/S0140-6736(74)90379-1. [DOI] [PubMed] [Google Scholar]
3.Bergmann K.C., Costabel U., Knape H., Kroidl R., Müller-Wening D., Repp H., Rust M., Schwarz H., Sennekamp J. Empfehlungen zur Diagno-sestellung einer exogen-allergischen Alveolitis. Allergologie. 1990;13:111. [Google Scholar]
4.Boyd G., McSharry C., McLeod K., Sriram S., Boyd F. Lymphocyte responses in pigeon breeders with extrinsic allergic alveolitis/hypersensitivity pneumonitis (EAA/HP) are predominantly T helper 2-type. Am J Resp Crit Care Med. 1999;159:A742. [Google Scholar]
5.Doerr W. Pneumokoniose durch Getreidestaub. Virchows Arch Pathol Anat. 1953;324:263. doi: 10.1007/BF00954507. [DOI] [PubMed] [Google Scholar]
6.Fink J.N. Hypersensitivity pneumonitis. Clinics in chest Medicine. 1992;13:303. [PubMed] [Google Scholar]
7.Fruhmann G. Pneumokoniosen durch organisches Material. Deutsches Ärzteblatt. 1988;85:3170. [Google Scholar]
8.Fuchs A., Liebetrau G. Die Vogelhalterlunge — eine Form der exogen allergischen Alveolitis. Z Klein Med. 1989;44:1407. [Google Scholar]
9.Heiner D.C., Snears J.W., Kniker W.T. Multiple precipitins to cow’s milk in chronic respiratory disease. Am J Dis Child. 1962;103:634. [PubMed] [Google Scholar]
10.Hinojosa M. Stipatosis or hypersensitivity pneumonitis caused by esparto (Stipa tenacissima) fibers. J Invest Allergol Clin Immunol. 2001;11:67–72. [PubMed] [Google Scholar]
11.Jelke G. Krank durch Fortschritt. Expositionelle Besonderheiten bei der exogen-allergischen Alveolitis. Allergologie. 1986;9:137. [Google Scholar]
12.Kroidl R.F., Nowak D., Seysen U. Exogen-allergische Alveolitis: Probleme und Fehler bei der Begutachtung. Allergologie. 1994;17:75. [Google Scholar]
13.Malmberg P., Rask-Andersen A. Organic dust toxic syndrome. Semin Resp Med. 1993;14:38. doi: 10.1055/s-2007-1006307. [DOI] [Google Scholar]
14.Marinkovich V.A. Hypersensitivity alveolitis. J Am Med Assoc. 1975;231:944. doi: 10.1001/jama.231.9.944. [DOI] [PubMed] [Google Scholar]
15.McCarthy D.S., Pepys J. Allergic bronchopulmonary aspergillosis. Clinical immunology: 1. Clinical features, 2. Skin, nasal and bronchial tests. Clin Allergy. 1971;1:261. doi: 10.1111/j.1365-2222.1971.tb00779.x. [DOI] [PubMed] [Google Scholar]
16.McSharry C., Banham S.W., Boyd G. Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy. 1985;15:487. doi: 10.1111/j.1365-2222.1985.tb02299.x. [DOI] [PubMed] [Google Scholar]
17.Molina C. Immunopathologie bronchopulmonaire. Paris: Masson; 1984. [Google Scholar]
18.Müller-Wening D., Repp H. Investigation on the protective value of breathing masks in farmer’s lung using an inhalation provocation test. Chest. 1989;95:100. doi: 10.1378/chest.95.1.100. [DOI] [PubMed] [Google Scholar]
19.Murray M.J., et al. Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin. N Engl J Med. 1965;273:1185. doi: 10.1056/NEJM196511252732204. [DOI] [PubMed] [Google Scholar]
20.Newman-Taylor A, Pickering CAC, Turner-Warwick M, Pepys J (1978) Respiratory allergy to a factor humidifier contaminant presenting as pyrexia of undetermined origin. Br Med J:II [DOI] [PMC free article] [PubMed]
21.Olenchock S.A., May J.J., Pratt D.S., et al. Presence of endotoxin in different agricultural environments. Am J Industr Med. 1990;18:279. doi: 10.1002/ajim.4700180307. [DOI] [PubMed] [Google Scholar]
22.Parkers W.R. Occupational lung disorders. London: Butterworth; 1994. [Google Scholar]
23.Patterson R. Studies of hypersensitivity lung disease with emphasis on a solid-phase radioimmunoassay as a potential diagnostic acid. J Allergy Clin Immunol. 1978;61:216. doi: 10.1016/0091-6749(78)90184-7. [DOI] [PubMed] [Google Scholar]
24.Pepys J. Farmer lung’s — a needle in a haystack, and Pandora’s box. Allergy Clin Immunol News. 1994;6:68. [Google Scholar]
25.Pepys I., Jenkins P., Festenstein G., Gregory P., Lacey M., Skinner F. Farmer’s lung. Thermophilic actinomycetes as a source of “farmer’s lung hay” antigen. Lancet. 1963;II:607. doi: 10.1016/S0140-6736(63)90398-2. [DOI] [PubMed] [Google Scholar]
26.Raulf M., Liebers V., Steppert C., Baur X. Increased gamma/delta positive T-cells in pneumonitis. Eur Respir J. 1994;7:140. doi: 10.1183/09031936.94.07010140. [DOI] [PubMed] [Google Scholar]
27.Rylander R., Malmberg P. Non-infectious fever: inhalation fever or toxic alveolitis? Br J Industr Med. 1992;49:296. doi: 10.1136/oem.49.4.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Salvaggio J.E., Buechner H.A., Seabury H. Bagassosis I. Precipitins against extracts of crude bagasse in the serum of patients with bagassosis. Ann Intern Med. 1966;64:748. doi: 10.7326/0003-4819-64-4-748. [DOI] [PubMed] [Google Scholar]
29.Sastre J., Ibanez M.D., Lopez M., Lehrer S.B. Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin Exp Allergy. 1990;20:13. doi: 10.1111/j.1365-2222.1990.tb02769.x. [DOI] [PubMed] [Google Scholar]
30.Schatz M., Patterson R. Immunopathogenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol. 1977;60:27. doi: 10.1016/0091-6749(77)90079-3. [DOI] [PubMed] [Google Scholar]
31.Schulz K.H., Felten G., Hausen B.M., Noster U. Allergy to spores of Pleurotus Florida. Lancet. 1974;I:625. doi: 10.1016/S0140-6736(74)92682-8. [DOI] [PubMed] [Google Scholar]
32.Schultze-Werninghaus G., Rust M. Asthma bronchiale und allergische Alveolitis durch Berufsallergene. Allergologie. 1988;II:437. [Google Scholar]
33.Seeliger H.P.R., Sühler H. Farmerlunge beim Tier. Berl Münch Tierärztl Wochenschr. 1975;88:163. [PubMed] [Google Scholar]
34.Sennekamp H.-J. Exogen allergische Alveolitis. Munich: Dustri; 1998. [Google Scholar]
35.Slavin R.G., Million L., Cherry J. Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment. J Allergy Clin Immunol. 1970;46:150. doi: 10.1016/0021-8707(70)90093-6. [DOI] [PubMed] [Google Scholar]
36.van Hage-Hamsten M., Johansson S.G.O., Höglund S., Tüll P., Wirén A., Zetterström O. Storage mite allergy is common in a farming population. Clin Allergy. 1985;15:555–564. doi: 10.1111/j.1365-2222.1985.tb02309.x. [DOI] [PubMed] [Google Scholar]
37.Vogelmeier C., Krombach F., Münzing S., et al. Activation of blood neutrophils in acute episodes of farmer’ lung. Am Rev Resp Dis. 1993;148:396. doi: 10.1164/ajrccm/148.2.396. [DOI] [PubMed] [Google Scholar]
38.von Essen S., Robbins R.A., Thompson A.B. Organic dust toxic syndrome. Clin Toxicol. 1990;28:389. doi: 10.3109/15563659009038584. [DOI] [PubMed] [Google Scholar]
39.Warren C.P.W. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax. 1977;32:567–569. doi: 10.1136/thx.32.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
40.de Weck A.L., Gutersohn J., Bütikofer E. La maladie des laveurs de fromage (“Käsewascher-krankheit”): une forme particulière du syndrome du poumon de fermier. Schweiz Med Wochenschr. 1969;99:872. [PubMed] [Google Scholar]
41.Westphal O., Lüderitz O. Bacterial endotoxins. J Med Pharma Chem. 1961;4:497. doi: 10.1021/jm50019a008. [DOI] [PubMed] [Google Scholar]
42.Wild L.G., Lopez M. Hypersensitivity pneumonitis: A comprehensive review. J Invest Allergol Clin Immunol. 2001;11:3–15. [PubMed] [Google Scholar]

References

1.Ackermann A.B., Ragaz A. A plea to expunge the word eczema from the lexicon of dermatology and dermatopathology. Am J Dermatopathol. 1982;4:315–326. doi: 10.1007/BF00509073. [DOI] [PubMed] [Google Scholar]
2.von Amida A. Tetrabiblos. Basel: Froben; 1549. p. 730. [Google Scholar]
3.Akdis M., Klunker S., Schliz M., Blaser K., Akdis C.A. Expression cutaneous lymphocyte-associated antigen on human CD4+ and DC8+ Th2 cells. Eur J Immunol. 2000;30:3533–3541. doi: 10.1002/1521-4141(2000012)30:12<3533::AID-IMMU3533>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
4.Bandmann H.J., Dohn W. Die Epicutantestung. 2nd edn. Munich: Bergmann; 1967. [Google Scholar]
5.Benezra C. Molecular recognition in allergic contact dermatitis. In: Ring J., Burg G., editors. New trends in allergy II. Berlin Heidelberg New York: Springer; 1986. pp. 218–224. [Google Scholar]
6.Bergstresser P.R., Tigelaar R.E., Dees J.H., Streilein J.W. Thy-1 antigen-bearing dendritic cells populate murine epidermis. J Invest Dermatol. 1983;81:286. doi: 10.1111/1523-1747.ep12518332. [DOI] [PubMed] [Google Scholar]
7.Bloch I. Der älteste Gebrauch des Wortes “Eczema”. Mh Prakt Dermatol. 1911;53:69–71. [Google Scholar]
8.Borelli S. Gewerbedermatosen, einschließlich Begutachtung. In: Korting G.W., editor. Dermatologie in Praxis und Klinik. Stuttgart: Thieme; 1980. [Google Scholar]
9.Braathen L.R., Thorsby E. Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T cell-responses. Br J Dermatol. 1983;108:139–146. doi: 10.1111/j.1365-2133.1983.tb00055.x. [DOI] [PubMed] [Google Scholar]
10.Brasch J., Geier J., Schnuch A. Differenzierte Kontaktallergenlisten dienen der Qualitätsverbesserung. Hautarzt. 1998;49:184–191. doi: 10.1007/s001050050725. [DOI] [PubMed] [Google Scholar]
11.Burg G., Przybilla B., Bogner J. Contact — allergy time. In: Ring J., Burg G., editors. New trends in allergy II. Berlin Heidelberg New York: Springer; 1986. pp. 230–239. [Google Scholar]
12.Bruynzeel DP (1983) Angry back or excited skin syndrome. Thesis, Amsterdam
13.Cavani A., Albanesi C., Traidl C., Sebastiani S., Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol. 2001;22:118–120. doi: 10.1016/S1471-4906(00)01815-9. [DOI] [PubMed] [Google Scholar]
14.Chase M.W. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med. 1946;61:257–259. doi: 10.3181/00379727-61-15294p. [DOI] [PubMed] [Google Scholar]
15.Cronin E. Contact dermatitis. Edinburgh: Churchill Livingstone; 1980. [Google Scholar]
16.De Groot A.C. Patch testing. Amsterdam: Elsevier; 1994. [Google Scholar]
17.Diepgen T.L., Coenraads P.J. The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health. 1999;72:496–506. doi: 10.1007/s004200050407. [DOI] [PubMed] [Google Scholar]
18.Enders F., Przybilla B., Ring J. Epikutantest mit einer Standardreihe. Hautarzt. 1988;39:779–786. [PubMed] [Google Scholar]
19.Enk A.H., Angeloni V.L., Udey M.C., Katz S.I. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol. 1993;150:3698–3703. [PubMed] [Google Scholar]
20.Faergemann J. Pityrosporum ovale-assoziierte Dermatosen. In: Braun-Falco O., Plewig G.K., Meurer M., editors. Fortschritte prakt. Derm Venereol. Berlin Heidelberg New York: Springer; 1993. pp. 234–237. [Google Scholar]
21.Fischer T., Bellberg K., Bruynzeel D.P., Ducombs G., Hannuksela M., Lachapelle I.M., Ring J., White I.R., Wilkinson J. European multicenter study of TRUE test. Contact Dermatol. 1988;19:91–97. doi: 10.1111/j.1600-0536.1988.tb05504.x. [DOI] [PubMed] [Google Scholar]
22.Foussereau J., Benezra C., Maibach H.I. Occupational contact dermatitis, clinical and chemical aspects. Copenhagen: Munksgaard; 1982. [Google Scholar]
23.Frosch P., Rustemeyer T., Schnuch A. Kontaktdermatitis, parts I and II. Hautarzt. 1996;47:874–882. doi: 10.1007/BF03355107. [DOI] [PubMed] [Google Scholar]
24.Fuchs T., Aberer W., editors. Kontakteczema. Deisenhofen: Dustri; 2004. [Google Scholar]
25.Gollhausen R., Ring J., Przybilla B. Der iterative Test zur Unterscheidung kontaktallergischer oder irritativer Epikutantestreaktionen. Allergologie. 1987;10:427. [Google Scholar]
26.Grabbe S., Kämpgen E., Schuler G. Dentritic cells: multi-lineal and multi-functional. Immunol Today. 2000;21:431–433. doi: 10.1016/S0167-5699(00)01694-7. [DOI] [PubMed] [Google Scholar]
27.Granstein R.D., Askari M. Cutaneous cells in activation of immunologic reactions: further characterization. J Invest Dermatol. 1986;87:141. [Google Scholar]
28.Halter S. Das vulgäre Eczema. In: Gottron A., Schönfeld W., editors. Dermatologie und Venerologie. Stuttgart: Thieme; 1959. [Google Scholar]
29.Happle R. Paraptisches Eczema. Hautarzt. 1994;45:1–3. doi: 10.1007/PL00013249. [DOI] [PubMed] [Google Scholar]
30.Hausen B., Vieluf I. Pflanzen-Allergene. Landsberg: Ecomed; 1998. Allergie-Pflanzen. [Google Scholar]
31.Hornstein O.P. Anmerkungen und Vorschläge zur Definition und Klassifikation der Eczemakrankheiten. Z Hautkr. 1986;61:1281–1296. [PubMed] [Google Scholar]
32.Hannuksela M., Salo H. The repeated open application test (ROAT) Contact Dermatol. 1986;14:211–227. doi: 10.1111/j.1600-0536.1986.tb01338.x. [DOI] [PubMed] [Google Scholar]
33.Jadassohn J. Verhandl Dtsch Derm Gesellschaft. 1895;5:103. [Google Scholar]
34.Kapsenberg M.L., Bos J.D., Wierenga E.A. Cells in allergic responses to haptens and proteins. Springer Semin Immunopathol. 1992;13:303–314. doi: 10.1007/BF00200530. [DOI] [PubMed] [Google Scholar]
35.Klaschka F. Hämatogenes Kontakteczema durch Nahrungsmittel. Allergologie. 1987;10:93–97. [Google Scholar]
36.Knop J., Malorny U., Macher E. Induction of T effector and T suppressor lymphocytes in vitro by haptenized bone marrow-derived macrophages. Cell Immunol. 1984;88:411–420. doi: 10.1016/0008-8749(84)90174-6. [DOI] [PubMed] [Google Scholar]
37.Kripke M.L., Munn C.G., Jeevan A., Tang M.M., Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol. 1990;145:2833–2842. [PubMed] [Google Scholar]
38.Langerhans P. Über die Nerven der menschlichen Haut. Virchows Arch A (Path Anat) 1868;44:325. doi: 10.1007/BF01959006. [DOI] [Google Scholar]
39.Lepoittevin J.-P., Benezra C., Sigman C.C., Baheri D., Fraginals R., Maibach H.I. Molecular aspects of allergic contact dermatitis. In: Rycroft R.J.G., Mennée T., Frosch P., editors. Textbook of contact dermatitis. Berlin Heidelberg New York: Springer; 1995. pp. 105–119. [Google Scholar]
40.Luderschmidt C., Heilgemair G., Ring J., Burg G. Polyvalente Kontaktallergie versus “Angry-back-Syndrom”. Allergologie. 1982;5:262–268. [Google Scholar]
41.Magnussen B., Kligman A.M. Usefulness of guinea pig tests for detection of contact sensitizers. In: Marzulli F.N., Maibach H.I., editors. Dermatotoxicology and pharmacology. London: Wiley; 1977. pp. 551–560. [Google Scholar]
42.Maibach H.I. The ESS, excited-skin-syndrome (alias the “angry-back”) In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 206–216. [Google Scholar]
43.Miescher G. In: Handbuch der Haut-und Geschlechtskrankheiten. Marchionini A., editor. Berlin Heidelberg New York: Springer; 1962. p. 1. [Google Scholar]
44.Mitchell J.C. The angry back syndrome: eczema creates eczema. Contact Dermatol. 1975;1:193–194. doi: 10.1111/j.1600-0536.1975.tb05380.x. [DOI] [PubMed] [Google Scholar]
45.Nater J.P., De Groot A.C. Unwanted effects of cosmetics and drugs used in dermatology. 2nd edn. Amsterdam: Elsevier; 1983. [Google Scholar]
46.Odia S., Vocks E., Rakoski J., Ring J. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol. 1996;76:472–474. doi: 10.2340/0001555576472474. [DOI] [PubMed] [Google Scholar]
47.Rietschel R.L., Fouler J.F. Fisher’s contact dermatitis. 5th edn. Philadelphia: Lippincott-Williams; 2001. [Google Scholar]
48.Ring J (ed) (1990) Endogenous and exogenous eczema. Semin Dermatol 9:195–246 [PubMed]
49.Ring J. Zum Wandel des Eczema-Begreiffes: Klassisches versus atopisches Eczema. Z Hautkr. 1996;10:752–756. [Google Scholar]
50.Römpp H. Chemielexikon. 8th edn. Stuttgart: Franckh’sche Verlagshandlung; 1982. [Google Scholar]
51.Ross R., Gillitzer R., Kleinz J., Schwing H., Kleinert U., Förstermann A.B., Reske-Kunz Involvement of NO in contact hypersensitivity. Int Immunol. 1998;10:61–69. doi: 10.1093/intimm/10.1.61. [DOI] [PubMed] [Google Scholar]
52.Rycroft R.J.G., Menné T., Frosch P., editors. Textbook of contact dermatitis. Berlin Heidelberg New York: Springer; 1995. [Google Scholar]
53.Schäfer T, Böhler E, Ruhdorfer S, Weigl L, Wessner D, Filipiak B, Wichmann HE, Ring J (2004) Epidemiology of contact allergy in adults. Allergy (in press) [DOI] [PubMed]
54.Schnuch A., Geier J., Uter W., et al. National rates and regional differences in sensitization to allergens of the standard series. Contact Dermatitis. 1997;37:200–209. doi: 10.1111/j.1600-0536.1997.tb02435.x. [DOI] [PubMed] [Google Scholar]
55.Schnuch A., Aberer W., Agathos M., Brasch J., Frosch P.J., Fuchs T., Richter G. Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) zur Durchführung des Epikutantests mit Kontaktallergenen. Hautarzt. 2001;52:864–866. doi: 10.1007/s001050170048. [DOI] [PubMed] [Google Scholar]
56.Schulz K.H., Fuchs T. Manuale allergologicum. Deisenhofen: Dustri; 1993. Der Epikutantest; pp. 1–39. [Google Scholar]
57.Schuler G., Steinman R.M. Murine epidermal Langerhans cells mature into potent immuno-stimulatory dendritic cells in vitro. J Exp Med. 1985;161:526–546. doi: 10.1084/jem.161.3.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Schwanitz H.J. Das atopische Palmoplantareczema. Berlin Heidelberg New York: Springer; 1986. [Google Scholar]
59.Schwanitz H.J., Szliska C., editors. Berufsdermatosen. Munich: Dustri; 2001. [Google Scholar]
60.Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 1993;260:496–497. doi: 10.1126/science.8097337. [DOI] [PubMed] [Google Scholar]
61.Silberberg I., Baer R.I., Rosenthal S.A. The role of Langerhans cells in contact allergy. I. An ultrastructural study in actively induced contact dermatitis in guinea pigs. Acta Derm Venereol. 1974;54:321–331. [PubMed] [Google Scholar]
62.Stingl G. New aspects of Langerhans cell function. Int J Dermatol. 1980;19:189. doi: 10.1111/j.1365-4362.1980.tb00297.x. [DOI] [PubMed] [Google Scholar]
63.Török I. Eczema s betegsegek. Budapest: Medicina; 1989. [Google Scholar]
64.Traidl C., Merk H.F., Cavani A., Hunzelmann N. New insights into the pathomechanisms of contact dermatitis by the use of transgenic mouse models. Skin Pharmacol Appl Skin Physiol. 2000;13:300–312. doi: 10.1159/000029938. [DOI] [PubMed] [Google Scholar]
65.Unna P.G. Seborrhoeal eczema. J Cutan GU Dis. 1887;5:449–459. [Google Scholar]
66.Uter W., Schnuch A., Geier J., et al. Epidemiology of contact dermatitis. The information network of Department of Dermatology (IVDK) in Germany. Eur J Dermatol. 1998;8:36–40. [PubMed] [Google Scholar]
67.Willan . On cutaneous diseases. London: Johnson; 1808. [Google Scholar]

References

1.Abeck D., Schmidt T., Fesq H., Strom K., Mempel M., Brockow K., Ring J. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol. 2000;42:254–257. doi: 10.1016/S0190-9622(00)90134-8. [DOI] [PubMed] [Google Scholar]
2.Abeck D., Ring J., editors. Atopisches Eczema (Neurodermitis) im Kindesalter. Darmstadt: Steinkopff; 2002. [Google Scholar]
3.Akdis C.A., Akdis M., Trautmann A., Blaser K. Immune regulation in atopic dermatitis. Curr Opin Immunol. 2000;12:641–646. doi: 10.1016/S0952-7915(00)00156-4. [DOI] [PubMed] [Google Scholar]
4.Atherton D.J. Allergy and atopic eczema. Clin Exp Dermatol. 1981;6:317–325. doi: 10.1111/j.1365-2230.1981.tb02311.x. [DOI] [PubMed] [Google Scholar]
5.Besnier E. Premiere note et observations preliminaires pour servir d’introduction a l’etude des prurigos diathesiques (dermatites multiformes prurigineuses chroniques exacerbantes et paroxystiques, du type du prurigo de Hebra) Ann Derm Syph. 1892;3(3):634–648. [Google Scholar]
6.Bieber T. FceR1 on human Langerhans cells: a receptor in search of new functions. Immunol Today. 1994;15:52–53. doi: 10.1016/0167-5699(94)90132-5. [DOI] [PubMed] [Google Scholar]
7.Bleck O., Abeck D., Ring J., Hoppe U., Vietzke J., Wolber R., Brandt O., Schreiner V. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids on non-lesional skin of atopic eczema. J Invest Dermatol. 1999;113:894–900. doi: 10.1046/j.1523-1747.1999.00809.x. [DOI] [PubMed] [Google Scholar]
8.Boguniewicz M., Leung D.Y.M. Atopic dermatitis: A question of balance. Arch Dermatol. 1998;134:870–871. doi: 10.1001/archderm.134.7.870. [DOI] [PubMed] [Google Scholar]
9.Bos J.D., Van Leent E.J., Sillevis Smitt J.H. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol. 1998;7:132–138. doi: 10.1111/j.1600-0625.1998.tb00313.x. [DOI] [PubMed] [Google Scholar]
10.Borelli S., Schnyder U.W. Neurodermitis constitutionalis sive atopica, part II: Atiologie, Pathophysiologie, Pathogenese, Therapie. In: Miescher G., Storck H., editors. Entzündliche Dermatosen I. Handbuch der Haut-und Geschlechts-krankheiten. Berlin Heidelberg New York: Springer; 1962. pp. 254–319. [Google Scholar]
11.Braun-Falco O., Ring J. Zur Therapie des atopischen Eczemas. Hautarzt. 1984;35:447–454. [PubMed] [Google Scholar]
12.Bruynzeel-Koomen C., Van Wichen D.F., Toonstra J., Berrens L., Bruynzeel P.L.B. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res. 1986;278:199–205. doi: 10.1007/BF00412924. [DOI] [PubMed] [Google Scholar]
13.Carucci J.A., Washenik K., Weinstein A., Shupack J., Cohen D.E. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol. 1998;134:785–786. doi: 10.1001/archderm.134.7.785. [DOI] [PubMed] [Google Scholar]
14.Cooper K.D., Stevens S.R. T cells in atopic dermatitis. J Am Acad Dermatol. 2001;45:510–512. doi: 10.1067/mjd.2001.117025. [DOI] [PubMed] [Google Scholar]
15.Cookson W.O., Ubhi B., Lawrence R., Abecasis G.R., Whalley A.J., Cox H.E., et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet. 2001;27:372–373. doi: 10.1038/86867. [DOI] [PubMed] [Google Scholar]
16.Darsow U., Vieluf D., Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. J Am Acad Dermatol. 1999;40:187–193. doi: 10.1016/S0190-9622(99)70186-6. [DOI] [PubMed] [Google Scholar]
17.Darsow U., Drzezga A., Frisch M., Munz F., Weilke F., Bartenstein P., Schwaiger M., Ring J. Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol. 2000;115:1029–1033. doi: 10.1046/j.1523-1747.2000.00193.x. [DOI] [PubMed] [Google Scholar]
18.Fartasch M., Abeck D., Werfel T., Diepgen T., Schmid-Ott G., Ring J., Gieler U. Aktueller Stand des interdisziplinären Modellprojektes “Neurodermitis-Schulung für Kinder und Jugendliche”. Hautarzt. 2000;51:299–301. doi: 10.1007/s001050051122. [DOI] [PubMed] [Google Scholar]
19.Giustizieri M.L., Mascia F., Frezzolini A., De Pita O., Chinni L.M., Gianetti A., Girolomoni G., Pastore S. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol. 2001;107:871–877. doi: 10.1067/mai.2001.114707. [DOI] [PubMed] [Google Scholar]
20.Hanifin J.M. Atopic dermatitis. J Am Acad Dermatol. 1982;8:1–13. doi: 10.1016/S0190-9622(82)70001-5. [DOI] [PubMed] [Google Scholar]
21.Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;114:146–148. [Google Scholar]
22.Herzberg J. Wenig bekannte Formen der Neurodermitis. Hautarzt. 1973;24:407–501. [PubMed] [Google Scholar]
23.Imokawa G. Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol. 2001;45:S29–32. doi: 10.1067/mjd.2001.117020. [DOI] [PubMed] [Google Scholar]
24.Jakob T. Mechanismen der Aktivierung und Mobilisation dentritischer Zellen in der Haut. München: Habilitationsschrift, Technische Universität; 2002. [Google Scholar]
25.Jung T. Zytokindysregulation bei atopischer Dermatitis. Munich: Dustri; 2002. [Google Scholar]
26.Kissling S., Wüthrich B. Dermatitis in young adults: personal follow-up 20 years after diagnosis in childhood. Hautarzt. 1994;45:368–371. doi: 10.1007/s001050050085. [DOI] [PubMed] [Google Scholar]
27.Korting G.W. Zur Pathogenese des endogenen Eczemas. Stuttgart: Thieme; 1954. [Google Scholar]
28.Kowalzick L., Kleinheinz A., Weichenthal M., Neuber K., Köhler I., et al. Low dose versus medium dose UVA1 treatment in severe atopic eczema. Acta Derm Venereol. 1995;75:43–45. doi: 10.2340/00015555754345. [DOI] [PubMed] [Google Scholar]
29.Krutmann J., Czech W., Diepgen T., Niedner R., Kapp A., Schöpf E. Highdose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol. 1993;26:225–230. doi: 10.1016/0190-9622(92)70031-A. [DOI] [PubMed] [Google Scholar]
30.Kunz B., Ring J., et al. Clinic diagnostic features of atopic eczema. In: Oranje A., et al., editors. Pediatric dermatology. Oxford: Blackwell; 1999. [Google Scholar]
31.Lee Y.-A., Wahn U., Kehrt R., Tarani L., Businco L., Gustafsson D., Andersson F., Oranje A.P., Wolkertstorfer A., v Berg A., Hoffmann U., Küster W., Wienke T., Rüschendorf F., Reis A. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nature Genetics. 2000;26:470. doi: 10.1038/82625. [DOI] [PubMed] [Google Scholar]
32.Leung D.Y.M. Atopic dermatitis and the immune system: The role of superantigens and bacteria. J Am Acad Dermatol. 2001;45:S13–16. doi: 10.1067/mjd.2001.117024. [DOI] [PubMed] [Google Scholar]
33.Leutgeb C., Bandmann H.J., Breit R. Handlinienmuster, ichthyosis vulgaris und dermatitis atopica. Arch Derm Forsch. 1972;244:244–354. doi: 10.1007/BF00600210. [DOI] [PubMed] [Google Scholar]
34.Neuber K. Atopisches Eczema und Staphylococcus aureus. Munich: Dustri; 2002. [Google Scholar]
35.Olesen A.B. Role of the early environment for expression of atopic dermatitis. J Am Acad Dermatol. 2001;45:37–40. doi: 10.1067/mjd.2001.117018. [DOI] [PubMed] [Google Scholar]
36.Oranje A.P. Atopic dermatitis (AD): Evaluation and therapy. Pediatr Dermatol. 2000;17:75–83. doi: 10.1046/j.1525-1470.2000.01716.x. [DOI] [PubMed] [Google Scholar]
37.Platts-Mills T.A.E., Mitchell E.B., Rowntree S., Chapman M.D., Wilkins S.R. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol. 1983;8:233–247. doi: 10.1111/j.1365-2230.1983.tb01776.x. [DOI] [PubMed] [Google Scholar]
38.Przybilla B., Ring J., Enders F., Winkelmann H. Stigmata of atopic constitution in patients with atopic eczema or atopic respiratory disease. Acta Derm Venereol. 1991;71:407–410. [PubMed] [Google Scholar]
39.Przybilla B., Eberlein-König B., Rueff F. Practical management of atopic eczema. Lancet. 1994;343:1342–1346. doi: 10.1016/S0140-6736(94)92474-0. [DOI] [PubMed] [Google Scholar]
40.Rajka G. Essential aspects of atopic dermatitis. Berlin Heidelberg New York: Springer; 1989. [Google Scholar]
41.Reitamo S., Rissanen J., Remitz A., Granlund H., Erkko P., Elg P., Autio P., Lauerma A. Tacrolismus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol. 1998;111:396–398. doi: 10.1046/j.1523-1747.1998.00323.x. [DOI] [PubMed] [Google Scholar]
42.Ring J. Atopic dermatitis: a disease of general vasoactive mediator dysregulation. Int Arch Allergy Appl Immunol. 1979;59:233–239. doi: 10.1159/000232264. [DOI] [PubMed] [Google Scholar]
43.Ring J. Atopy: condition, disease, or syndrome? In: Ruzicka T., Ring J., Przybilla B., editors. Handbook of atopic eczema. Berlin Heidelberg New York: Springer; 1991. pp. 3–8. [Google Scholar]
44.Ring J., Bieber T., Vieluf D., et al. Atopic eczema. Langerhans cells and allergy. Int Arch Allergy Appl Immunol. 1991;94:194–201. doi: 10.1159/000235361. [DOI] [PubMed] [Google Scholar]
45.Ring J., Schröpl F. Das atopische Eczema. Frankfurt: Medizinisches Hörspiel; 1985. [Google Scholar]
46.Ring J., Kunz B., Bieber T., Vieluf D., Przybilla B. The “atopy patch test” with aeroallergens in atopic eczema. J Allerg Clin Immunol. 1989;82:195. [Google Scholar]
47.Ring J., Brockow K., Abeck D. The therapeutic concept of “patient management” in atopic eczema. Allergy. 1996;51:206–215. [PubMed] [Google Scholar]
48.Ring J., editor. Neurodermitis. Landsberg: Ecomed; 1998. [Google Scholar]
49.Ruzicka T., Ring J., Przybilla B., editors. Handbook of atopic eczema. Berlin Heidelberg New York: Springer; 1991. [Google Scholar]
50.Saurat J.-H. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol. 1985;114:125–128. [PubMed] [Google Scholar]
51.Schäfer T., Krämer U., Vieluf D., Abeck D., Behrendt H., Ring J. The excess of atopic eczema in East Germany is related to the intrinsic type. Br J Dermatol. 2000;143:992–998. doi: 10.1046/j.1365-2133.2000.03832.x. [DOI] [PubMed] [Google Scholar]
52.Schnyder U.W. Neurodermitis, Asthma, Rhinitis, eine genetisch allergologische Studie. Basel: Karger; 1960. [Google Scholar]
53.Schöpf E., Kapp A., Kim C.W. T-cell function in atopic dermatitis. Controlled examination of concanavalin A. Dose-response relations in cultured lymphocytes. Arch Dermatol Res. 1978;262:37–44. doi: 10.1007/BF00455571. [DOI] [PubMed] [Google Scholar]
54.Schultz-Larsen F. Etiological studies based on a twin population. Copenhagen: Laegeforeningens; 1985. Atopic dermatitis. [Google Scholar]
55.Stingl G. IgE-mediated, Fcε RI-dependent allergen presentation: A pathogenic factor in atopic dermatitis? J Am Acad Dermatol. 2001;45:S517–S520. doi: 10.1067/mjd.2001.117023. [DOI] [PubMed] [Google Scholar]
56.Taieb A. Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis. 1999;41:177–180. doi: 10.1111/j.1600-0536.1999.tb06125.x. [DOI] [PubMed] [Google Scholar]
57.Thestrup-Pedersen K., Ring J. Atopic dermatitis: summary of the 1st Georg Rajka Symposium 1998 and a literature review. Acta Derm Venerol. 1999;79:257–264. doi: 10.1080/000155599750010517. [DOI] [PubMed] [Google Scholar]
58.Trautmann A., Akdis M., Kleemann D., Altznauer F., Simon H.U., Graeve T., Noll M., Brocker E.B., Blase K., Akdis C.A. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000;106:25–35. doi: 10.1172/JCI9199. [DOI] [PMC free article] [PubMed] [Google Scholar]
59.Uehara M. Clinical and histological features of dry skin in atopic dermatitis. Acta Derm Venereol. 1985;114(Suppl):8246. doi: 10.2340/000155551148286. [DOI] [PubMed] [Google Scholar]
60.Valenta R., Seiberler S., Natter S., Mahler V., Mossabeb R., Ring J., Stingl G. Autoallergy: A pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol. 2000;105:432–437. doi: 10.1067/mai.2000.104783. [DOI] [PubMed] [Google Scholar]
61.Wahlgren C.F., Scheynius A., Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol. 1990;70:323–329. [PubMed] [Google Scholar]
62.Wakim M., Alazard M., Yajima A., Speights D., Saxon A., Stiehm E. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol. 1998;81:153–158. doi: 10.1016/S1081-1206(10)62802-5. [DOI] [PubMed] [Google Scholar]
63.Werfel T. Allergenspezifische T-Zell-Antwort bei Eczemakrankheiten. Munich: Dustri; 2000. [Google Scholar]
64.Williams HC (ed) (2000) Atopic dermatitis. The epidemiology, causes and prevention of atopic eczema. Cambridge University Press, Cambridge
65.Wise F., Sulzberger M.B. Footnote on problem of eczema, neurodermatitis and lichenification. In: Wise F., Sulzberger M.B., editors. The 1933 Year book of dermatology and syphilology. Chicago: Year Book Publishers; 1933. pp. 38–39. [Google Scholar]
66.Wollenberg A., Wen S., Bieber T. Phenotyping of epidermal dendritic cells — clinical applications of a flow cytometric micromethod. Cytometry. 1999;37:147–155. doi: 10.1002/(SICI)1097-0320(19991001)37:2<147::AID-CYTO8>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
67.Wright S., Burton J.L. Oral-evening-primrose-seed oil improves atopic eczema. Lancet. 1982;2:1120–1122. doi: 10.1016/S0140-6736(82)92784-2. [DOI] [PubMed] [Google Scholar]
68.Wüthrich B. Zur Immunpathologie der Neurodermitis constitutionalis. Bern: Huber; 1975. [Google Scholar]
69.Wüthrich B., editor. The atopic syndrome in the third millennium. Basel: Karger; 1999. [Google Scholar]
70.Zachariae H., Cramers M., Herlin T., Jensen J., Kragballe K., Ternowitz T., Thestrup-Pedersen K. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol. 1985;114(Suppl):48–54. doi: 10.2340/000155551144854. [DOI] [PubMed] [Google Scholar]
71.Stalder R., Taieb A., et al. Consensus Report of the European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCO-RAD index. Dermatology. 1993;186:23–31. doi: 10.1159/000247298. [DOI] [PubMed] [Google Scholar]

References

1.Alpermann H.G., Sandow J., Vogel H.G. Tierexperimentelle Untersuchungen zur topischen und systemischen Wirksamkeit von Prednisolon-17-ethylcarbonat-21-propionat. Arzneimittelfor-schung/Drug Res. 1982;32:633. [PubMed] [Google Scholar]
2.Barnes P.J., Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 1993;14:436–440. doi: 10.1016/0165-6147(93)90184-L. [DOI] [PubMed] [Google Scholar]
3.Braun-Falco O., Ring J. Zur Therapie des atopischen Ekzems. Hautarzt. 1984;35:447–454. [PubMed] [Google Scholar]
4.Carnuccui R., di Rosa M., Guerrasio B., Iuvone T., Sautebin L. Vasocortin: a new glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol. 1987;90:443–445. doi: 10.1111/j.1476-5381.1987.tb11193.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
5.Claman W.N. Antiinflammatory effects of corticosteroids Immunol. Allergy Practice. 1984;4:317–329. [Google Scholar]
6.Clark C.R. Intracellular localisation of steroid receptors. In: Sluyser M., editor. Interaction of steroid hormone receptors with DNA. Chichester: Ellis Horwood; 1985. pp. 7–56. [Google Scholar]
7.Flower R.J., Rothwell N.J. Lipocortin-I: cellular mechanisms and clinical relevance. Trends Pharmacol Sci. 1994;15:71–76. doi: 10.1016/0165-6147(94)90281-X. [DOI] [PubMed] [Google Scholar]
8.Guin J.D. Contact sensitivity to topical corticosteroids. J Am Acad Dermatol. 1984;10:773–782. doi: 10.1016/S0190-9622(84)70093-4. [DOI] [PubMed] [Google Scholar]
9.Hatz H. Kortison und Kortikoide. Stuttgart: Deutscher Apothekerverlag; 1998. [Google Scholar]
10.Hornstein OP, Nürnberg E (eds) (1985) Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Thieme, Stuttgart
11.Kaiser H. Cortisonderivate in Klinik und Praxis. Stuttgart: Thieme; 1977. [Google Scholar]
12.Kligman A.M. Topical steroids: Perspectives and retrospectives. In: Ring J., Burg G., editors. New trends in allergy. II. Berlin Heidelberg New York: Springer; 1986. pp. 342–352. [Google Scholar]
13.Lubach D., Kietzmann M. In: Dermatokortikoide — Pharmakologie und Therapie. Marghescu S., Wolff H.H., Zaun H., editors. Freiburg: Kohlhammer; 1992. [Google Scholar]
14.Maibach H., Stougthon R.B. Topical corticosteroids. Med Clin N Am. 1973;57:1253. doi: 10.1016/s0025-7125(16)32226-x. [DOI] [PubMed] [Google Scholar]
15.Marghescu S. Externe Kortikoidtherapie: Kontinuierliche versus diskontinuierliche Anwendung. Hautarzt. 1983;34:114–117. [PubMed] [Google Scholar]
16.Miyachi Y. Adrenal axis suppression caused by a small dose of a potent topical corticosteroid. Arch Dermatol. 1982;118:451. doi: 10.1001/archderm.118.7.451. [DOI] [PubMed] [Google Scholar]
17.Niedner R., Ziegenmeyer J., editors. Dermatika — Therapeutischer Einsatz, Pharmakologie und Pharmazie. Stuttgart: Wiss Verlagsgesellsch; 1992. [Google Scholar]
18.Poulsen J., Rorsman H. Ranking of glucocorticoid creams and ointments. Acta Derm Venereol. 1980;60:57. [PubMed] [Google Scholar]
19.Ponec M., Kempanaar S.A., DeKloet E.R. Corticosteroids and cultured human epidermal keratinocytes. J Invest Dermatol. 1981;76:211–214. doi: 10.1111/1523-1747.ep12525761. [DOI] [PubMed] [Google Scholar]
20.Przybilla B., Ring J. Äußerliche Behandlung mit Glukokortikosteroiden. Med Monatsschr Pharm. 1983;6:192–205. [PubMed] [Google Scholar]
21.Ring J., Fröhlich H.H. Wirkstoffe in der dermatologischen Therapie. 2nd edn. Berlin Heidelberg New York: Springer; 1985. [Google Scholar]
22.Schaefer H., Zesch A., Schalla W., Stüttgen G. Pharmakokinetik externer Glucocorticoide. Allergologie. 1980;3:194. [Google Scholar]
23.Schell H., Hornstein O.P. Endogener Kortisolrhythmus und Epidermisproliferation. Akt Derm. 1980;6:27–33. [Google Scholar]
24.Schleimer R.P. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol. 1993;45([Suppl]):1. doi: 10.1007/BF01844196. [DOI] [PubMed] [Google Scholar]
25.Schmutzler W. Antiallergische und antientzündliche Pharmakotherapie. In: Heppt W., Renz H., Röcken M., editors. Allergologie. Berlin Heidelberg New York: Springer; 1999. pp. 160–174. [Google Scholar]
26.Schöpf E(1972) Nebenwirkungen externer Corticoidtherapie. Hautarzt 23:295 [PubMed]
27.Schöpf E. Kortikosteroide in der Dermatologie. Allergologie. 1980;3:306. [Google Scholar]
28.Sulzberger M.B., Witten V.H. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19:101. doi: 10.1038/jid.1952.14. [DOI] [PubMed] [Google Scholar]
29.Wendt H., Frosch P.J. Klinisch-pharmakologische Modelle zur Prüfung von Corticoidexterna. Basel: Karger; 1982. [Google Scholar]
30.Wilckens T. Glucocorticoids and immune function: hormonal dysfunction. Trends Pharmacol Sci. 1995;16:193–197. doi: 10.1016/S0165-6147(00)89021-5. [DOI] [PubMed] [Google Scholar]

References

1.Bergner T., Przybilla B. Photosensitization caused by ibuprofen. J Am Acad Dermatol. 1992;26:114–116. doi: 10.1016/0190-9622(92)70018-B. [DOI] [PubMed] [Google Scholar]
2.Breit R. Rötung und Bräunung der Haut durch UVA. Munich: Zuckschnverdt; 1987. [Google Scholar]
3.Eberlein-König B., Fesq H., Abeck D., Przybilla B., Placzek M., Ring J. Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol Photoimmunol Photomed. 2000;16:50–52. doi: 10.1034/j.1600-0781.2000.d01-2.x. [DOI] [PubMed] [Google Scholar]
4.Epstein S. Photoallergy and primary photosensitivity to sulfanilamide. J Invest Dermatol. 1939;2:43–51. doi: 10.1038/jid.1939.5. [DOI] [Google Scholar]
5.Ferguson J., Johnson B.E. Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic. Br J Dermatol. 1993;128:185–195. doi: 10.1111/j.1365-2133.1993.tb00173.x. [DOI] [PubMed] [Google Scholar]
6.Fjellner B (1981) Experimental and clinical pruritus. Studies on some putative peripheral mediators. The influence of ultraviolet light and transcutaneous nerve stimulation. Thesis, Stockholm [DOI] [PubMed]
7.Fotiades J., Soter N.A., Lim H.W. Results of evaluation of 203 patients for photosensitivity in a 7.3-year period. J Am Acad Dermatol. 1995;33:597–602. doi: 10.1016/0190-9622(95)91277-0. [DOI] [PubMed] [Google Scholar]
8.Frain-Bell W. Cutaneous photobiology. New York: Oxford University Press; 1986. [Google Scholar]
9.Galosi A., Przybilla B., Ring J., Dorn M. Systemische Photoprovokation mit Surgam. Allergologie. 1984;7:143–144. [Google Scholar]
10.Gigli I., Lim H.W. Release of proinflammatory peptides by complement in porphyrin-induced photosensitivity. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. p. 5848. [Google Scholar]
11.Gollhausen R., Przybilla B., Galosi A., Köhler K., Ring J. Environmental influences of UVB erythema. Photodermatology. 1987;4:148–153. [PubMed] [Google Scholar]
12.Hasei K., Ichihashi M. Solar urticaria. Determinations of action and inhibition spectra. Arch Dermatol. 1982;118:346–350. doi: 10.1001/archderm.118.5.346. [DOI] [PubMed] [Google Scholar]
13.Hölzle E., Plewig G., v Kries R., Lehmann P. Polymorphous light eruption. J Invest Dermatol. 1987;88:32–38. doi: 10.1111/1523-1747.ep12468916. [DOI] [PubMed] [Google Scholar]
14.Hölzle E., Neumann N., Hausen B., Przybilla B., Schauder S., Hönigsmann H., Bircher A., Plewig G. Photopatch testing: The 5-year experience of the German, Austrian and Swiss photopatch test group. J Am Acad Dermatol. 1991;25:59–68. doi: 10.1016/0190-9622(91)70175-2. [DOI] [PubMed] [Google Scholar]
15.Hönigsmann H., Stingl G., editors. Therapeutic photomedicine. Basel: Karger; 1986. [Google Scholar]
16.Horio T. Chlorpromazine photoallergy. Arch Dermatol. 1975;111:1469–1471. doi: 10.1001/archderm.111.11.1469. [DOI] [PubMed] [Google Scholar]
17.Ippen H. Photochemie der Haut. In: Herrmann F., Oppen H., Schaefer H., Stüttgen G., editors. Biochemie der Haut. Stuttgart: Thieme; 1973. p. 146. [Google Scholar]
18.Jitsukawa K., Suizu R., Hidano A. Chlorella photosensitization, a new phytophotodermatosis. Int J Dermatol. 1984;23:263. doi: 10.1111/j.1365-4362.1984.tb01245.x. [DOI] [PubMed] [Google Scholar]
19.Jung E.G. Die belichtete Epikutantestung. Akt Derm. 1981;7:163–165. [Google Scholar]
20.Jung E.G., Hardmeier T. Zur Histologie der photoallergischen Testreaktion. Dermatologica. 1967;135:243–252. doi: 10.1159/000254190. [DOI] [PubMed] [Google Scholar]
21.Kavli G., Volden G. Phytophotodermatitis. Photodermatology. 1984;1:65–75. [PubMed] [Google Scholar]
22.Kripke M.L. Photoimmunology, the first decade. Curr Probl Dermatol. 1986;15:164–175. doi: 10.1159/000412100. [DOI] [PubMed] [Google Scholar]
23.Lehmann P. Die Deutschsprachige Arbeitsgemeinschaft Photopatch-Test (DAPT) Haut-arzt. 1990;41:295–297. [PubMed] [Google Scholar]
24.Lischka G., Jung E.G. Lichtkrankheiten der Haut. 2nd edn. Erlangen: Perimed; 1982. [Google Scholar]
25.Ljunggren B., Bjellerup M. Systemic drug photosensitivity. Photodermatology. 1986;3:26–35. [PubMed] [Google Scholar]
26.Ljunggren B. Severe phototoxic burn following celery ingestion. Arch Dermatol. 1990;126:1334–1336. doi: 10.1001/archderm.126.10.1334. [DOI] [PubMed] [Google Scholar]
27.Maurer T. A manual of predictive test methods. New York: Dekker; 1983. Contact and photocontact allergens. [Google Scholar]
28.Plewig G., Hölzle E., Roser-Maaß E., Hofmann C. Photoallergy. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1985. pp. 152–169. [Google Scholar]
29.Przybilla B., Ring J., Schwab U., Galosi A., Dorn M., Braun-Falco O. Photosensibilisierende Eigenschaften nicht-steroidaler Antirheumatika im Photopatch-Test. Hautarzt. 1987;38:18–25. [PubMed] [Google Scholar]
30.Przybilla B. Phototestungen bei Lichtdermatosen. Hautarzt. 1987;38:S23–S28. [Google Scholar]
31.Przybilla B., Schwab-Przybilla U., Ruzicka T., Ring J. Phototoxicity of non-steroidal antiinflammatory drugs demonstrated in vitro by a photobasophil-histamine-release test. Photodermatology. 1987;4:73–78. [PubMed] [Google Scholar]
32.Przybilla B., Ring J., Eberlein B. Inhibition of in vitro basophil histamine release by UVA irradiation. J Allergy Clin Immunol. 1988;83:302. doi: 10.1016/0091-6749(88)90771-3. [DOI] [Google Scholar]
33.Przybilla B., Bergner T. Diagnostik von lichtallergischen Exanthemen im erscheinungsfreien Intervall. Hautarzt. 1992;43:100–101. [PubMed] [Google Scholar]
34.Przybilla B., Eberlein-König B. Photoprovokationstests. In: Przybilla B., Bergmann K., Ring J., editors. Praktische allergologische Diagnostik. Darmstadt: Steinkopff; 2000. [Google Scholar]
35.Ring J., Przybilla B., Ruzicka T. Nonsteroidal antiinflammatory drugs induce UV-dependent histamine and leukotriene release from peripheral human leukocytes. Int Arch Allergy Appl Immunol. 1987;82:344–346. doi: 10.1159/000234222. [DOI] [PubMed] [Google Scholar]
36.Ring J., Przybilla B. UV irradiation and allergy. Allergologie. 1990;12:75–79. [Google Scholar]
37.Ruzicka T., Walter J.F., Printz M.P. Changes in arachidonic acid metabolism in ultraviolet irradiated hairless mouse skin. J Invest Dermatol. 1983;81:300–303. doi: 10.1111/1523-1747.ep12519287. [DOI] [PubMed] [Google Scholar]
38.Schauder S., Ippen H. Photoallergic and allergic contact dermatitis from dibenzoylmethanes. Photodermatology. 1986;3:140–147. [PubMed] [Google Scholar]
39.Schauder S., Schrader A., Ippen H. Sonnenschutzkosmetik in Deutschland. 4th edn. Berlin: Blackwell; 1996. Göttinger Liste 1996. [Google Scholar]
40.Schmidt T., Abeck D., Ring J. Photoallergic contact dermatitis due to combined UVB-(4-methylbenzylidene camphor/octyl methoxy-cinnamate) and UVA-(benzophenone-3/butyl-methoxy-dibenzoylmethane) absorber. Dermatology. 1998;196:354–357. doi: 10.1159/000017915. [DOI] [PubMed] [Google Scholar]
41.Schulz K.H., Wiskemann K., Wolf K. Klinische und experimentelle Untersuchungen über die photodynamische Wirksamkeit von Phenotiazinderivaten, insbesondere Megaphen. Arch Klin Exp Dermatol. 1956;202:285–298. doi: 10.1007/BF00476712. [DOI] [PubMed] [Google Scholar]
42.Terui T., Okuyama R., Tagami H. Molecular events occurring behind ultraviolet-induced skin inflammation. Curr Opin Allergy Clin Immunol. 2001;1:461–467. doi: 10.1097/01.all.0000011061.54491.2e. [DOI] [PubMed] [Google Scholar]
43.Wessner D., Hofmann H., Ring J. Phytopho-todermatitis due to Ruta graveolens applied as protection against evil spells. Contact Dermatitis. 1999;41:232–233. doi: 10.1111/j.1600-0536.1999.tb06145.x. [DOI] [PubMed] [Google Scholar]
44.Wucherpfennig V. Biologie und praktische Verwendbarkeit der Erythemschwelle des UV. Strahlentherapie. 1931;40:201–243. [Google Scholar]

References

1.Aberer W., Kränke B. Überempfindlichkeitsreaktionen auf Impfstoffe. Allergologie. 1997;20:407–411. [Google Scholar]
2.Adkinson N.F. Drug allergy. In: Middleton E., Reed C.E., Ellis E.F., Adkinson N.F., Yunginger J.W., Busse W.W., editors. Allergy: principles and practice. St. Louis: CV Mosby; 1998. pp. 1212–1224. [Google Scholar]
3.Baldo B.A. Diagnosis of allergy to penicillins and cephalosporins. Structural and immunochemical considerations. Allergy Clin Immunol Int. 2000;12:206–212. doi: 10.1027/0838-1925.12.5.206. [DOI] [Google Scholar]
4.Bates D.W., Cullen D.J., Laird N., et al. Incidence of adverse drug events and potential adverse drug events. JAMA. 1995;274:29–34. doi: 10.1001/jama.274.1.29. [DOI] [PubMed] [Google Scholar]
5.Berg P.A., Daniel P.T., Brattig N. Immunologie und Nachweis medikamentöser Allergien. In: Fuchs E., Schulz K.H., editors. Manuale allergologicum IV. München-Deisenhofen: Dustri; 1987. pp. 1–13. [Google Scholar]
6.Bircher A.J. Arzneimittelallergie und Haut. Stuttgart: Thieme; 1996. [Google Scholar]
7.Bircher A.J. Hyposensibilisierung bei Arzneimittelallergie. In: Ring J., Darsow U., editors. Allergie 2000. München-Deisenhofen: Dustri; 2001. pp. 219–228. [Google Scholar]
8.Brockow K., Romano A., Blanca M., Ring J., Pichler W., Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57:45–51. doi: 10.1034/j.1398-9995.2002.13027.x. [DOI] [PubMed] [Google Scholar]
9.Classen D.C., Pestotnik S.L., Evans R.S., Burke J.P. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847–2851. doi: 10.1001/jama.266.20.2847. [DOI] [PubMed] [Google Scholar]
10.Coleman J.W., Blanca M. Mechanisms of drug allergy. Immunol Today. 1998;19:196–198. doi: 10.1016/S0167-5699(97)01231-0. [DOI] [PubMed] [Google Scholar]
11.Demoly P., Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol. 2001;1:305–310. doi: 10.1097/01.all.0000011031.16814.e0. [DOI] [PubMed] [Google Scholar]
12.Demoly P, et al. (2004) Provocative testing. Allergy (in press)
13.DeShazo R.D., Kemp S.F. Allergic reactions to drugs and biologic agents. JAMA. 1997;278:1895–1906. doi: 10.1001/jama.278.22.1895. [DOI] [PubMed] [Google Scholar]
14.Dogliotti M. An instance of fatal reaction to the penicillin scratch test. Dermatologica. 1968;136:489–496. doi: 10.1159/000254145. [DOI] [PubMed] [Google Scholar]
15.Eapen S.S., Connor E.L., Gern J.E. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child. Ann Allergy Asthma Immunol. 2000;85:395–397. doi: 10.1016/S1081-1206(10)62554-9. [DOI] [PubMed] [Google Scholar]
16.Eichler G., Merk H.F. Unerwünschte Arzneimittelreaktionen durch Antibiotika. Allergologie. 1997;20:368–374. [Google Scholar]
17.Fam A.G., Dunne S.M., Iazzetta J., Paton T.W. Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum. 2001;44:231–238. doi: 10.1002/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
18.Federlin K. Insulinallergie. Dtsch Med Wochenschr. 1974;99:535–537. doi: 10.1055/s-0028-1107798. [DOI] [PubMed] [Google Scholar]
19.Fisher M.M., Baldo B.A. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intens Care. 2000;28:167–170. doi: 10.1177/0310057X0002800207. [DOI] [PubMed] [Google Scholar]
20.Gadde J., Spence M., Wheeler B., Adkinson N.F. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993;270:2456–2463. doi: 10.1001/jama.270.20.2456. [DOI] [PubMed] [Google Scholar]
21.Gall H., Merk H., Scherb W., Sterry W. Anticonvulsiva-Hypersensitivitätssyndrom auf Carbamazepin. Hautarzt. 1994;45:494–498. doi: 10.1007/s001050050112. [DOI] [PubMed] [Google Scholar]
22.Hedin H., Richter W., Ring J. Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies. Int Arch Allergy Appl Immunol. 1976;52:145–152. doi: 10.1159/000231676. [DOI] [PubMed] [Google Scholar]
23.Hoigné R. Klinische und serologisch-experimentelle Untersuchungen. Bern: Huber; 1965. Arzneimittel-Allergien. [Google Scholar]
24.Hoigné R., Schlumberger H.P., Vervloet D., Zoppi M. Epidemiology of allergic drug reactions. In: Burr M.L., editor. Epidemiology of clinical allergy. Basel: Karger; 1993. pp. 147–170. [PubMed] [Google Scholar]
25.Jäger L., Merk H.F. Arzneimittel-Allergie. Jena: Gustav Fischer; 1996. [Google Scholar]
26.Karch F.E., Lasagna L. Adverse drug reactions. A critical review. JAMA. 1975;234:1236–1241. doi: 10.1001/jama.234.12.1236. [DOI] [PubMed] [Google Scholar]
27.Kelkar P.S., Li J.-C. Cephalosporin allergy. N Engl J Med. 2001;345:804–811. doi: 10.1056/NEJMra993637. [DOI] [PubMed] [Google Scholar]
28.Kleinhans D. Reaktionen vom Soforttyp auf Analgetika-Wirkstoffe. Allergie und Intoleranz. Allergologie. 1985;8:254–259. [Google Scholar]
29.Kraft D., Wide L. Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy. Br J Dermatol. 1976;94:593–601. doi: 10.1111/j.1365-2133.1976.tb05156.x. [DOI] [PubMed] [Google Scholar]
30.Lasagna L. The placebo effect. J Allergy Clin Immunol. 1986;78:161–165. doi: 10.1016/0091-6749(86)90008-4. [DOI] [PubMed] [Google Scholar]
31.Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA. 1998;279:1200–1205. doi: 10.1001/jama.279.15.1200. [DOI] [PubMed] [Google Scholar]
32.Maucher O.M., Fuchs A. Kontakturtikaria im Epikutantest bei Pyrazolonallergie. Hautarzt. 1983;34:383–386. [PubMed] [Google Scholar]
33.Menzel S.H., Vente C., Fuchs T. Heparin-Allergie. Allergo J. 1997;6:372–376. [Google Scholar]
34.Merk H. Arzneimittelallergie: Einfluß des Fremdstoff-Metabolismus. Allergologie. 1989;12:171–173. [Google Scholar]
35.Merk H.F. Skin metabolism. In: Lepoittevin J.P., Basketter D.A., Goossens K.A., Karlberg A.T., editors. Allergic contact dermatitis. Berlin Heidelberg New York: Springer; 1998. pp. 68–80. [Google Scholar]
36.Moneret-Vautrin D., Laxenaire M.C. The risk of allergy related to general anaesthesia. Clin Exp Allergy. 1993;23:629–633. doi: 10.1111/j.1365-2222.1993.tb01788.x. [DOI] [PubMed] [Google Scholar]
37.O’Donnell B.F., Tan C.Y. Delayed hypersensitivity reaction to heparin. Br J Dermatol. 1993;129:634–636. doi: 10.1111/j.1365-2133.1993.tb00502.x. [DOI] [PubMed] [Google Scholar]
38.Pallela F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
39.Parker C.W. Drug allergy. N Engl J Med. 1975;292:511–521. doi: 10.1056/NEJM197503062921006. [DOI] [PubMed] [Google Scholar]
40.Pichler W.J. Diagnostische Möglichkeiten bei Medikamentenallergien. Schweiz Med Wochenschr. 1993;123:1183–1192. [PubMed] [Google Scholar]
41.Pichler W.J., Yawalkar N. Allergic reactions to drugs: involvement of T cells. Thorax. 2000;55([Suppl 2]):S61–S65. doi: 10.1136/thorax.55.suppl_2.S61. [DOI] [PMC free article] [PubMed] [Google Scholar]
42.Pouyanne P., Haramburu F., Imbs J.L., Bégaud B. Admissions to hospital caused by adverse drug reactions: cross incidence study. Br Med J. 2000;320:1036. doi: 10.1136/bmj.320.7241.1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Przybilla B., Bonnländer A.R., Ring J. Anaphylactoid reactions to mild analgesics. In: Ring J., Burg G., editors. New trends in allergy. II. Berlin Heidelberg New York: Springer; 1986. pp. 262–271. [Google Scholar]
44.Przybilla B., Fuchs T., Ippen H., et al. Empfehlungen für die Aufklärung von Überempfindlichkeitsreaktionen auf Arzneimittel. Allergologie. 1991;14:58–60. [Google Scholar]
45.Reilly T.P., Lash L.H., Dollo M.A., et al. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol. 2000;114:1164–1173. doi: 10.1046/j.1523-1747.2000.00985.x. [DOI] [PubMed] [Google Scholar]
46.Ring J. Anaphylaktoide Reaktionen nach Infusion natürlicher und künstlicher Kolloide. Berlin Heidelberg New Yor: Springer; 1978. [Google Scholar]
47.Ring J. Exacerbation of eczema by formalin-containing hepatitis B vaccine in a formaldehyde-allergic patient. Lancet. 1986;2:522–523. doi: 10.1016/S0140-6736(86)90397-1. [DOI] [PubMed] [Google Scholar]
48.Ring J. Diagnostik von Arzneimittel-bedingten Unverträglichkeiten. Hautarzt. 1987;38:516–522. [Google Scholar]
49.Schaub N., Bircher A.J. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy. 2000;55:191–193. doi: 10.1034/j.1398-9995.2000.00467.x. [DOI] [PubMed] [Google Scholar]
50.Schnyder B., Pichler W.J. Skin laboratory tests in amoxicillin-and penicillin-induced morbilliform skin eruption. Clin Exp Allergy. 2000;30:590–595. doi: 10.1046/j.1365-2222.2000.00787.x. [DOI] [PubMed] [Google Scholar]
51.Schulz K.H., Kasemir H.D. Arzneimittelallergie. In: Fuchs E., Schulz K.H., editors. Manuale allergologicum. München-Deisenhofen: Dustri; 1990. pp. 1–71. [Google Scholar]
52.Solensky R., Earl H.S., Gruchalla R.S. Clinical approach to penicillin-allergic patients: a survey. Ann Allergy Asthma Immunol. 2000;84:329–333. doi: 10.1016/S1081-1206(10)62782-2. [DOI] [PubMed] [Google Scholar]
53.Stejskal V.D.M., Olin R.G., Forsbeck M. The lymphocyte transformation test for diagnosis of drug-induced occupational allergy. J Allergy Clin Immunol. 1986;77:411–426. doi: 10.1016/0091-6749(86)90175-2. [DOI] [PubMed] [Google Scholar]
54.Sullivan T.J. Antigen-specific desensitization of patients allergic to penicillin. J Allergy Clin Immunol. 1982;69:500–508. doi: 10.1016/0091-6749(82)90174-9. [DOI] [PubMed] [Google Scholar]
55.Templeton B. Suicide by anaphylaxis attempted with penicillin. JAMA. 1965;192:264. doi: 10.1001/jama.1965.03080160084041. [DOI] [PubMed] [Google Scholar]
56.Van Arsdel P.P., Jr Allergy and adverse drug reactions. J Am Acad Derm. 1982;6:833–845. doi: 10.1016/S0190-9622(82)70073-8. [DOI] [PubMed] [Google Scholar]
57.Velcovsky H.-G., Federlin K. Unverträglichkeitsreaktionen gegenüber Insulin, auch Human-insulin, bei Diabetikern. Allergologie. 1987;10:287–296. [Google Scholar]
58.Vervloet D., Durham S. Adverse reactions to drugs. Br Med J. 1998;316:1511–1514. doi: 10.1136/bmj.316.7143.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
59.Vieluf D. Arzneimittelreaktionen. In: Przybilla B., Bergmann K., Ring J., editors. Praktische allergologische Diagnostik. Darmstadt: Steinkopff; 2000. pp. 224–242. [Google Scholar]
60.Vieluf D., Ring J. Der Allergie-Paß. MMW Fortschr Med. 2001;143:608–610. [PubMed] [Google Scholar]
61.Vittorio C.C., Muglia J.J. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 1995;155:2285–2290. doi: 10.1001/archinte.155.21.2285. [DOI] [PubMed] [Google Scholar]
62.De Weck A.L., Bundgaard M., editors. Allergic reactions to drugs. Handbook of experimental pharmacology. Berlin Heidelberg New York: Springer; 1984. [Google Scholar]
63.De Weck A.L. Zellulärer Allergen-Stimulie-rungstest (CAST) Allergologie. 1997;20:487–502. [Google Scholar]
64.Weiss M.E., Adkinson N.F. Allergy to protamine. Clin Rev Allergy. 1991;9:339–355. doi: 10.1007/BF02802312. [DOI] [PubMed] [Google Scholar]
65.Zanni M.P., von Greyerz S., Schnyder B., et al. HLA-restricted, processing-and metabolism-independent pathway of drug recognition by human ab T lymphocytes. J Clin Invest. 1998;102:1591–1598. doi: 10.1172/JCI3544. [DOI] [PMC free article] [PubMed] [Google Scholar]

References

1.Brockow K., Ring J. Mechanisms of pseudo-allergic reactions due to radiographic contrast media. Allergy Clin Immunol Int. 1996;8:123–125. [Google Scholar]
2.Brockow K., Vieluf D., Püschel K., Grosch J., Ring J. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to non-ionic radiocontrast medium. J Allergy Clin Immunol. 1999;104:237–238. doi: 10.1016/S0091-6749(99)70141-7. [DOI] [PubMed] [Google Scholar]
3.Capron A., Ameisen J., Joseph M., Auriault C., Tarnel A.B., Caen J. New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol. 1985;77:107–114. doi: 10.1159/000233762. [DOI] [PubMed] [Google Scholar]
4.Conroy M.C., de Weck A.L. Effect of aspirin and indomethacin on histamine release from leukocytes of patients with suspected intolerance to aspirin. Int Arch Allergy Appl Immunol. 1981;66([Suppl 1]):152–153. doi: 10.1159/000232890. [DOI] [Google Scholar]
5.Czech W., Schöpf E., Kapp A. Release of sulfidoleukotrienes in vitro: Its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm Res. 1995;44:291–295. doi: 10.1007/BF02032571. [DOI] [PubMed] [Google Scholar]
6.Dahlen B., Szczeklik A., Murray J.J. Celecoxib in patients with asthma and aspirin intolerance (letter) N Engl J Med. 2001;344:142. doi: 10.1056/NEJM200101113440215. [DOI] [PubMed] [Google Scholar]
7.Denborough M.A., Lovell R.R.H. Anaesthetic deaths in a family. Lancet. 1960;II:362. doi: 10.1093/bja/34.6.395. [DOI] [PubMed] [Google Scholar]
8.Doenicke A, Koenig UD (eds) (1983) Immunologie in Anästhesie und Intensivmedizin. Sertürner Workshops Einbek. Springer, Berlin Heidelberg New York
9.Dukor P., Kallos P., Schlumberger H.D., West G.B., editors. Pseudo-allergic reactions. Basel: Karger; 1980. [Google Scholar]
10.Fitzgerald G.A., Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345:433–442. doi: 10.1056/NEJM200108093450607. [DOI] [PubMed] [Google Scholar]
11.Gaetani G.F., Luzatto L. Haemolytic reactions induced by drugs and other agents: the role of red cell enzyme abnormalities and of abnormal haemoglobins. In: Dukor P., Kallos P., Schlumberger H.D., West G.B., editors. Pseudo-allergic reactions; involvement of drugs and chemicals. Basel: Karger; 1980. pp. 1–19. [Google Scholar]
12.Grimm V, Rakoski J, Ring J (2004) Selective COX-2 inhibitors also can elicit symptoms in patients with aspirin idiosyncrasy. J Allergy Clin Immunol (in press)
13.Hoigné R. Allergische und pseudo-allergische Reaktionen auf Penicillinpräparate. Acta Allergol. 1962;17:521. [Google Scholar]
14.Incaudo G., Schatz M., Patterson R., Rosenberg M., Yamamoto E., Hamburger R.N. Administration of local anesthetics to patients with a history of prior adverse reaction. J Allergy Clin Immunol. 1978;61:339–345. doi: 10.1016/0091-6749(78)90057-X. [DOI] [PubMed] [Google Scholar]
15.Kallos P., Kallos L. Pseudo-allergic reactions: involvement of drugs and chemical. Basel: Karger; 1980. Histamine and some other mediators of pseudo-allergic reactions; p. 28. [Google Scholar]
16.Kleinhans D., Galinsky T. Zur möglichen Provokation eines Bronchialasthmas und einer Urtikaria durch Natriumdisulfit. Allergologie. 1982;4:120–121. [Google Scholar]
17.Lasser E.C., Lang J.H., Lyon S.G., Hamblin A.E., Howard M.M. Prekallikrein-kallikrein conversion rate as a predictor of contrast media catastrophes. Radiology. 1981;140:11–15. doi: 10.1148/radiology.140.1.6166025. [DOI] [PubMed] [Google Scholar]
18.Lorenz W., Doenicke A. Histamine release in clinical conditions. Mt Sinai J Med N Y. 1978;45:357–386. [PubMed] [Google Scholar]
19.Meßmer K., Lorenz W., Sunder-Plassmann L., Klövekorn W.P., Hutzel M. Histamine release as cause of hypotension following rapid colloid infusion. Arch Pathol Pharm. 1970;267:433–439. doi: 10.1007/BF00997279. [DOI] [PubMed] [Google Scholar]
20.Paul E., Gall H.-M., Mechlin A., Möller R., Müller I. Acetylsalicylic acid (ASA)-augmentation in relation to ASA-intolerance. Allergo J. 2001;10:269–272. [Google Scholar]
21.Pierzchalska M., Mastalerz L., Sanak M., et al. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes preludes its value for aspirin sensitivity in asthma. Clin Exp Allergy. 2000;30:1785–1791. doi: 10.1046/j.1365-2222.2000.00953.x. [DOI] [PubMed] [Google Scholar]
22.Przybilla B., Ring J. Pseudo-allergische Arzneimittelreaktionen: Pathophysiologie und Diagnostik. Z Hautkr. 1987;62:430–443. [PubMed] [Google Scholar]
23.Ring J. Anaphylaktoide Reaktionen nach Infusion natürlicher und künstlicher Kolloide. Berlin Heidelberg New York: Springer; 1978. [Google Scholar]
24.Ring J., Brockow K., et al. Pseudo-allergische Arzneimittelreaktionen. In: Schultze-Werninghaus G., et al., editors. Manuale allergologicum. 2nd edn. Munich: Dustri; 2004. [Google Scholar]
25.Ring J., Arroyave C.M., Fritzler M.J., Tan E.M. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement dependent and independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol. 1978;32:105–118. [PMC free article] [PubMed] [Google Scholar]
26.Ring J., Rothenberger K.H., Clauß W. Prevention of anaphylactoid reactions after radiographic contrast media in fusion by combined histamine H1-and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol. 1985;78:9–14. doi: 10.1159/000233854. [DOI] [PubMed] [Google Scholar]
27.Ring J., Walz U. Indomethacin enhances in vitro histamine release induced by anti-IgE and Ca-Ionophore but inhibits C5a-induced release reactions from basophils of atopics and normals. Int Arch Allergy Appl Immunol. 1985;77:225–227. doi: 10.1159/000233794. [DOI] [PubMed] [Google Scholar]
28.Ring J. Pseudo-allergic reactions. In: Korenblat P.E., Wedner H.J., editors. Allergy: theory and practice. Philadelphia: Saunders; 1992. pp. 243–264. [Google Scholar]
29.Ruzicka T., Gerstmeier M., Przybilla B., Ring J. Allergy to local anesthetics: comparison of patch test with prick and intradermal test results. J Am Acad Dermatol. 1987;16:1202–1208. doi: 10.1016/S0190-9622(87)70158-3. [DOI] [PubMed] [Google Scholar]
30.Samter M., Beers R.F. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68:975–983. doi: 10.7326/0003-4819-68-5-975. [DOI] [PubMed] [Google Scholar]
31.Sánchez-Borges M., Capriles-Hulett A., Caballero-Fonseca F. NSAID hypersensitivity in the COX-2 inhibitor era. ACI Int. 2001;13:211–218. [Google Scholar]
32.Schick E., Weber L., Gall H. Delayed hypersensitivity reaction to the non-ionic contrast medium iopromide. Contact Dermatitis. 1996;35:312. doi: 10.1111/j.1600-0536.1996.tb02403.x. [DOI] [PubMed] [Google Scholar]
33.Simon R.A. Adverse reactions to drug additives. J Allergy Clin Immunol. 1984;74:623. doi: 10.1016/0091-6749(84)90116-7. [DOI] [PubMed] [Google Scholar]
34.Stevenson D.D. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol. 1984;74:617–622. doi: 10.1016/0091-6749(84)90115-5. [DOI] [PubMed] [Google Scholar]
35.Stevenson D.D., Simon R.A. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol. 2001;108:47–51. doi: 10.1067/mai.2001.119410. [DOI] [PubMed] [Google Scholar]
36.Szczeklik A., Sanak M. Genetic mechanisms in aspirin-induced asthma. Am J Resp Crit Care Med. 2000;161:S142–146. doi: 10.1164/ajrccm.161.supplement_1.ltta-28. [DOI] [PubMed] [Google Scholar]
37.Szczeklik A., Nizankowska E., Sanak M., Swierczynska M. Aspirin-induced rhinitis and asthma. Curr Opin Allergy Clin Immunol. 2001;1:27–33. doi: 10.1097/01.all.0000010981.95396.58. [DOI] [PubMed] [Google Scholar]
38.Till G., Rother U., Gemsa D., Gerhardt P. Aktivierung des Komplementsystems bei Zwischenfällen nach Kontrastmittelinjektionen. Verh Dtsch Ges Inn Med. 1977;83:1589–1591. [PubMed] [Google Scholar]
39.Vervloet D.L., Dor P., Arneud A., Senft M., Alazia M., Charpin J. Anaphylactic reactions to succinylcholine. Prevention of mediator release by choline. J Allergy Clin Immunol. 1985;75:150. doi: 10.1016/0091-6749(85)90319-7. [DOI] [PubMed] [Google Scholar]
40.Virchow C., editor. Analgetika, Asthma. Frankfurt: Programmed; 1986. [Google Scholar]
41.Voigtländer V., Walter E., Siess R., Rother U. Acetylsalicylic acid intolerance: a possible role of complement. Int Archs Allergy Appl Immunol. 1981;66([Suppl 1]):154–155. doi: 10.1159/000232891. [DOI] [Google Scholar]
42.Wahl R., Kleinhans D. IgE-mediated allergic reactions to fruit gums and investigation of cross-reactivity between gelatine and modified gelatine-containing products. Clin Exp Allergy. 1989;19:77–80. doi: 10.1111/j.1365-2222.1989.tb02348.x. [DOI] [PubMed] [Google Scholar]
43.Wedi B., Kapp A. Aspirin induced adverse skin reactions: new pathophysiological aspects. Thorax. 2000;55([Suppl 2]):S70–S71. doi: 10.1136/thorax.55.suppl_2.S70. [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Wüthrich B. Allergische und pseudo-allergische Reaktionen der Haut durch Arzneimittel und Lebensmitteladditiva. Schweiz Rdsch Med. 1983;72:691–699. [PubMed] [Google Scholar]
45.Yoshida S., Ishizaki Y., Onuma K., Shoji T., Nakagawa H., Amayasu H. Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma. J Allergy Clin Immunol. 2000;106:1203–1204. doi: 10.1067/mai.2000.110926. [DOI] [PubMed] [Google Scholar]

References

1.Aberer W., Stingl G., Wolff K. Stevens-Johnson-Syndrom und toxische epidermale Nekrolyse nach Sulfonamideinnahme. Hautarzt. 1982;33:484–490. [PubMed] [Google Scholar]
2.Archard H.O. Stomatologic disorders of an internal and integumental nature. In: Fitzpatrick T.B., Eisen A.Z., Wolff K., Freedberg I.M., Austen K.F., editors. Dermatology in general medicine. New York: McGraw Hill; 1979. p. 834. [Google Scholar]
3.Arndt K.A., Jick H. Rate of cutaneous reactions to drugs. J Am Med Assoc. 1976;235:918. doi: 10.1001/jama.235.9.918. [DOI] [PubMed] [Google Scholar]
4.Bachot N., Roujeau J.-C. Physiopathology and treatment of severe drug eruptions. Curr Opin Allergy Clin Immunol. 2001;1:293–298. doi: 10.1097/01.all.0000011029.46401.66. [DOI] [PubMed] [Google Scholar]
5.Barreiro P., Soriano V., Casas E., et al. Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids. AIDS. 2000;14:2153–2157. doi: 10.1097/00002030-200009290-00012. [DOI] [PubMed] [Google Scholar]
6.Behrendt H., Gollnick H., Bonnekoh B. Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psioriasis. Eur J Dermatol. 2000;10:365–369. [PubMed] [Google Scholar]
7.Bergner T., Przybilla B., Ring J. Anaphylactoid reaction to the coloring agent Erythrosine in an antiallergic drug. Allergy Clin Immunol News. 1989;1:177–179. [Google Scholar]
8.Bigby M., Stern R. Cutaneous reactions to nonsteroidal anti-inflammatory drugs. J Am Acad Dermatol. 1985;12:866–876. doi: 10.1016/S0190-9622(85)70110-7. [DOI] [PubMed] [Google Scholar]
9.Billingham R.E., Streilein J.W. Toxic epidermal necrolysis and homologous disease in hamsters. Arch Dermatol. 1968;98:528. doi: 10.1001/archderm.98.5.528. [DOI] [PubMed] [Google Scholar]
10.Bork K. Unerwünschte Wirkungen systemisch verabreichter Medikamente an Haut und hautnahen Schleimhüten bei Erwachsenen und Kindern. Stuttgart: Schattauer; 1985. Kutane Arzneimittelnebenwirkungen. [Google Scholar]
11.Braun-Falco O, Bandmann HJ (eds) (1970) Das Lyell-Syndrom. Das Syndrom der verbrühten Haut. Huber, Bern
12.Braun-Falco O., Plewig G., Wolff H.H. Dermatologie und Venerologie. 4th edn. Berlin Heidelberg New York: Springer; 1998. [Google Scholar]
13.Craven N.M. Management of toxic epidermal necrolysis. Hosp Med. 2000;61:778–781. doi: 10.12968/hosp.2000.61.11.1463. [DOI] [PubMed] [Google Scholar]
14.Crowson A.N., Magro C.M. Recent advances in the pathology of cutaneous drug eruptions. Dermatol Clin. 1999;17:537–560. doi: 10.1016/S0733-8635(05)70106-6. [DOI] [PubMed] [Google Scholar]
15.Davis J.P., Chesney P.J., Wand P.J., LaVenture M. Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors and prevention. N Engl J Med. 1980;303:1429–1435. doi: 10.1056/NEJM198012183032501. [DOI] [PubMed] [Google Scholar]
16.Fellner M.J., Prutkin L. Morbilliform eruptions caused by penicillin. A study by electron microscopy and immunologic tests. J Invest Dermatol. 1970;55:390–395. doi: 10.1111/1523-1747.ep12260501. [DOI] [PubMed] [Google Scholar]
17.French L.E., Tschopp J. Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease; potential for therapeutic inhibition. Schweiz Med Wochenschr. 2000;130:1656–1661. [PubMed] [Google Scholar]
18.Goerz G., Ruzicka T. Lyell-Syndrom. Berlin: Grosse; 1978. [Google Scholar]
19.Gutierrez-Ramos J.C., Lloyd C., Gonzalo J.A. Eotaxin from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today. 1999;20:500–504. doi: 10.1016/S0167-5699(99)01522-4. [DOI] [PubMed] [Google Scholar]
20.Hari Y., Frutig-Schnyder K., Hurni M., Yawalkar N., Zanni M.P., Schnyder B., Kappeler A., von Greyerz S., Braathen L.R., Pichler W.J. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy. 2001;31:1398–1408. doi: 10.1046/j.1365-2222.2001.01164.x. [DOI] [PubMed] [Google Scholar]
21.Hofmann C., Burg G., Jung C. Kutane Nebenwirkungen der Goldtherapie. Klinische und histologische Ergebnisse. Z Rheum. 1986;45:100–106. [PubMed] [Google Scholar]
22.Hertl M., Jugert F., Merk H.F. CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol. 1995;132:215–220. doi: 10.1111/j.1365-2133.1995.tb05016.x. [DOI] [PubMed] [Google Scholar]
23.Hurwitz M., Rivera H.P., Gooch M.H., Slama T.G., Handt A., Weiss J. Toxic shock syndrome or toxic epidermal necrolysis? J Am Acad Dermatol. 1982;7:246–254. doi: 10.1016/S0190-9622(82)70114-8. [DOI] [PubMed] [Google Scholar]
24.Kaplan A.P. Drug induced skin disease. J Allergy Clin Immunol. 1984;74:573–579. doi: 10.1016/0091-6749(84)90109-X. [DOI] [PubMed] [Google Scholar]
25.Kasemir H., Kerp L. Arzneimittel-Allergene und Arzneimittel-Allergien. In: Filipp G., editor. Allergologie. Gräfelfing: Werk-Verlag; 1980. p. 144. [Google Scholar]
26.Kauppinen K., Stubb S. Drug eruptions: Causative agents and clinical types. A series of inpatients during a 10-year period. Acta Derm Venereol. 1984;64:320–324. [PubMed] [Google Scholar]
27.Kazmierowski J.A., Wuepper K.D. Erythema multiforme: Clinical spectrum and immunopathogenesis. Springer Semin Immunopathol. 1981;4:45. doi: 10.1007/BF01891884. [DOI] [PubMed] [Google Scholar]
28.Kleinhans D., Fuchs T. Orale Provokation bei einem durch Barbitursäure verursachten Lyell-Syndrom. Akt Derm. 1984;10:122–124. [Google Scholar]
29.Knowles S.R., Uetrecht J., Shear N.H. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet. 2000;356:1587–1591. doi: 10.1016/S0140-6736(00)03137-8. [DOI] [PubMed] [Google Scholar]
30.Konstantinow A., Mühlbauer W., Balda B.R., Ring J. Toxische epidermale Nekrolysen (Arzneimittel-induziertes Lyell-Syndrom) Dtsch Med Wochenschr. 2001;126:141–144. doi: 10.1055/s-2001-11051. [DOI] [PubMed] [Google Scholar]
31.Le Cleach L., Delaire S., Boumsell L., et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225–230. doi: 10.1046/j.1365-2249.2000.01119.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
32.Luderschmidt C., Linderkamp O., Ring J. Drug-induced toxic epidermal necrolysis (Lyell’s syndrome) in a 4-year-old girl. Eur J Pediatr. 1985;14:91–93. doi: 10.1007/BF00491939. [DOI] [PubMed] [Google Scholar]
33.Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956;68:355–361. doi: 10.1111/j.1365-2133.1956.tb12766.x. [DOI] [PubMed] [Google Scholar]
34.Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Derm. 1967;79:662–671. doi: 10.1111/j.1365-2133.1967.tb11434.x. [DOI] [PubMed] [Google Scholar]
35.Marghescu S. Pathomechanismus — Klinik — Testung — Therapie. Erlangen: Perimed; 1978. Allergische Arznei-Exantheme. [Google Scholar]
36.Merk H., Gerecke D. AIDS-Bericht. Berlin: Grosse; 1986. Arzneimittelnebenwirkungen bei Patienten mit LAV/HTLV-III-Infektion; pp. 139–142. [Google Scholar]
37.Merk H.F., Hertl M. Immunologic mechanisms of cutaneous drug reactions. Semin Cutan MedSurg. 1996;15:228–235. doi: 10.1016/S1085-5629(96)80035-6. [DOI] [PubMed] [Google Scholar]
38.Merot Y., Saurat J.H. Clues to pathogenesis of toxic epidermal necrolysis. Int J Dermatol. 1985;24:165–168. doi: 10.1111/j.1365-4362.1985.tb05749.x. [DOI] [PubMed] [Google Scholar]
39.Mockenhaupt M., Norgauer J. Schwere arzneimittelinduzierte Hautreaktionen. Allergologie. 2001;24:419–432. [Google Scholar]
40.Mougdil A., Porat S., Brunnel P., Jordan S.C. Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin. Clin Pediatrics. 1995;34:47–51. doi: 10.1177/000992289503400109. [DOI] [PubMed] [Google Scholar]
41.Murphy G.F., Guillén F.J., Flynn T.C. Cytotoxic T lymphocytes and phenotypically abnormal epidermal dendritic cells in fixed cutaneous eruptions. Hum Pathol. 1985;16:1264–1271. doi: 10.1016/S0046-8177(85)80040-X. [DOI] [PubMed] [Google Scholar]
42.Pichler W.J., Yawalkar N. Allergic reactions to drugs: involvement of T cells. Thorax. 2000;55([Suppl 2]):S61–S65. doi: 10.1136/thorax.55.suppl_2.S61. [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Pichler W.J., Zanni M., von Greyerz S., et al. High IL-5 production by human drug-specific T cell clones. Int Arch Allergy Immunol. 1997;113:177–180. doi: 10.1159/000237539. [DOI] [PubMed] [Google Scholar]
44.Ring J. Diagnostik von Arzneimittel-bedingten Unverträglichkeitsreaktionen. Hautarzt. 1987;38:16–22. [Google Scholar]
45.Ring J., et al. Drug-induced Leyell’s syndrome (toxic epidermal necrolysis) In: Pichler W.J., et al., editors. Progress in allergy and clinical immunology. Toronto: Hogrefe & Huber; 1989. pp. 455–461. [Google Scholar]
46.Ring J., Przybilla B., Gollhausen R. Progressive pigmentary purpura provoked by a phytotherapeutic drug containing Echinacea extract. Allergy Clin Immunol News. 1989;114:108–109. [Google Scholar]
47.Ring J., Kraus K., Fröschl M., Brunner R., Przybilla B., Burg G., Braun-Falco O. AIDS, HIV-Infektion und allergische Reaktionen. AIDS Forschung. 1987;2:643–646. [Google Scholar]
48.Roujeau J.C., Kelly J.P., Naldi L., et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600–1607. doi: 10.1056/NEJM199512143332404. [DOI] [PubMed] [Google Scholar]
49.Roujeau J.-C., Stern R.S. Severe cutaneous adverse reactions to drugs. N Engl J Med. 1994;331:1272–1285. doi: 10.1056/NEJM199411103311906. [DOI] [PubMed] [Google Scholar]
50.Ruiz-Maldonado R. Acute disseminated epidermal necrosis types 1,2, and 3: Study of sixty cases. J Am Acad Dermatol. 1985;13:623–635. doi: 10.1016/S0190-9622(85)70207-1. [DOI] [PubMed] [Google Scholar]
51.Rzany B., Hering O., Mockenhaupt M., et al. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 1996;135:6–11. doi: 10.1111/j.1365-2133.1996.tb03598.x. [DOI] [PubMed] [Google Scholar]
52.Sachs B., Merk H. Demonstration and characterization of drug-specific lymphocyte reactivity in drug allergies. Allergy Clin Immunol Int. 2001;13:91–98. doi: 10.1027/0838-1925.13.3.91. [DOI] [Google Scholar]
53.Schöpf E., Stühmer A., Rzany B., Victor N., Zentgraf R., Kapp J.F. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol. 1991;127:839–842. doi: 10.1001/archderm.127.6.839. [DOI] [PubMed] [Google Scholar]
54.Schulz K.H. Stellenwert und Aussagekraft von Testmethoden bei allergischen Arznei-Exanthemen. In: Braun-Falco O., Wolff H.H., editors. Fortschritte der praktischen Dermatologie und Venerologie. Berlin Heidelberg New York: Springer; 1966. p. 71. [Google Scholar]
55.Steigleder G.K. Haut. In: Heintz R., editor. Erkrankungen durch Arzneimittel. Diagnostik, Klinik, Pathogenese und Therapie. Stuttgart: Thieme; 1966. pp. 103–130. [Google Scholar]
56.Schulz J.T., Sheridan R.L., Ryan C.M., et al. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil. 2000;21:199–204. doi: 10.1097/00004630-200021030-00004. [DOI] [PubMed] [Google Scholar]
57.Smith C.L., Brown I., Torraca B.M. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus. Clin Infect Dis. 1997;25:1477–1478. doi: 10.1086/516993. [DOI] [PubMed] [Google Scholar]
58.Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet. 1978;II:1116–1118. doi: 10.1016/S0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]
59.Viard I., Wehrli P., Bullani R., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282:490–493. doi: 10.1126/science.282.5388.490. [DOI] [PubMed] [Google Scholar]
60.Stern R.S., Wintroub B.U., et al. Cutaneous reactions to drugs. In: Freedberg I.M., Eisen A.Z., Wolff K., et al., editors. Fitzpatrick’s dermatology in general medicine. 5th edn. New York: McGraw Hill; 1999. pp. 1633–1642. [Google Scholar]
61.Wolff HH, Winzer M (1986) Histopathological patterns of drug eruptions. In: Ring J, Burg G (eds) New trends in allergy II. Springer, Berlin Heidelberg New York, pp 240–253
62.Zürcher K., Krebs A. Cutaneous drug reactions. Basel: Karger; 1992. [Google Scholar]

References

1.Apostolou I., Takahama Y., Belmant C., Kawanos T., Huerre M., Marchal G., Cui J., Taniguchi M., Nakauchi H., Fournie J.-J., Kourilsky P., Gachelin G. Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA. 1999;96:5141–5146. doi: 10.1073/pnas.96.9.5141. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Baumgarten C. Häufigste Nebenwirkungen bei der spezifischen Hyposensibilisierung. Allergologie. 1978;1:223–228. [Google Scholar]
3.Bode U., Ring J., Schmoeckel C. Granulom-bildung nach intrakutaner Applikation von Procain-Polyvinylpyrrolidon (PVP) Hautarzt. 1984;35:474–477. [PubMed] [Google Scholar]
4.Bork K., Hoede N. Vortäuschung maligner Tumoren durch nicht deklariertes PVP in Arzneimitteln. Hautarzt. 1982;33:373–377. [PubMed] [Google Scholar]
5.Boros D.L. The role of lymphokines in granulomatous inflammations. Lymphokines. 1981;3:257–281. [Google Scholar]
6.Braun-Falco O., Plewig G., Wolff H.H. Derma tologie und Venerologie. 4th edn. Berlin Heidelberg New York: Springer; 1998. [Google Scholar]
7.Castrow F.F.I.I., Krull E. An injectable collagen implant — update. J Am Acad Dermatol. 1983;9:889–893. doi: 10.1016/S0190-9622(83)70204-5. [DOI] [PubMed] [Google Scholar]
28.Cooperman L.S., Mackinnon V., Bechler G., Pharriss B.B. Injectable collagen: A six-year clinical investigation. Aesth Plast Surg. 1983;9:145–151. doi: 10.1007/BF01570347. [DOI] [PubMed] [Google Scholar]
9.Dahl M., Ullmann S., Goetz R.W. Vasculitis in granuloma anulare. Arch Dermatol. 1977;113:463–467. doi: 10.1001/archderm.113.4.463. [DOI] [PubMed] [Google Scholar]
10.Eberlein-König B., Hein R., Abeck D., Engst R., Ring J. Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C. Br J Dermatol. 1999;140:370–372. doi: 10.1046/j.1365-2133.1999.02687.x. [DOI] [PubMed] [Google Scholar]
11.Eder M., Gedigk P. Lehrbuch der allgemeinen Pathologie und pathologischen Anatomie. Berlin Heidelberg New York: Springer; 1986. [Google Scholar]
12.Ellingsworth L.R., DeLustro F., Brennan J.E., Sawamura S., McPherson J. The human immune response to reconstituted bovine collagen. J Immunol. 1986;36:877–882. [PubMed] [Google Scholar]
13.Harms M., Masouyé I., Saurat J.H. Silica granuloma mimicking granulomatous cheilitis. Dermatologica. 1990;181:246–247. doi: 10.1159/000247945. [DOI] [PubMed] [Google Scholar]
14.Kleinhans D., Knoth W. Immunhistochemischer Fibrin-Nachweis beim Granuloma anulare. Arch Dermatol Res. 1977;258:231–234. doi: 10.1007/BF00561124. [DOI] [PubMed] [Google Scholar]
15.Klepzig K., Ring J., Burg G. Pseudolymphom nach Hyposensibilisierung. Allergologie. 1987;10:432. [Google Scholar]
16.Kligman A.M., Armstrong R.C. Histologic response to intradermal zyderm und zyplast (glutaraldehyde crosslinked) collagen in humans. J Dermatol Surg Oncol. 1986;12:351–357. doi: 10.1111/j.1524-4725.1986.tb01920.x. [DOI] [PubMed] [Google Scholar]
17.Konz B. Injizierbares Kollagen. In: Braun-Falco O., Burg G., editors. Fortschritte der praktischen Dermatologie und Venerologie. Berlin Heidelberg New York: Springer; 1983. pp. 193–198. [Google Scholar]
18.Kuhn K., Timpl R. Myelofibrosis and the biology of connective tissue. New York: Liss; 1984. Collagens. Molecular and antigenic structure; p. 45. [PubMed] [Google Scholar]
19.Lombardi T., Kuffer R., Dubrez B. Polishing-paste-induced silica granuloma of the gingiva. Dermatology. 2001;203:177–179. doi: 10.1159/000051738. [DOI] [PubMed] [Google Scholar]
20.McCoy J.P., Schade W.J., Siegle R.J., Vanderveen E.E., Zachary C.B., Waldinger T.P., Swanson N.Y. Immune responses to bovine collagen implants. J Am Acad Dermatol. 1987;16:955–960. doi: 10.1016/S0190-9622(87)70120-0. [DOI] [PubMed] [Google Scholar]
22.Rapaport M. Granuloma annulare caused by injectable collagen. Arch Dermatol. 1984;120:837. doi: 10.1001/archderm.120.7.837c. [DOI] [PubMed] [Google Scholar]
23.Raupach B., Kaufman S. Immune responses to intracellular bacteria. Curr Opin Immunol. 2001;13:417–428. doi: 10.1016/S0952-7915(00)00236-3. [DOI] [PubMed] [Google Scholar]
24.Roach D.R., Briscoe H., Saunders B., France M.P., Riminton S., Britton W.J. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med. 2001;193:239–246. doi: 10.1084/jem.193.2.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Roitt I., Delves P. Essential immunology. 10th edn. Oxford: Blackwell; 2001. [Google Scholar]
26.Sandritter W., Beneke G. Allgemeine Pathologie. Stuttgart: Schattauer; 1984. [Google Scholar]
27.Sellem P.H., Caranzan F.R., Bene M.C., Faure G.C. Immunogenicity of injectable collagen implants. J Dermatol Surg Oncol. 1987;13:1199–1202. doi: 10.1111/j.1524-4725.1987.tb02431.x. [DOI] [PubMed] [Google Scholar]
28.Shelley W.B., Hurley H.J. The pathogenesis of silica granulomas in man: A nonallergic colloidal phenomenon. J Invest Dermatol. 1960;34:107–123. [PubMed] [Google Scholar]
29.Schurig V., Konz B., Ring J., Dorn M. Granulombildung an Test-und Behandlungsstellen durch intrakutan verabreichtes, injizierbares Kollagen. Hautarzt. 1986;37:42–45. [PubMed] [Google Scholar]
30.Shelley W.B., Hurrley H.J. The allergic origin of zirconium deodorant granulomas. Br J Dermatol. 1958;70:75–82. doi: 10.1111/j.1365-2133.1958.tb13297.x. [DOI] [PubMed] [Google Scholar]

References

1.Almon R.R., Andrew C.G., Appel S.H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 1974;186:55–57. doi: 10.1126/science.186.4158.55. [DOI] [PubMed] [Google Scholar]
2.Atkinson M.A., Maclaren N.K. The pathogenesis of insulin-dependent diabetes mellitus. N Engl JMed. 1994;331:1428–1436. doi: 10.1056/NEJM199411243312107. [DOI] [PubMed] [Google Scholar]
3.Beck K., Hertel J., Rasmussen N.G., et al. Effect of maternal thyroid antibodies and postpartum thyroiditis on the fetus and neonate. Acta Endocrinol. 1991;125:146. doi: 10.1530/acta.0.1250146. [DOI] [PubMed] [Google Scholar]
4.Chapel H., Haeney M. Essentials of clinical immunology. 3rd edn. Oxford: Blackwell; 1993. [Google Scholar]
5.Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., Greaves M.W. Autoantibodies against high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599–1604. doi: 10.1056/NEJM199306033282204. [DOI] [PubMed] [Google Scholar]
6.King C., Sarvetnick N. Organ-specific auto-immunity. Curr Opin Immunol. 1997;9:863–871. doi: 10.1016/S0952-7915(97)80191-4. [DOI] [PubMed] [Google Scholar]
7.Peter H.H., Pichler W.J. Klinische Immuno-logie. 2nd edn. Munich: Urban & Schwarzenberg; 1996. [Google Scholar]
8.Roitt I.M. Essential immunology. 8th edn. Oxford: Blackwell; 1996. [Google Scholar]
9.Shoenfeld Y., Isenberg D., editors. Natural autoantibodies. Boca Raton, Florida: CRC Press; 1993. [Google Scholar]
10.Stadler B.M., Miescher S., Horn M., et al. Allergic manifestations as the results of a conditional autoimmune response. Int Arch Allergy Immunol. 2001;124:411–413. doi: 10.1159/000053773. [DOI] [PubMed] [Google Scholar]
11.Tan E.M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/S0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
12.Valenta R., Seiberler S., Natter S., et al. Auto-allergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol. 2000;105:432–437. doi: 10.1067/mai.2000.104783. [DOI] [PubMed] [Google Scholar]
13.Venter J.C., Fraser C.M. The development of monoclonal antibodies to beta-adrenergic receptors and their use in receptor purification and characterization. In: Eisenbarth G., Fellows R., editors. Monoclonal antibodies in endocrine research. New York: Raven Press; 1981. pp. 119–134. [Google Scholar]
14.Vincent A., Mewsom-Davis J. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol. 1982;49:257–265. [PMC free article] [PubMed] [Google Scholar]
15.Wegmann D.R. The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus. Curr Opin Immunol. 1996;8:860–864. doi: 10.1016/S0952-7915(96)80016-1. [DOI] [PubMed] [Google Scholar]

References

1.Abbey S.E., Garfinkel P.E. Neurasthenia and chronic fatigue syndrome: The role of culture in making of a diagnosis. Am J Psychiatry. 1991;148:1638–11646. doi: 10.1176/ajp.148.12.1638. [DOI] [PubMed] [Google Scholar]
2.Altenkirch H. Multiple chemical sensitivity (MCS)-Syndrom. Gesundheitswesen. 1995;57:661–666. [PubMed] [Google Scholar]
3.Bartenstein P.F., Grundwald F., Herholz K., Kuwert T., Tatsch K., Sabri O., Weiller C. Rolle der Positronen-Emissions-Tomographie (PET) und Single-Photon-Emissions-Tomographie (SPECT) bei der sogenannten “Multiple Chemical Sensitivity” (MCS) Nuklearmedizin. 1999;38:297–301. [PubMed] [Google Scholar]
4.Bell I.R., Miller C.S., Schwarz G.E., et al. Neu-ropsychiatric and somatic characteristics of young adults with and without self-reported chemical odor intolerance and chemical sensitivity. Arch Environ Health. 1996;51:9–21. doi: 10.1080/00039896.1996.9935987. [DOI] [PubMed] [Google Scholar]
5.Binkley K., King N., Poonai N., Seeman P., Ulpian C., Kennedy J. Idiopathic environmental intolerance: Increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol. 2001;107:887–890. doi: 10.1067/mai.2001.114243. [DOI] [PubMed] [Google Scholar]
6.Bornschein S., Hausteiner C., Zilker T., Bickel H., Förstl H. Psychiatrische und somatische Morbidität bei Patienten mit vermuteter Multiple Chemical Sensitivity (MCS) Nervenarzt. 2000;71:737–744. doi: 10.1007/s001150050658. [DOI] [PubMed] [Google Scholar]
7.Bullinger M. Psychological effects of air pollution on healthy residents — a time-series approach. J Environ Psychol. 1989;9:103–118. doi: 10.1016/S0272-4944(89)80002-7. [DOI] [Google Scholar]
8.Cullen M.R. The worker with multiple chemical sensitivities: An overview. State Art Rev Occup Med. 1987;2:655–661. [PubMed] [Google Scholar]
9.Derbolowsky J. Die Glaubwürdigkeit wieder herstellen. Zeitschr Umweltmed. 1999;7:2–4. [Google Scholar]
10.Eberlein-König B., Przybilla B., Kühnl P., Pechak J., Gebefügi I., Kleinschmidt J., Ring J. Influence of airborne nitrogen dioxide or formaldehyde on parameters of skin function and cellular activation in patients with atopic eczema and control subjects. J Allergy Clin Immunol. 1998;101:141–143. doi: 10.1016/S0091-6749(98)70212-X. [DOI] [PubMed] [Google Scholar]
11.Eikmann T., Herr C. Ein Paradigmenwechsel in der Umweltmedizin? Umwelt Forschung Prax. 2001;6:179–180. [Google Scholar]
12.Fabig K.-R. Glutathion-S-Transferase T1 und Multiple Chemikaliensensitivität (MCS) Umwelt Medizin Gesellschaft. 1999;12:226–232. [Google Scholar]
13.Gieler U., et al. Therapeutische Aspekte des MCS-Syndroms. Umweltmed Forschung Praxis. 1998;3:3–10. [Google Scholar]
14.Grimm V., Ruhdorfer S., Eberlein-König B., Scherer G., Engst R., Ring J. Defizit der Glutathi-ontransferase bei Patienten mit Öko-Syndrom? Allergo J. 1999;8([Suppl 1]):32. [Google Scholar]
15.Hüppe M., Bullinger M. Verfahren zur MCS-Diagnostik. Zusammenfassung und Bewertung einer Umfrage. Umweltmed Forschung Prax. 1997;2:291–294. [Google Scholar]
16.IPCS (International Programme on Chemical Safety) Report of Multiple Chemical Sensitivities (MCS) Workshop. Berlin, Inst Arch Occup Environ Health. 1996;69:224–226. [Google Scholar]
17.Kofler W. Umweltängste, Toxikopie-Mechanismus, komplexes evolutionäres Coping-Modell und die Notwendigkeit neuartiger Auflagen für genehmigungspflichtige Anlagen. In: Aurand K., Hazard B.P., Tretter F., editors. Umweltbelastungen und Ängste. Wiesbaden: Westdeutscher Verlag; 1993. pp. 225–226. [Google Scholar]
18.Kröling P. Zur Problematik des “Sick building”-Syndroms. Allergologie. 1989;3:118–129. [Google Scholar]
19.Molina C., Caillaud D., Molina N. Sick building syndrome and atopy. Indoor Air. 1993;1:369–373. [Google Scholar]
20.Neuhann HF, Wiesmüller GA (1994) Diagnostische Strategien bei gebäudebezogenen Gesundheitsstörungen. In: Luftverunreinigung in Innenräumen. VDI Berichte 1122
21.Nixon P.G.F. “Total allergy syndrome” or fluctuating hypercarbia? Lancet. 1982;I:516. doi: 10.1016/s0140-6736(82)91440-4. [DOI] [PubMed] [Google Scholar]
22.Österberg O.P., Akesson B., Bergendorf U., Karlson B., Seger L. Suprathreshold intensity and annoyance reactions in experimental challenge to toluene and n-butyl acetate among subjects with long-term solvent exposure. Scand J Work Environ Health. 1998;24:432–438. [PubMed] [Google Scholar]
23.Ring J., Gabriel G., Vieluf D., Przybilla B. “Das klinische Ökologie-Syndrom” (“Öko-Syndrom”): Polysomatische Beschwerden bei vermuteter Allergie gegen Umweltschadstoffe. Münch Med Wochenschr. 1991;133:50–55. [Google Scholar]
24.Ring J., Eberlein-König B., Behrendt H. “Eco-Syndrome” (“multiple chemical sensitivity”-MCS) Zbl Hyg Umweltmed. 1999;202:207–218. [PubMed] [Google Scholar]
25.Ring J., Triendl C., Behrendt H., Borelli S. Das Öko-Syndrom (multiple chemical sensitivity) und verwandte Syndrome. In: Przybilla B., Bergmann K., Ring J., editors. Praktische allergologische Diagnostik. Darmstadt: Steinkopff; 2000. pp. 351–371. [Google Scholar]
26.Röttgers H.R. Psychisch Kranke in der Umweltmedizin. Deutsches Ärzteblatt. 2000;97:A835–A840. [Google Scholar]
27.Selner J.C., Staudemayer H. Neuropsycho-physiologic observation in patients presenting with environmental illness. Toxicol Indust Health. 1992;8:145–155. [PubMed] [Google Scholar]
28.Staudenmayer H., Selner J., Buhr M. Double-blind provocation chamber challenges in 20 patients presenting with “multiple chemical sensitivity”. Regul Toxicol Pharmacol. 1993;18:44–53. doi: 10.1006/rtph.1993.1043. [DOI] [PubMed] [Google Scholar]
29.Staudenmayer H., Selner M., Selner J. Adult sequelae of childhood abuse presenting as environmental illness. Ann Allergy. 1993;71:538–546. [PubMed] [Google Scholar]
30.Terr A. Immunological issues in “multiple chemical sensitivities”. Regul Toxicol Pharmacol. 1993;18:54–60. doi: 10.1006/rtph.1993.1044. [DOI] [PubMed] [Google Scholar]
31.Tretter F. Umweltbezogene funktionelle Syndrome. Int Praxis. 1996;37:669–686. [Google Scholar]
32.Triendl C., Borelli S., Rakoski J., Herschbach P., Behrendt H., Ring J. Das “Öko-Syndrom” (multiple chemical sensitivity”): Allergologisch-umweltmedizinisches Management. Allergologie. 1999;22:744–760. [Google Scholar]
33.Voack C., Borelli S., Ring J. Der umweltme-dizinische 4-Stufenplan. Münch Med Wochenschr. 1997;139:69–72. [Google Scholar]
34.Wiesmüller G.A., Hornberg D. Multiple Chemikalienüberempfindlichkeiten (MCS). Eine Herausforderung moderner Diagnostik und Therapie. Allergologie. 2001;24:507–51. [Google Scholar]
35.Zilker M. Pathophysiological mechanisms of fibromyalgia. Clin J Pain. 1991;7([Suppl 1]):8–15. [PubMed] [Google Scholar]
36.Wüthrich B. Allergien: Umweltkrankheiten Nummer 1. Der Allergie-Patient im Span-nungsfeld zwischen Schul-und Alternativmedizin. Dermatol Beruf Umwelt/Occup Environ Der-matol. 2001;49:136 141. [Google Scholar]
37.Walkowiak J., Wiener J.-A., Fastabend A., Heinzow B., Krämer U., Schmidt E., Steingrüber H.-J., Wundram S., Winneke G. Environmental exposure to polychlorinated biphenyls and quality of the home environment: effect on psychodevelopment in early childhood. Lancet. 2001;358:1602–1607. doi: 10.1016/S0140-6736(01)06654-5. [DOI] [PubMed] [Google Scholar]

[CR1] 1.Bachert C., Hauser U., Prem B., Rudack C., Ganzer U. Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol. 1995;1([Suppl]):44–49. doi: 10.1007/BF02484434. [DOI] [PubMed] [Google Scholar]

[CR2] 2.Bachmann W., Bachert C. Quantitative evaluation of rhinomanometric curves. A new simple method. Laryngol Rhinol Otol. 1984;63:58–61. doi: 10.1055/s-2007-1008242. [DOI] [PubMed] [Google Scholar]

[CR3] 3.Bousquet J., Vignola A.M., Campbell A.M., Michel F.B. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol. 1996;110:207–218. doi: 10.1159/000237289. [DOI] [PubMed] [Google Scholar]

[CR4] 4.Busse W.W., Holgate S.T. Asthma and rhinitis. Oxford: Blackwell; 1995. [Google Scholar]

[CR5] 5.Canonica G.W., Ciprandi G., Pesce G.P., Buscaglia S., Paolieri F., Bagnasco M. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol. 1995;107:99–102. doi: 10.1159/000236943. [DOI] [PubMed] [Google Scholar]

[CR6] 6.Durham S.R. Mechanisms of mucosal inflammation in the nose and lungs. Clin Exp Allergy. 1998;28([Suppl 2]):15–16. [PubMed] [Google Scholar]

[CR7] 7.Ellegard E., Karlsson G. Nasal congestion during pregnancy. Clin Otolaryngol. 1999;24:307–311. doi: 10.1046/j.1365-2273.1999.00264.x. [DOI] [PubMed] [Google Scholar]

[CR8] 8.Heppt W. Zytologie der Nasenschleimhaut. Berlin Heidelberg New York: Springer; 1998. [Google Scholar]

[CR9] 9.Malm L., van-Wijk R.G., Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. Rhinology. 1999;37:133–135. [PubMed] [Google Scholar]

[CR10] 10.Mygind N., Dahl R., Pedersen S., Thestrup-Pedersen K. Essential Allergy. Oxford: Blackwell Science; 1996. [Google Scholar]

[CR11] 11.Mygind N., Laussen L.C., Dahl M. Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy. 2000;55:11–15. doi: 10.1034/j.1398-9995.2000.00108.x. [DOI] [PubMed] [Google Scholar]

[CR12] 12.Naclerio R.M. Pathophysiology of perennial allergic rhinitis. Allergy. 1997;52:41–44. doi: 10.1111/j.1398-9995.1997.tb04816.x. [DOI] [PubMed] [Google Scholar]

[CR13] 13.Nolte D., Renovanz H.D., Schumann K. Obere und untere Luftwege als funktionelle Einheit. Munich: Dustri; 1982. Nase und Respirationstrakt. [Google Scholar]

[CR14] 14.Passalacqua G., Bachert C., Davies R.J., Durham S.R., et al. Inhaled and nasal corticosteroids: safety aspects. Allergy. 2000;55:16–33. doi: 10.1034/j.1398-9995.2000.00370.x. [DOI] [PubMed] [Google Scholar]

[CR15] 15.Simons F.E. Learning impairment and allergic rhinitis. Allergy Asthma Proc. 1996;17:185–189. doi: 10.2500/108854196778996895. [DOI] [PubMed] [Google Scholar]

[CR16] 16.Simons F.E. Allergic rhinobronchitis: The asthma-allergic rhinitis link. J Allergy Clin Immunol. 1999;104:534–540. doi: 10.1016/S0091-6749(99)70320-9. [DOI] [PubMed] [Google Scholar]

[CR17] 17.van Cauwenberge P., Bachert C., Passalacqua G., Bousquet J., Canonica G.W., Durham S.R., Fokkens W.J., Howarth P.H., Lund V., Malling H.J., Mygind N., Passali D., Scadding G.K., Wang D.Y. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55:116–134. doi: 10.1034/j.1398-9995.2000.00526.x. [DOI] [PubMed] [Google Scholar]

[CR18] 18.Tas E., Bircher A.J. Therapie der Rhinitis allergica. Ther Umsch. 2001;58:309–314. doi: 10.1024/0040-5930.58.5.309. [DOI] [PubMed] [Google Scholar]

[CR19] 19.van Wijk R.G., de Graaf-in’tVeld C., Garrelds I.M. Nasal hyperreactivity. Rhinology. 1999;37:50–55. [PubMed] [Google Scholar]

[CR20] 20.World Health Organization (2004) Allergic rhinitis and its impact on asthma (ARIA). In: Bousquet J, et al. (eds) Executive summary. WHO (in press)

[CR21] 21.Wüthrich B., Schindler C., Leuenberger P., Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol. 1995;106:149–156. doi: 10.1159/000236836. [DOI] [PubMed] [Google Scholar]

[CR22] 1.National Institutes of Health . Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. Bethesda: NIH; 1997. [Google Scholar]

[CR23] 2.American Thoracic Society Guidelines for methacholine challenge and exercise challenge testing. Am J Respir Crit Care Med. 2000;161:309–329. doi: 10.1164/ajrccm.161.1.ats11-99. [DOI] [PubMed] [Google Scholar]

[CR24] 3.Bachert C. Asthma and rhinitis: management implications. Eur Respir J. 1997;7:294–295. [Google Scholar]

[CR25] 4.Barnes P.J., Chung F., Page C.P. Inflammatory mediators of asthma. Pharmacol Rev. 1998;50:515–596. [PubMed] [Google Scholar]

[CR26] 5.Baur X. Charakterisierung ursächlicher Allergene. Berlin Heidelberg New York: Springer; 1986. Asthma, alveolitis, aspergillose. [Google Scholar]

[CR27] 6.Bernstein D.J. Allergic reactions to workplace allergens. JAMA. 1997;278:1907–1913. doi: 10.1001/jama.278.22.1907. [DOI] [PubMed] [Google Scholar]

[CR28] 7.Borelli S., Düngemann H., editors. Fortschritte der Allergologie und Dermatologie. Basel: IMP-Verlag; 1981. [Google Scholar]

[CR29] 8.Busse W.W., Elias J., Sheppard D., et al. Airway remodeling and repair. Am J Respir Crit Care Med. 1999;160:1035–1042. doi: 10.1164/ajrccm.160.3.9902064. [DOI] [PubMed] [Google Scholar]

[CR30] 9.Crapo R.O. Pulmonary function testing. N Engl J Med. 1994;331:25–30. doi: 10.1056/NEJM199407073310107. [DOI] [PubMed] [Google Scholar]

[CR31] 10.Debelic M., editor. Bronchitis im Kindes-und Jugendlichenalter. Munich: Dustri; 1986. [Google Scholar]

[CR32] 11.Doerschug K.C., Peterson M.W., Dayton C.S., et al. Asthma guidelines. An assessment of physician understanding and practice. Am J Respir Crit Care Med. 1999;159:1735–1741. doi: 10.1164/ajrccm.159.6.9809051. [DOI] [PubMed] [Google Scholar]

[CR33] 12.Düngemann H (1978) Karenz-Expositionsprophylaxe. Atemwegs Lungenkrankh 4

[CR34] 13.Dykewicz MS, Fineman S. Diagnosis and management of rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998;81:478–518. doi: 10.1016/s1081-1206(10)63155-9. [DOI] [PubMed] [Google Scholar]

[CR35] 14.Fischer A., McGregor G.P., Saria A., Philipp B., Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest. 1996;98:2284–2291. doi: 10.1172/JCI119039. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR36] 15.Fruhmann G. Sonstige Berufskrankheiten: Obstruktive Atemwegserkrankungen. In: Ferlinz R., editor. Pneumologie. Stuttgart: Thieme; 1994. [Google Scholar]

[CR37] 16.Fuchs E. Gewerbliche Allergene als Ursache obstruktiver Lungenerkrankungen. Früherkennung und Abklärung. Schweiz Med Wochenschr. 1982;112:185. [PubMed] [Google Scholar]

[CR38] 17.Fuchs E., Schultze-Werninghaus G. Themen der Medizin. Nürnberg: Wander; 1986. Asthma bronchiale. [Google Scholar]

[CR39] 18.Gonsior E., Henzgen M., Jörres R.F., Kroidl R.F., Merget R., Riffelmann F.W., Wallenstein G.W. Leitlinie für die Durchführung bronchialer Provokationstests mit Allergenen. Deutsche Ges für Allergologie und klinische Immunologie. Allergo J. 2001;10:193–199. doi: 10.1055/s-2002-20553. [DOI] [PubMed] [Google Scholar]

[CR40] 19.Hansen K. Bronchialasthma (Bronchiolenasthma) und verwandte Störungen. In: Hansen K., editor. Allergie. Stuttgart: Thieme; 1957. [Google Scholar]

[CR41] 20.Hansel TT, Bauer PJ (eds) (2001) New drugs for asthma, allergy and COPD. Progress in respiration research, vol 31. Karger, Basel

[CR42] 21.Henderson W.R., Shelhamer J.H., Reingold D.B., Smith L.J., Evans R., Kaliner M. Alpha-adrenergic hyper-responsiveness in asthma. N Engl J Med. 1979;300:642–647. doi: 10.1056/NEJM197903223001203. [DOI] [PubMed] [Google Scholar]

[CR43] 22.Holgate S.T., Davies D.E., Lackie P.M., Wilson S.Y., Puddicombe S.L., Lordan J.L. Epitheliolmesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 2000;105:193–204. doi: 10.1016/S0091-6749(00)90066-6. [DOI] [PubMed] [Google Scholar]

[CR44] 23.Kay AB, Austen KF, Lichtenstein LM (eds) (1984) Asthma. Physiology, immunopharmacology and treatment. Academic Press, London

[CR45] 24.Kerschensteiner M., Gallmeier E., Behrens L., Vargas Leal V., Misgeld T., Klinkert W.E.F., Kohlbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neutrophic factor in vitro and in inflammatory brain lesions: A neutroprotective role of inflammation? J Exp Med. 1999;189:865–870. doi: 10.1084/jem.189.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR46] 25.Kjellmann N-IM (1976) Immunoglobulin E and atopic allergy in childhood. Linköping University Medicine Dissertation No. 36

[CR47] 26.König P. Therapie des Status asthmaticus. Internist. 1985;26:208. [PubMed] [Google Scholar]

[CR48] 27.Kunkel G. Neurogene Aspekte der allergischen Entzündungsreaktion. In: Ring J., Darsow V., editors. Allergie 2000: Probleme, Strategien und praktische Konsequenzen. Munich: Dustri; 2001. pp. 179–181. [Google Scholar]

[CR49] 28.Kroegel C., editor. Moderne Therapie des Asthma bronchiale. Stuttgart: Thieme; 1997. [Google Scholar]

[CR50] 29.Lebowitz M.D., Barbee R., Burrows B. Family concordance of IgE, atopy, and disease. J Allergy Clin Immunol. 1984;73:259–264. doi: 10.1016/S0091-6749(84)80017-2. [DOI] [PubMed] [Google Scholar]

[CR51] 30.Magnussen H. Überempfindlichkeit der Atemwege. Dtsch med Wochenschr. 1990;115:1604–1610. doi: 10.1055/s-2008-1065199. [DOI] [PubMed] [Google Scholar]

[CR52] 31.Middleton E. Jr, et al., editors. Allergy: principles and practice. 5th edn. St. Louis: Mosby; 1998. pp. 544–558. [Google Scholar]

[CR53] 32.Milgrom H., Fick R.B., Su J.Q., et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med. 1999;341:1966–1973. doi: 10.1056/NEJM199912233412603. [DOI] [PubMed] [Google Scholar]

[CR54] 33.Nadel J.A., editor. Physiology and pharmacology of the airways. New York: Marcel Dekker; 1980. [Google Scholar]

[CR55] 34.Niggemann B., Illi S., Madloch C. Histamine challenges discriminate between symptomatic and asymptomatic children. Eur Resp J. 2001;17:246–253. doi: 10.1183/09031936.01.17202460. [DOI] [PubMed] [Google Scholar]

[CR56] 35.Nolte D. Asthma: Das Krankheitsbild, der Asthmapatient, die Therapie. 6th edn. Munich: Urban & Schwarzenberg; 1996. [Google Scholar]

[CR57] 36.Reinhardt D., editor. Asthma bronchiale im Kindesalter. Berlin Heidelberg New York: Springer; 1996. [Google Scholar]

[CR58] 37.Schultze-Werninghaus G (ed) (1999) Deutsche Atemwegsliga: Empfehlungen zur Allergiediagnostik bei Atemwegserkrankungen in der Praxis. Pneumologie 48:300–304 [PubMed]

[CR59] 38.Schultze-Werninghaus G. Die Immuntherapie (allergenspezifische Hyposensibilisierung) bei Asthma bronchiale. Atemw Lungenkrh. 1997;23:701–707. [Google Scholar]

[CR60] 39.Slavin RG, Reisman RE (eds) Expert guide to allergy and immunology. American College of Physicians, Philadelphia, pp 23–40

[CR61] 40.Szepanski R., Lecheler J. Standard-und Qualitätssicherung der Asthmaschulung im Kindes-und Jugendalter. Präv Rehab. 1995;7:1–41. [Google Scholar]

[CR62] 41.Tiffeneau R., Beauvallet M. Production exclusive d’effets pulmonaires locaux par inhalation d’aerosol d’acetylcholine. Son utilisation comme test d’insufficance respiratoire. Sem Hop. 1945;21:154–166. [Google Scholar]

[CR63] 42.Townsley R.G. IgE levels and methacholine inhalation responses in monozygous and dizygous twins. J Allergy Clin Immunol. 1976;57:227. [Google Scholar]

[CR64] 43.Virchow J.C., Kroegel C., Walker C., Matthyss H. Cellular and immunological markers of allergic and intrinsic bronchial asthma. Lung. 1994;172:313–334. doi: 10.1007/BF00172846. [DOI] [PubMed] [Google Scholar]

[CR65] 44.Virchow J.C., Prasse A., Naya I., Summertin A., Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;62:578–585. doi: 10.1164/ajrccm.162.2.9905041. [DOI] [PubMed] [Google Scholar]

[CR66] 45.Wahn U., Seger S., Wahn V., editors. Pädiatrische Allergologie und Immunologie. 3rd edn. Munich: Urban und Fischer; 1999. [Google Scholar]

[CR67] 46.Wettengel R., Berdel D., Cegla U., et al. Empfehlungen der Deutschen Atemwegsliga zum Asthmamanagement bei Erwachsenen und Kindern. Med Klin. 1994;89:57–67. [PubMed] [Google Scholar]

[CR68] 47.Worth H., Meyer A., Folgering H., Kirsten D., Lecheler J., Magnussen H., Pleyer K., Schmidt S., Schmitz M., Taube K., Wettengel R. Empfehlungen der Deutschen Atemwegsliga zum Sport und körperlichen Training bei Patienten mit obstruktiven Atemwegserkrankungen. Pneumologie. 2000;54:61–67. doi: 10.1055/s-2000-9066. [DOI] [PubMed] [Google Scholar]

[CR69] 48.Wüthrich B. Zum Allergenkatalog beruflicher Inhalationsallergien. Berufsdermatosen. 1976;24:123. [Google Scholar]

[CR70] 1.Abeck D., Thomsen S., Plötz S., Ring J. Die Biologische Urtikaria-Therapie. Acta Biol. 1999;38:3–23. [Google Scholar]

[CR71] 2.Beissert S., Stauder H., Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42:1030–1032. doi: 10.1016/S0190-9622(00)90299-8. [DOI] [PubMed] [Google Scholar]

[CR72] 3.Bork K., Witzke G. Long-term prophylaxis with C1-inhibitor (C1INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J Allergy Clin Immunol. 1989;83:677. doi: 10.1016/0091-6749(89)90082-1. [DOI] [PubMed] [Google Scholar]

[CR73] 4.Braun-Falco O. Entwicklungen in der Dermatologie. In: Braun-Falco O., Marghescu S., editors. Fortschritte der praktischen Dermatologie und Venerologie. Berlin Heidelberg New York: Springer; 1976. p. 417. [Google Scholar]

[CR74] 5.Champion R.H. Urticaria then and now. Br J Dermatol. 1988;119:427–436. doi: 10.1111/j.1365-2133.1988.tb03246.x. [DOI] [PubMed] [Google Scholar]

[CR75] 6.Doeglas H.M.G. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol. 1975;93:135. doi: 10.1159/000144504. [DOI] [PubMed] [Google Scholar]

[CR76] 7.Ellis M.H. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol. 1998;102:876–877. doi: 10.1016/S0091-6749(98)70032-6. [DOI] [PubMed] [Google Scholar]

[CR77] 8.Fiebiger E., Hammerschmid F., Stingl G., Maurer D. Anti-FcεRIα autoantibodies in autoimmune-mediated disorders. J Clin Invest. 1998;101:243–251. doi: 10.1172/JCI511. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR78] 9.Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664–671. doi: 10.1067/mai.2000.105706. [DOI] [PubMed] [Google Scholar]

[CR79] 10.Haas N., et al. Vergleichende Studie zur Häufigkeit, Diagnostik und Therapie der Urtikaria in einer Hautpoliklinik. Allergologie. 1995;18:110–113. [Google Scholar]

[CR80] 11.Henz B.M. Das Spektrum der Urtikaria. In: Henz B.M., Zuberbier T., Grabbe J., editors. Urtikaria. Klinik, Diagnostik, Therapie. Berlin Heidelberg New York: Springer; 1996. pp. 1–17. [Google Scholar]

[CR81] 12.Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599–1604. doi: 10.1056/NEJM199306033282204. [DOI] [PubMed] [Google Scholar]

[CR82] 13.Illig L., Paul E. Die Stellung der Antihistaminika in der Urtikaria-Therapie. Hautarzt. 1978;29:407. [PubMed] [Google Scholar]

[CR83] 14.Juhlin L. Modem approaches to treatment of chronic urticaria. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. p. 279. [Google Scholar]

[CR84] 15.Kaplan A.P. The pathogenic basic of urticaria and angioedema: Recent advances. Am J Med. 1981;70:755–757. doi: 10.1016/0002-9343(81)90528-3. [DOI] [PubMed] [Google Scholar]

[CR85] 16.Kumar S.A., Martin B.L. Urticaria and angioedema: diagnostic and treatment considerations. J Am Osteopath Assoc. 1999;99([Suppl]):1–4. [PubMed] [Google Scholar]

[CR86] 17.Leznoff A., Sussmann G.L. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: A study of 90 patients. J Allergy Clin Immunol. 1989;84:66. doi: 10.1016/0091-6749(89)90180-2. [DOI] [PubMed] [Google Scholar]

[CR87] 18.Leznoff A. Chronic urticaria. Can Fam Physician. 1998;44:2170–2176. [PMC free article] [PubMed] [Google Scholar]

[CR88] 19.Maibach H.I., Johnson H.L. Contact urticaria syndrome. Contact urticaria to diethyltoluamide. Arch Dermatol. 1975;111:720–730. doi: 10.1001/archderm.111.6.720. [DOI] [PubMed] [Google Scholar]

[CR89] 20.Merk H. Urticaria und Rhinitis allergica. In: Hornbostel H., Kaufmann W., Siegenthaler W., editors. Innere Medizin in Praxis und Klinik. 4th edn. Stuttgart: Thieme; 1992. pp. 3281–3293. [Google Scholar]

[CR90] 21.Meurer M. Urticaria vasculitis. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 148–151. [Google Scholar]

[CR91] 22.Müller J., Vieluf D., Ring J. Schilddrüsenhormone als Amplifikatoren der Histamin-Freisetzung unter Insektengift-Hyposensibilisierung. Allergo J. 1993;2([Suppl 2]):77–8. [Google Scholar]

[CR92] 23.Ollert M., Ring J. Urtikaria und Angioödem. In: Przybilla B., Bergmann K., Ring J., editors. Praktische allergologische Diagnostik. Darmstadt: Stein-kopff; 2000. pp. 328–334. [Google Scholar]

[CR93] 24.Opferkuch W., Kövary P.M., Jaeger U., Echternacht-Happle K., Gronemeyer W., Hammar C., Niemczyk H., Rieger C. Clinical aspects and therapy of hereditary angioneurotic edema. In: Ring J., Burg G., editors. New trends in Allergy. Berlin Heidelberg New York: Springer; 1981. p. 272. [Google Scholar]

[CR94] 25.Paul E., Bödeker R.-H. Behandlung der chronischen Urticaria mit Terfenadin und Ranitidin. Allergologie. 1987;10:113. [Google Scholar]

[CR95] 26.Ring J., Brockow K., Ollert M., Engst R. Antihistamines in urticaria. Clin Exp Allergy. 1999;29([Suppl 1]):31–37. doi: 10.1046/j.1365-2222.1999.00006.x. [DOI] [PubMed] [Google Scholar]

[CR96] 27.Ring J., Przybilla B. Diagnostik der chronischen Urtikaria. Med Welt. 1987;38:256–259. [Google Scholar]

[CR97] 28.Sabroe R.A., Grattan C.E., Francis D.M., Barr R.M., Kobza B. A., Greaves M.W. The autologous serum skin test: A screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999;140:446–452. doi: 10.1046/j.1365-2133.1999.02707.x. [DOI] [PubMed] [Google Scholar]

[CR98] 29.Schäfer T., Ring J., et al. Epidemiology adverse food reactions due to allergy and other forms of hypersensitivity. In: Eisenbrand G., et al., editors. Food allergies and intolerances. VCH Weinheim: DFG; 1996. pp. 40–54. [Google Scholar]

[CR99] 30.Schmutzler W. Histamin als Mediator allergischer Reaktionen. Allergologie. 1997;20:536–542. [Google Scholar]

[CR100] 31.Skrebova N., Takiwaki H., Miyaoka Y., Arase S. Localized heat urticaria: a clinical study using laser Doppler flowmetry. J Dermatol Sci. 2001;26:112–118. doi: 10.1016/S0923-1811(00)00162-6. [DOI] [PubMed] [Google Scholar]

[CR101] 32.Schrallhammer-Baenkler S., Ring J., Landthaler M. Localized heat urticaria. Arch Dermatol Res. 1985;277:406. doi: 10.1007/BF00509243. [DOI] [Google Scholar]

[CR102] 33.Toubi E., Blant A., Kessel A., Golan T.D. Low dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy. 1997;52:312–316. doi: 10.1111/j.1398-9995.1997.tb00996.x. [DOI] [PubMed] [Google Scholar]

[CR103] 34.Warin R.P., Champion R.H. Urticaria. London: Saunders; 1974. [Google Scholar]

[CR104] 35.Wüthrich B. Therapie der akuten und chronischen Urtikaria und des Quincke-Ödems. Schweiz Rundschau Med. 1989;78:576–581. [PubMed] [Google Scholar]

[CR105] 36.Zuberbier T., Henz B.M. Diagnostik der Urtikaria. In: Henz B.M., Zuberbier T., Grabbe J., editors. Urtikaria. Klinik, Diagnostik, Therapie. Berlin Heidelberg New York: Springer; 1996. pp. 137–156. [Google Scholar]

[CR106] 37.Zuberbier T, Aberer W, Grabbe J, Hartmann K, Merk H, Ollert M, Rueff F, Wedi B, Wenning J (2004) Diagnostik und Therapie der Urtikaria. Leitlinie der DDG und DGAI. Allergo J (in press) [DOI] [PubMed]

[CR107] 1.Barnard J.H. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259–264. doi: 10.1016/0091-6749(73)90044-4. [DOI] [PubMed] [Google Scholar]

[CR108] 2.Bochner B.S., Lichtenstein L.M. Anaphylaxis. N Engl J Med. 1991;324:81–88. doi: 10.1056/NEJM199106203242506. [DOI] [PubMed] [Google Scholar]

[CR109] 3.Brockow K., Kiehn M., Riehtmüller C., Vieluf D., Berger J., Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera venom immunotherapy: a prospective randomized placebo-controlled trial. J Allergy Clin Immunol. 1997;100:458–463. doi: 10.1016/S0091-6749(97)70135-0. [DOI] [PubMed] [Google Scholar]

[CR110] 4.Brown M.J., Brown D.C., Murphy M.B. Hypokalemia from beta-2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309:1414–1419. doi: 10.1056/NEJM198312083092303. [DOI] [PubMed] [Google Scholar]

[CR111] 5.Capurro N., Levi R. The heart as target organ in systemic allergic reactions. Circ Res. 1975;36:520–528. doi: 10.1161/01.res.36.4.520. [DOI] [PubMed] [Google Scholar]

[CR112] 6.Delage C., Irey H.C. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forens Sci. 1972;17:525. [PubMed] [Google Scholar]

[CR113] 7.De Soto H., Turk P. Cimetidine in anaphylactic shock refractory to standard therapy. Anesth Analg. 1989;69:264–265. doi: 10.1213/00000539-198908000-00029. [DOI] [PubMed] [Google Scholar]

[CR114] 8.Eisenberg M.S., Mengest T.J. Cardiac resuscitation. N Engl J Med. 2001;344:1304–1313. doi: 10.1056/NEJM200104263441707. [DOI] [PubMed] [Google Scholar]

[CR115] 9.Endrich B., Ring J., Intaglietta M. Effects of radiopaque contrast media on the microcirculation of the rabbit omentum. Radiology. 1979;132:331–339. doi: 10.1148/132.2.331. [DOI] [PubMed] [Google Scholar]

[CR116] 10.Fisher M.M.D. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anesth Intensive Care. 1986;17:17–21. doi: 10.1177/0310057X8601400105. [DOI] [PubMed] [Google Scholar]

[CR117] 11.Fuchs E., Ferlinz R. Allergische Krankheiten. In: v Wolff H.R., Weihrauch T.R., editors. Internistische Therapie. 6th edn. Munich: Urban und Schwarzenberg; 1986. pp. 275–288. [Google Scholar]

[CR118] 12.Gronemeyer W. Noradrenalin statt Adrenalin beim anaphylaktischen Schock. Dtsch Med Wochenschr. 1980;102:101. [PubMed] [Google Scholar]

[CR119] 13.Hannaway P.J., Hoppler G.D.K. Severe anaphylaxis and drug induced beta-blockage. N Engl J Med. 1983;308:1536. [PubMed] [Google Scholar]

[CR120] 14.Hermann K., Ring J. The renin-angiotensin system in patients with repeated anaphylactic reactions during Hymenoptera venom hyposensitization and sting challenge. Int Arch Allergy Immunol. 1997;11:251–156. doi: 10.1159/000237462. [DOI] [PubMed] [Google Scholar]

[CR121] 15.Johansson S.G.O., Hourihane J.O.B., Bousquet J., Bruijnzeel-Koomen, Dreborg S., Haahtela T., Kowalski M.L., Mygind N., Ring J., van Cauwenberge P., van Hage-Hamsten M., Wüthrich B. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813–824. doi: 10.1034/j.1398-9995.2001.t01-1-00001.x. [DOI] [PubMed] [Google Scholar]

[CR122] 16.Kleinhans D. Anstrengungs-induzierte Urtikaria und Anaphylaxie. Med Klein. 1987;82:103–104. [PubMed] [Google Scholar]

[CR123] 17.Laubenthal H. Ergebnisse einer multizentrischen Studie. Berlin Heidelberg New York: Springer; 1986. Dextrananaphylaxie, Pathomechanismus und Prophylaxe. [Google Scholar]

[CR124] 18.Lockey R.F., Benedict L.M., Turkeltaub T.B., Bukantz S.C. Fatalities from immunotherapy (IT) and skin testing (ST) J Allergy Clin Immunol. 1987;79:666–677. doi: 10.1016/S0091-6749(87)80164-1. [DOI] [PubMed] [Google Scholar]

[CR125] 19.Lorenz W., Doenicke A., Dittmann I., Hug P., Schwarz B. Anaphylaktoide Reaktionen nach Applikation von Blutersatzmitteln beim Menschen. Verhinderung dieser Nebenwirkung von Haemaccel durch Praemedikation mit H1 und H2-Antagonisten. Anaesthesist. 1977;26:644. [PubMed] [Google Scholar]

[CR126] 20.Marone G., Patelle V., de Crescanzo A., Genovese M. Human heart mast cells in anaphylaxis and cardiovascular disease. Int Arch Allergy Immunol. 1995;107:72–75. doi: 10.1159/000236935. [DOI] [PubMed] [Google Scholar]

[CR127] 21.Maulitz R.M., Pratt D.S., Schocket A.L. Exercise-induced anaphylactic reaction to shellfish. J Allergy Clin Immunol. 1979;63:433. doi: 10.1016/0091-6749(79)90218-5. [DOI] [PubMed] [Google Scholar]

[CR128] 22.Meßmer K. Plasma substitutes and indications for their use. In: Tinker J., Rapin M., editors. Care of the critically ill patient. Berlin Heidelberg New York: Springer; 1983. pp. 569–575. [Google Scholar]

[CR129] 23.Müller U. Spätkomplikationen bei Anaphylaxie. In: Ring J., Darsow U., editors. Allergie 2000: Probleme, Strategien und praktische Kon-sequenzen. Munich: Dustri; 2001. pp. 249–252. [Google Scholar]

[CR130] 24.Pavek K., Wegmann A., Nordström L., Schwander D. Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Klin Wochenschr. 1982;60:941–947. doi: 10.1007/BF01716952. [DOI] [PubMed] [Google Scholar]

[CR131] 25.Przybilla B., Ring J. Anaphylaxis to ethanol and sensitization to acetic acid. Lancet. 1983;1:483. doi: 10.1016/S0140-6736(83)91487-3. [DOI] [PubMed] [Google Scholar]

[CR132] 26.Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144–1150. doi: 10.1046/j.1365-2222.2000.00864.x. [DOI] [PubMed] [Google Scholar]

[CR133] 27.Reimers A., Müller U. Behandlung des anaphylaktischen Schocks. Ther Umschau. 2000;58:325–328. doi: 10.1024/0040-5930.58.5.325. [DOI] [PubMed] [Google Scholar]

[CR134] 28.Richet C. De l’anaphylaxie ou sensibilite croissante des organismes a des doses successives de poison. Arch Fisiol. 1904;1:129. [Google Scholar]

[CR135] 29.Richter W., Hedin H., Ring J., Kraft D., Messmer K. Anaphylaktoide Reaktionen nach Dextran I. Immunologische Grundlagen und klinische Befunde. Allergologie. 1980;3:9. [Google Scholar]

[CR136] 30.Ring J., Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466–468. doi: 10.1016/S0140-6736(77)91953-5. [DOI] [PubMed] [Google Scholar]

[CR137] 31.Ring J. Anaphylaktoide Reaktionen nach Infusion naturlicher und künstlicher Kolloide. Berlin Heidelberg New York: Springer; 1978. [Google Scholar]

[CR138] 32.Ring J., Darsow U. Idiopathic anaphylaxis. Curr Allergy Asthma Rep. 2002;2:40–45. doi: 10.1007/s11882-002-0036-8. [DOI] [PubMed] [Google Scholar]

[CR139] 33.Ring J., Galosi A., Przybilla B. Contact anaphylaxis from emulgade F. Contact Dermatitis. 1986;15:49–40. doi: 10.1111/j.1600-0536.1986.tb01272.x. [DOI] [Google Scholar]

[CR140] 34.Ring J., Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol. 1999;17:387–399. doi: 10.1007/BF02737644. [DOI] [PubMed] [Google Scholar]

[CR141] 35.Rohrer C.L., Pichler W.J., Helbling A., et al. Anaphylaxie: Klinik, Ätiologie und Verlauf bei 118 Patienten. Schweiz Med Wochenschr. 1998;128:53–63. [PubMed] [Google Scholar]

[CR142] 36.Sheffer A.L., Austen K.F. Exercise-induced anaphylaxis. J Allergy Clin Immunol. 1980;66:106. doi: 10.1016/0091-6749(80)90056-1. [DOI] [PubMed] [Google Scholar]

[CR143] 37.Simons F.E., Gu X., Johnston L.M., Simons K.J. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics. 2000;106:1040–1044. doi: 10.1542/peds.106.5.1040. [DOI] [PubMed] [Google Scholar]

[CR144] 38.Smedegard G., Revenäs B., Arfors K.E. Anaphylaxis in the monkey: hemodynamics and blood flow distribution. Acta Physiol Scand. 1979;106:191. doi: 10.1111/j.1748-1716.1979.tb06389.x. [DOI] [PubMed] [Google Scholar]

[CR145] 39.Smith P.L., Kagey-Sobotka A., Blecker E.R., Traystman R., Kaplan A.P., Gralink H., Valentine M.D., Permut S., Lichtenstein L.M. Physiologic manifestations of human anaphylaxis. J Clin Invest. 1980;60:1072. doi: 10.1172/JCI109936. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR146] 40.Sullivan T.J. Cardiac disorders in penicillin-induced anaphylaxis: association with intravenous epinephrine therapy. J Am Med Assoc. 1982;248:2161. doi: 10.1001/jama.248.17.2161. [DOI] [PubMed] [Google Scholar]

[CR147] 41.Stark B.J., Sullivan T.J. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78:76–83. doi: 10.1016/0091-6749(86)90117-X. [DOI] [PubMed] [Google Scholar]

[CR148] 42.Tryba M., Ahnefeld F.W., Barth J., Dick W., Doenicke A., Fuchs T., Gervais H., Laubenthal H., Löllgen H., Lorenz W., Mehrkens H.H., Meuret G.H., Möllmann H., Piepenbrock S., Przybilla B., Ring J., Schmutzler W., Schultze-Werninghaus G., Schüttler J., Schuster J.P., Sefrin P., Zander J., Zenz M. Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Allergo J. 1994;3:211–222. doi: 10.1007/s001010050050. [DOI] [PubMed] [Google Scholar]

[CR149] 43.Waldhausen E., Keser G., Marquardt B. Der anaphylaktische Schock. Anästhesist. 1987;36:150–158. [PubMed] [Google Scholar]

[CR150] 44.Wegmann A., Reuker H., Pavek K., Schwander D. Katecholamintherapie und Herzrhyth-musstörungen im anaphylaktischen und anaphylaktoiden Schock. Anaesthesist. 1983;32([Suppl]):320. [Google Scholar]

[CR151] 45.Wiggins C.A., Dykowicz M.S., Patterson R. Idiopathic anaphylaxis. Classification, evaluation and treatment of 123 patients. J Allergy Clin Immunol. 1988;82:849–855. doi: 10.1016/0091-6749(88)90089-9. [DOI] [PubMed] [Google Scholar]

[CR152] 46.Zaloga G.P., Delacey W., Holmboe E., Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med. 1986;105:65–66. doi: 10.7326/0003-4819-105-1-65. [DOI] [PubMed] [Google Scholar]

[CR153] 1.Aas K. The diagnosis of hypersensitivity to ingested foods. Reliability of skin prick testing and the radioallergosorbent test with different materials. Clin Allergy. 1978;8:39–50. doi: 10.1111/j.1365-2222.1978.tb00446.x. [DOI] [PubMed] [Google Scholar]

[CR154] 2.Andrée C. L’allergie digestive, concept ou realité? Presse Med. 1984;27:1667–1669. [PubMed] [Google Scholar]

[CR155] 3.Bauer C.P., Grübl A. Hypoallergene Babynahrung. In: Behr-Völtzer C., Hamm M., Vieluf D., Ring J., editors. Diät bei Nahrungsmittelallergien und-intoleranzen. 2nd edn. Munich: Urban & Vogel; 2002. pp. 105–111. [Google Scholar]

[CR156] 4.Ballmer-Weber B.K., Wüthrich B. Die Nahrungsmittelallergie und ihre diätetische Behandlung. Aktuell Ernähr Med. 2001;26:196–201. doi: 10.1055/s-2001-17723. [DOI] [Google Scholar]

[CR157] 5.Behr-Völtzer C., Hamm M., Vieluf D., Ring J., editors. Diät bei Nahrungsmittelallergien und-intoleranzen. 2nd edn. Munich: Urban & Vogel; 2002. [Google Scholar]

[CR158] 6.Balmer-Weber B, Bengtsson U, et al. (2004) Standardization of food challenges in patients with immediate reactions to foods. Position paper EAACI. Allergy (in press) [DOI] [PubMed]

[CR159] 7.Bischoff S.C., Mayer J., Wedemeyer J., et al. Colonoscopic allergen provocation (CO-LAP): a new diagnostic approach for gastrointestinal food allergy. Gut. 1997;40:745–753. doi: 10.1136/gut.40.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR160] 8.Bock S.A., Sampson H.A., Atkins F.M., Zeiger R.S., et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol. 1988;82:986–997. doi: 10.1016/0091-6749(88)91021-4. [DOI] [PubMed] [Google Scholar]

[CR161] 9.Brostoff J., Challacombe S.J., editors. Food allergy and intolerance. London: Bailliere Tindall; 1987. [Google Scholar]

[CR162] 10.Bruijnzeel-Koomen C., Ortolani C., Aas K., et al. Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy. 1995;50:623–635. doi: 10.1111/j.1398-9995.1995.tb02579.x. [DOI] [PubMed] [Google Scholar]

[CR163] 11.Deutsche Gesellschaft für Ernährung, editor. Richtig essen. Berlin: F+G Rollendruck; 1995. [Google Scholar]

[CR164] 12.Diätverband — Bundesverband der Hersteller von Lebensmitteln für besondere Ernährungszwecke, editor. Product & Diät. Hemmingen: Presto; 1998. [Google Scholar]

[CR165] 13.Ebner C., Hirschwehr R., Bauer L., et al. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin) J Allergy Clin Immunol. 1995;95:962–969. doi: 10.1016/S0091-6749(95)70096-X. [DOI] [PubMed] [Google Scholar]

[CR166] 14.Egger J., Carter C.M., Wilson J., Turner M.W., Soot-hill J.F. Is migraine food allergy? A double blind controlled trial of oligoantigenic diet treatment. Lancet. 1983;2:865–869. doi: 10.1016/S0140-6736(83)90866-8. [DOI] [PubMed] [Google Scholar]

[CR167] 15.Ehlers I., Henz B., Zuberbier T. Diagnose und Therapie pseudo-allergischer Reaktionen der Haut durch Nahrungsmittel. Allergologie. 1996;19:270–276. [Google Scholar]

[CR168] 16.Eisenbrand G., Aulepp H., Dayan A.D., et al. Food allergies and intolerances. Weinheim: VCH Verlagsge-sellschaft; 1996. [Google Scholar]

[CR169] 17.Eisenmann A., Ring J., von der Helm D., Meurer M., Braun-Falco O. Vasculitis allergica durch Nahrungsmittelallergie. Hautarzt. 1988;39:318–321. [PubMed] [Google Scholar]

[CR170] 18.Ewan P.W., Clark A.T. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet. 2001;357:111–115. doi: 10.1016/S0140-6736(00)03543-1. [DOI] [PubMed] [Google Scholar]

[CR171] 19.Feingold B. Why your child is hyperactive. New York: Random; 1975. [Google Scholar]

[CR172] 20.Franck P., Moneret V. D., Dousset B., et al. The allergenicity of soybean-based products is modified by food technologies. Int Arch Allergy Immunol. 2002;128:212–219. doi: 10.1159/000064254. [DOI] [PubMed] [Google Scholar]

[CR173] 21.Häberle M. Klinische und lebensmittelchemische Aspekte bei Unverträglichkeits-Reaktionen auf Salicylat-und Additiva-haltige Lebens-mittel. Zbl Haut. 1987;153:75–95. [Google Scholar]

[CR174] 22.Henzgen M., Schlenvoigt G., Diener C., Jäger L. Nahrungsmittelallergie bei Frühblüher-pollinose und deren Beeinflussung mittels Hyposensibilisierung. Allergologie. 1991;14:90–9. [Google Scholar]

[CR175] 23.Hjorth N., Roed-Petersen J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis. 1976;2:28–42. doi: 10.1111/j.1600-0536.1976.tb02975.x. [DOI] [PubMed] [Google Scholar]

[CR176] 24.Holt P.G. Mucosal immunity in relation to the development of tolerance/sensitization. Allergy. 1998;53:6–19. doi: 10.1111/j.1398-9995.1998.tb04932.x. [DOI] [PubMed] [Google Scholar]

[CR177] 25.Host A. Importance of the first meal on the development of cow’s milk allergy and intolerance. Allergy Proc. 1991;12:27–32. doi: 10.2500/108854191778879287. [DOI] [PubMed] [Google Scholar]

[CR178] 26.Hourihane J.O., Kilburn A., Dean P., Warner J.O. Clinical characteristics of peanut allergy. Clin Exp Allergy. 1997;27:634–639. doi: 10.1111/j.1365-2222.1997.tb01190.x. [DOI] [PubMed] [Google Scholar]

[CR179] 27.Isolauri E. Probiotics in the prevention and treatment of allergic disease. Pediatr Allergy Immunol. 2001;12([Suppl 14]):56–59. doi: 10.1034/j.1399-3038.2001.121413.x. [DOI] [PubMed] [Google Scholar]

[CR180] 28.Jäger L., Wüthrich B. Nahrungsmittelallergien und-intoleranzen. Ulm: Gustaf Fischer; 1998. [Google Scholar]

[CR181] 29.Jarisch R., Pirker C., Möslinger T., Götz M. The role of histamine in wine intolerance. J Allergy Clin Immunol. 1997;89:197. [Google Scholar]

[CR182] 30.Jorde W. Orale Desensibilisierung. In: Fillipp G., editor. Allergologie. Munich: Banaschewski; 1980. p. 53. [Google Scholar]

[CR183] 31.Kanny G., Hatahet R., Moneret-Vautrin A., Kohler C., Bellut A. Allergy and intolerance to flavouring agents in atopic dermatitis in young children. Allerg Immunol. 1994;6:204–210. [PubMed] [Google Scholar]

[CR184] 32.Klaschka F. Hämatogenes Kontaktekzem durch Nahrungsmittel. Allergologie. 1987;10:93–96. [Google Scholar]

[CR185] 33.Kurek M., Janowska E. Allergische und pseudoallergische Reaktionen auf Aromastoffe in der Nahrung. Z Hautkrankheiten H+G. 2001;76:699–703. [Google Scholar]

[CR186] 34.Mempel M., Rakoski J., Ring J., Ollert M. Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol. 2003;111:1406–1409. doi: 10.1067/mai.2003.1497. [DOI] [PubMed] [Google Scholar]

[CR187] 35.Möller C. Effect of pollen immunotherapy on food hypersensitivity in children with birch pollinosis. Ann Allergy. 1989;62:343–345. [PubMed] [Google Scholar]

[CR188] 36.Montes R.G., Perman J.A. Lactose intolerance: pinpointing the source of nonspecific gastrointestinal symptoms. Postgrad Med. 1991;89:175–178. doi: 10.1080/00325481.1991.11700961. [DOI] [PubMed] [Google Scholar]

[CR189] 37.Niggemann B., Reibel S., Roehr C.C., et al. Predictors of positive food challenge outcome in non-IgE-mediated reactions to food in children with atopic dermatitis. J Allergy Clin Immunol. 2001;106:1053–1058. doi: 10.1067/mai.2001.120192. [DOI] [PubMed] [Google Scholar]

[CR190] 38.Nordlee J.A., Taylor S.L., Townsend J.A., Thomas L.A., Bush R.K. Identification of a Brazilnut allergen in transgenic soybeans. N Engl J Med. 1996;334:688–692. doi: 10.1056/NEJM199603143341103. [DOI] [PubMed] [Google Scholar]

[CR191] 39.Ortolani C., Ballmer-Weber B.K., Hansen K.S., et al. Hazelnut allergy: a double-blind, placebo-controlled food challenge multicenter study. J Allergy Clin Immunol. 2000;105:577–581. doi: 10.1067/mai.2000.103052. [DOI] [PubMed] [Google Scholar]

[CR192] 40.Pichler W.J., Stich O. Nahrungsmittelallergien bei Pollensensibilisierungen, part II: Kreuzreaktionen bei Beifußpollen-Sensibilisierungen. Allergologie. 1993;16:494–501. [Google Scholar]

[CR193] 41.Pratschke E. Mediatoren der immunologischen Stimulation gastraler Funktionen: Experimentelle Untersuchungen am Beispiel der Gastrinfreisetzung. München: Habilitationsschrift; 1986. [Google Scholar]

[CR194] 42.Przybilla B., Ring J. Food allergy and atopic eczema. Semin Dermatol. 1990;9:220–225. [PubMed] [Google Scholar]

[CR195] 43.Reimann H.J., Ring J., Ultsch B., Wendt P. Intragastral provocation under endoscopic control (IPEC) in food allergy. Clin Allergy. 1985;15:195–202. doi: 10.1111/j.1365-2222.1985.tb02273.x. [DOI] [PubMed] [Google Scholar]

[CR196] 44.Ring J. Nahrungsmittelallergie und andere Unverträglichkeitsreaktionen durch Nahrungsmittel. Klin Wochenschr. 1984;62:795–802. doi: 10.1007/BF01711852. [DOI] [PubMed] [Google Scholar]

[CR197] 45.Ring J. Nahrungsmittel-Allergie und Gentechnik. In: Steinhart H., Tanner W., editors. Bayerische Akademie der Wissenschaften. Rundgespräche der Kommission für Ökologie, vol 16. Lebensmittel und Gentechnik. Munich: Dr. Friedrich Pfeil; 1999. pp. 61–72. [Google Scholar]

[CR198] 46.Ring J. Gentechnologie und Lebensmittelallergie (DGAI-Stellungnahme) Allergo J. 1997;6:214. [Google Scholar]

[CR199] 47.Ring J., Braun-Falco O. Allergie-Diät Verfahren zur Diagnostik und Therapie von Nahrungsmittel-Allergien und-Pseudo-Allergien. Hautarzt. 1987;38:198–205. [PubMed] [Google Scholar]

[CR200] 48.Roe D.A. Nutrition and the skin. New York: Liss; 1986. [Google Scholar]

[CR201] 49.Sampson H.A. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 2001;107:891–896. doi: 10.1067/mai.2001.114708. [DOI] [PubMed] [Google Scholar]

[CR202] 50.Schäfer T., Bohler E., Ruhdorfer S., et al. Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy. 2001;56:1172–1179. doi: 10.1034/j.1398-9995.2001.00196.x. [DOI] [PubMed] [Google Scholar]

[CR203] 51.Schauder P., Ollenschläger G. Prävention und Therapie. 2nd edn. Munich: Urban & Fischer; 2002. Ernährungsmedizin. [Google Scholar]

[CR204] 52.Schindler H., Bräckle J., Karch B. Kochbuch für Allergiker. Munich: Ehrenwirth; 1981. [Google Scholar]

[CR205] 53.Seifert J., Ring J., Brendel W. Prolongation of skin allografts after oral application of antilymphocyte serum in rats. Nature. 1975;249:776. doi: 10.1038/249776a0. [DOI] [PubMed] [Google Scholar]

[CR206] 54.Stefanini G.F., Saggioro A., Alvisi V., et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535–541. doi: 10.3109/00365529509089786. [DOI] [PubMed] [Google Scholar]

[CR207] 55.Stevenson D.D., Simon R.A. Sensitivity to ingested metabisulphites in asthmatic subjects. J Allergy Clin Immunol. 1981;68:26–32. doi: 10.1016/0091-6749(81)90119-6. [DOI] [PubMed] [Google Scholar]

[CR208] 56.Strobel S., Hourihane J.O. Gastrointestinal allergy: clinical symptoms and immunological mechanisms. Pediatr Allergy Immunol. 2001;12([Suppl 14]):43–46. doi: 10.1034/j.1399-3038.2001.121410.x. [DOI] [PubMed] [Google Scholar]

[CR209] 57.Thiel C.L., Fuchs E. Berichtsband. Berlin: Grosse; 1981. Über korrelative Beziehungen bei Kräuterpollen-und Gewürzallergenen, RAST 3; pp. 178–185. [Google Scholar]

[CR210] 58.Turjanmaa K. Atopy patch test, an additional new tool in the diagnosis of food allergy. Acta Dermatovenerol Croat. 2001;9:69–71. [Google Scholar]

[CR211] 59.Vieths S., Meyer A.H., Ehlers I., et al. Zur Deklaration “versteckter Allergene” in Lebensmitteln. Allergo J. 2001;10:130–136. [Google Scholar]

[CR212] 60.Wagner G., Ring J. Anaphylaktische Reaktionen bei Nuß-und Mohnallergie. Notfallmedizin. 1981;7:361. [Google Scholar]

[CR213] 61.Wahn U., Seger R., Wahn V. Pädiatrische Allergologie und Immunologie. 3rd edn. Munich: Urban & Fischer; 1999. [Google Scholar]

[CR214] 62.Warin R.P., Smith R.J. Challenge test battery in chronic urticaria. Br J Dermatol. 1975;94:401–406. doi: 10.1111/j.1365-2133.1976.tb06117.x. [DOI] [PubMed] [Google Scholar]

[CR215] 63.De Weck A.L., Griot-Wenk M., Schneider H., et al. Human allergogeneticists should listen to their dog’s barking. In: Ring J., Behrendt H., et al., editors. New trends in allergy V. Berlin Heidelberg New York: Springer; 2002. pp. 27–36. [Google Scholar]

[CR216] 64.Werfel T. Allergenspezifische T-Zell-Antwort bei Ekzemkrankheiten. München-Deisenhofen: Dustri; 2000. [Google Scholar]

[CR217] 65.Werfel T., Wedi B., Kleine-Tebbe J., et al. Vorgehen bei Verdacht auf eine pseudoallergische Reaktion auf Nahrungsmittelinhaltsstoffe. Allergo J. 1999;8:135–341. [Google Scholar]

[CR218] 66.Werner M. Krankheiten infolge peroraler Allergeninvasion. In: Hansen K., Werner M., editors. Lehrbuch der klinischen Allergie. Stuttgart: Thieme; 1967. p. 179. [Google Scholar]

[CR219] 67.Wüthrich B. Nahrungsmittelallergien. Internist. 1986;27:362–371. [PubMed] [Google Scholar]

[CR220] 68.Wüthrich B., Ballmer-Weber B.K. Food-induced anaphylaxis. Allergy. 2001;56([Suppl 67]):102–104. doi: 10.1034/j.1398-9995.2001.00930.x. [DOI] [PubMed] [Google Scholar]

[CR221] 69.Wüthrich B. Lethal or life-threatening allergic reactions to food. J Invest Allergol Clin Immunol. 2000;10:59–65. [PubMed] [Google Scholar]

[CR222] 70.Wüthrich B. Nahrungsmittel und Allergie. München-Deisenhofe: Dustri; 2002. [Google Scholar]

[CR223] 1.Albrecht I., Eichler G., Müller U., Hoigné R. On the significance of severe local reactions to hymenoptera stings. Clin Allergy. 1980;10:675. doi: 10.1111/j.1365-2222.1980.tb02151.x. [DOI] [PubMed] [Google Scholar]

[CR224] 2.Barnard J.H. Studies of 400 hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259. doi: 10.1016/0091-6749(73)90044-4. [DOI] [PubMed] [Google Scholar]

[CR225] 3.Bauer C.P. Stichprovokationen zur Diagnostik von Insektengift-Allergien? Allergologie. 1986;9:14. [Google Scholar]

[CR226] 4.Benson R., Semenov H. Allergy in its relation to bee sting. J Allergy. 1930;1:105. doi: 10.1016/S0021-8707(30)90149-9. [DOI] [Google Scholar]

[CR227] 5.Benton A.W., Morse R.A., Stewart J.D. Venom collection from honey bees. Science. 1963;142:228. doi: 10.1126/science.142.3589.228. [DOI] [PubMed] [Google Scholar]

[CR228] 6.Brehler R. Ultra-Rush-Hyposensibilisierung. Allergologie. 1999;22([Suppl 2]):570–571. [Google Scholar]

[CR229] 7.Brockow K., Kiehn M., Riethmüller C., et al. Efficacy of antihistamine treatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1997;100:458–463. doi: 10.1016/S0091-6749(97)70135-0. [DOI] [PubMed] [Google Scholar]

[CR230] 8.De Bandt M., Atassi-Dumont M., Kahn M.F., et al. Serum sickness after wasp venom immunotherapy: clinical and biological study. J Rheumatol. 1997;24:1195–1197. [PubMed] [Google Scholar]

[CR231] 9.Forck G., Kästner H., Kalveram C. Insect venom tolerance: IgG-“blocking” antibodies and sting provocation. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. p. 269. [Google Scholar]

[CR232] 10.Fuchs E. Allergie. Münch Med Wochenschr. 1959;100:1711. [Google Scholar]

[CR233] 11.Golden D.B.K., Valentine M.D., Kagey-Sobotka A., Lichtenstein M.L. Prevalence of hymenoptera venom allergy. J Allergy Clin Immunol. 1982;69:124. doi: 10.1016/S0091-6749(62)80408-4. [DOI] [Google Scholar]

[CR234] 12.Habermann E. Bee and wasp venoms. Science. 1972;177:314. doi: 10.1126/science.177.4046.314. [DOI] [PubMed] [Google Scholar]

[CR235] 13.Hemmer W., Focke M., Jarisch R. In-vitro-Doppelpositivität gegen Bienen-und Wespengift. Allergologie. 1999;22([Suppl 2]):63–64. [Google Scholar]

[CR236] 14.Hunt K.J., Valentine M.D., Sobotka A.K., Benton A.W., Amodio F.J., Lichtenstein L.M. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299:157. doi: 10.1056/NEJM197807272990401. [DOI] [PubMed] [Google Scholar]

[CR237] 15.Jarisch R. Die Bienengiftallergie (Modell einer IgE-mediierten Soforttypallergie) Wien Klin Wochenschr. 1980;92([Suppl 122]):3. [PubMed] [Google Scholar]

[CR238] 16.Jeßberger B., Habig J., Karl S., et al. Hymenopterengiftallergie: Hyposensibilisierungstherapie trotz vorhandener Kontraindikationen. Allergologie. 1994;17:255–260. [Google Scholar]

[CR239] 17.Kämmerer H. Fragekasten. Münch Med Wochenschr. 1941;88:939. [Google Scholar]

[CR240] 18.Kiehn M., Ring J. Hyposensibilisierung mit Insektengiftextrakten bei Patienten mit Hymenopterengift-Allergie im höheren Lebensalter. Allergo J. 1993;2([Suppl 2]):90–94. [Google Scholar]

[CR241] 19.King T.P., Lu G., Gonzalez M., Qian N., Soldatova L. Yellow jacket venom allergens, hyaluronidase and phospholipase: Sequence similarity and antigenic cross-reactivity with their hornet and wasp homologues and possible implications for clinical allergy. J Allergy Clin Immunol. 1996;98:588–600. doi: 10.1016/S0091-6749(96)70093-3. [DOI] [PubMed] [Google Scholar]

[CR242] 20.Lerch E., Müller U.R. Long-term protection after stopping venom immunotherapy: results of restings in 200 patients. J Allergy Clin Immunol. 1998;101:606–612. doi: 10.1016/S0091-6749(98)70167-8. [DOI] [PubMed] [Google Scholar]

[CR243] 21.Lessof M., Sobotka A.K., Lichtenstein L.M. Protection against anaphylaxis in hymenopterasensitive patients by passive immunization. J Allergy Clin Immunol. 1976;57:246. [PubMed] [Google Scholar]

[CR244] 22.Lichtenstein L.M., Valentine M.D., Sobotka A.K. A case for venom treatment in anaphylactic sensitivity to hymenoptera sting. N Engl J Med. 1974;290:1223. doi: 10.1056/NEJM197405302902204. [DOI] [PubMed] [Google Scholar]

[CR245] 23.Light W.V., Reismann R.E., Rosario N.A., Arbesman C.E. Comparison of the allergenic properties of bee venom and whole bee body extract. Clin Allergy. 1976;6:293. doi: 10.1111/j.1365-2222.1976.tb01909.x. [DOI] [PubMed] [Google Scholar]

[CR246] 24.Lockey R.F. Systemic reactions to stinging ants. J Allergy Clin Immunol. 1975;54:132. doi: 10.1016/0091-6749(74)90050-5. [DOI] [PubMed] [Google Scholar]

[CR247] 25.Lonsdorf G., Ring J., Burg G. Anaphylaktische Reaktionen nach Insektenstichen. Notfall Medizin. 1981;7:409. [Google Scholar]

[CR248] 26.Lotter G. Sensibilisierung für Bienengift durch Typhus-Antitoxin und Desensibilisierung mit Forapin. Münch Med Wochenschr. 1939;86:330–33. [Google Scholar]

[CR249] 27.Loveless M.H., Fackler W.R. Wasp venom allergy and immunity. Ann Allergy. 1956;14:347. [PubMed] [Google Scholar]

[CR250] 28.Mauss V. Einfluß von Lebensweise, Populationsdynamik und Abwehrverhalten aculeater Hymenopteren auf das Stichrisiko für den Menschen. Allergologie. 1999;22:542–545. [Google Scholar]

[CR251] 29.Mauss V., Treiber R. Betreuungsschlüssel für die Faltenwespen (Hymenoptera: Masarinae, Polistinae, Vespinae) der Bundesrepublik Deutschland. Hambu: Deutscher Jugendbund für Naturbeobachtung; 1994. [Google Scholar]

[CR252] 30.Mueller H.L., Schmid W.H., Rubinstein R. Stinging-insect hypersensitivity. A 20-year old study of immunologic treatment. Pediatrics. 1975;55:530. [PubMed] [Google Scholar]

[CR253] 31.Müller U.R. Klinik, Diagnostik und Therapie. Stuttgart: G. Fischer; 1988. Insektenstichallergie. [Google Scholar]

[CR254] 32.Müller U. New development in the diagnosis and treatment of hymenoptera venom allergy. Int Arch Allergy Immunol. 2001;124:447–499. doi: 10.1159/000053779. [DOI] [PubMed] [Google Scholar]

[CR255] 33.Müller U., Mosbech H. Position paper: Immunotherapy with hymenoptera venoms. Allergy. 1993;48([Suppl 2]):37–46. doi: 10.1111/j.1398-9995.1993.tb04755.x. [DOI] [Google Scholar]

[CR256] 34.Mumcuoglu Y., Rufli T. Dermatologische Entomologie. 12. Apidael Bienen. 13. Vespidae Wespen. Schweiz Rundsch Med. 1980;69:1317. [Google Scholar]

[CR257] 35.O’Connor R., Peck M.L. Handbook of experimental pharmacology. Berlin Heidelberg New York: Springer; 1978. Venoms of Apidae; p. 613. [Google Scholar]

[CR258] 36.Ollert M., Ring J. Prognostische Bedeutung von Immunoblot-Untersuchungen bei Hymenopterengift-Allergie. Allergologie. 1999;22([Suppl 2]):578–579. [Google Scholar]

[CR259] 37.Parrish H.M. Analysis of 460 fatalities from venomous animals in the United States. Am J Med Sci. 1963;245:129. doi: 10.1097/00000441-196302000-00001. [DOI] [PubMed] [Google Scholar]

[CR260] 38.Przybilla B., Ring J., Galosi A., Geursen R.G., Stickl H.A. Bee-venom immunoglobulin for prophylaxis of anaphylactic reactions during bee venom immunotherapy (rush hyposensitization) Immunol Allergy Practice. 1986;8:107–111. [Google Scholar]

[CR261] 39.Przybilla B. Pathophysiologische und klinische Aspekte der allergischen Reaktion vom Soforttyp und der Immunglobulin-E-Immunantwort: Untersuchungen unter besonderer Berücksichtigung der Bienen-und Wespengiftallergie. Munich: Habilitationsschrift; 1986. [Google Scholar]

[CR262] 40.Przybilla B., Ring J., Grießhammer B., Braun-Falco O. Schnellhyposensibilisierung mit Hymenopterengiften-Verträglichkeit und Therapieerfolg. Dtsch Med Wochenschr. 1987;112:416. doi: 10.1055/s-2008-1068068. [DOI] [PubMed] [Google Scholar]

[CR263] 41.Przybilla B., Ring J., Rieger B. Die Indikation zur Hymenopterengift-Hyposensibilisierung kann nicht anhand eines diagnostischen Parameters bewertenden Punkteschemas gestellt werden. Allergologie. 1992;13:114–119. [Google Scholar]

[CR264] 42.Rakoski J., von Mayenburg J. Das Ultra-Rush-Verfahreneine-eine neue Methode zur Über-prüfung der Aktualität von Insektengiftallergien. Allergologie. 1986;9:73–74. [Google Scholar]

[CR265] 43.Ring J., Lonsdorf G., Schury W., Burg G. Bienen-und Wespengift-Allergie. Klinik Prophylaxe und Therapie. Münch Med Wochenschr. 1982;124:587. [PubMed] [Google Scholar]

[CR266] 44.Ring J., Gottsmann M., Przybilla B., Eisenmenger W. Tod nach 1000 Bienenstichen. Münch Med Wochenschr. 1986;128:339. [Google Scholar]

[CR267] 45.Ring J., Przybilla B., Müller U. Insektengiftallergie: Aktuelles für die Praxis. Allergo J. 1997;6([Suppl 1]):571–57. [Google Scholar]

[CR268] 46.Rueff F., Reißig J., Przybilla B. Nebenwirkungen der Schnellhyposensibilisierung mit Hymenopterengift. Allergo J. 1997;6([Suppl 1]):659–664. [Google Scholar]

[CR269] 47.Rueff F., Przybilla B., Fuchs T., Gall H., Rakoski J., Stolz W., Vieluf D. Diagnose und Therapie der Bienen-und Wespengiftallergie. Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI) Allergo J. 2000;9:458–472. [Google Scholar]

[CR270] 48.Rzany B., Przybilla B., Jarisch R., et al. Clinical characteristics of immunotherapy with Hymenoptera venoms. A retrospective study. Allergy. 1991;46:251–254. doi: 10.1111/j.1398-9995.1991.tb00582.x. [DOI] [PubMed] [Google Scholar]

[CR271] 49.Schäfer T., Przybilla B. IgE antibodies to hymenoptera venoms in the serum are common in the general population and are related to indications of atopy. Allergy. 1996;51:372–377. [PubMed] [Google Scholar]

[CR272] 50.Schumacher M.J., Tveten M.S., Egen N.B. Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol. 1994;93:831–835. doi: 10.1016/0091-6749(94)90373-5. [DOI] [PubMed] [Google Scholar]

[CR273] 51.Schuberth K.C., Golden D.B.K., Kagey-Sobotka A., Valentine M., Lichtenstein L.M. Evaluation and treatment of insect sting allergy. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. p. 260. [Google Scholar]

[CR274] 52.Settipane G.A., Newstead G.J., Boyd G.K. Frequency of hymenoptera allergy in an atopic and normal population. J Allergy Clin Immunol. 1972;50:176. doi: 10.1016/0091-6749(72)90045-0. [DOI] [PubMed] [Google Scholar]

[CR275] 53.Stibich A.S., Carbonaro P.A., Schwartz R.A. Insect bite reactions: an update. Dermatology. 2001;202:193–197. doi: 10.1159/000051635. [DOI] [PubMed] [Google Scholar]

[CR276] 54.Tokura Y. Lymphocyte populations associated with exaggerated insect bite reactions. J Am Acad Dermatol. 1994;31:298. doi: 10.1016/S0190-9622(08)81992-5. [DOI] [PubMed] [Google Scholar]

[CR277] 55.Tunget C.L., Clark R.F. Invasion of the “killer” bees. Separating fact from fiction. Postgrad Med. 1993;94:92–102. [PubMed] [Google Scholar]

[CR278] 56.Urbanek R. Neue Konzepte der Behandlung von Insektengiftallergien. Derm Beruf Umwelt. 1979;27:44. [PubMed] [Google Scholar]

[CR279] 57.Van der Zwan J.C., Flintermann J., Jankowski I.G., et al. Hyposensitisation to wasp venom in six hours. Br Med J. 1983;287:1329–1331. doi: 10.1136/bmj.287.6402.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR280] 58.Weed R.I. Exaggerated delayed hypersensitivity to mosquito bite in chronic lymphocyte leukemia. Blood. 1965;26:257–268. [PubMed] [Google Scholar]

[CR281] 1.Abelson M.B., Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol. 1993;38:115–132. doi: 10.1016/0039-6257(93)90036-7. [DOI] [PubMed] [Google Scholar]

[CR282] 2.Allansmith M.R. The eye and immunology. St. Louis: Mosby; 1982. [Google Scholar]

[CR283] 3.Allansmith M.R., Ross R.N. Ocular allergy and mast cell stabilizers. Surv Ophthalmol. 1986;30:229–244. doi: 10.1016/0039-6257(86)90119-0. [DOI] [PubMed] [Google Scholar]

[CR284] 4.Anderson D.F. The conjunctival late-phase reaction and allergen provocation in the eye. Clin Exp Allergy. 1996;26:1105–1107. doi: 10.1111/j.1365-2222.1996.tb00494.x. [DOI] [PubMed] [Google Scholar]

[CR285] 5.Bialasiewicz A.A. Augenheilkunde. In: Heppt W., Renz H., Röcken M., editors. Allergologie. Berlin Heidelberg New York: Springer; 1998. pp. 262–271. [Google Scholar]

[CR286] 6.Bielory L. Allergic and immunologic disorders of the eye, part II: ocular allergy. J Allergy Clin Immunol. 2000;106:1019–1032. doi: 10.1067/mai.2000.111029. [DOI] [PubMed] [Google Scholar]

[CR287] 7.Bonini S., Bucci M.G., et al. Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol. 1990;86/(6):869–876. doi: 10.1016/S0091-6749(05)80148-4. [DOI] [PubMed] [Google Scholar]

[CR288] 8.Bonini S., Bonini S., Lambiase A., et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology. 2000;107:1157–1163. doi: 10.1016/S0161-6420(00)00092-0. [DOI] [PubMed] [Google Scholar]

[CR289] 9.Foster C.S., Rice B.A., Dutt J.E. Immunopathology of atopic keratoconjuncitivitis. Ophthalmology. 1991;98:1190–1196. doi: 10.1016/s0161-6420(91)32154-7. [DOI] [PubMed] [Google Scholar]

[CR290] 10.Friedlaender M.H. Contact allergy and toxicity in the eye. Int Ophthalmol Clin. 1988;28/(4):317–320. doi: 10.1097/00004397-198802840-00012. [DOI] [PubMed] [Google Scholar]

[CR291] 11.Friedlaender M.H. Allergy and immunology of the eye. New York: Raven; 1993. [Google Scholar]

[CR292] 12.Fuchs E. Über sympathisierende Entzündung. Albrecht v. Graefes Arch Ophthal. 1905;61:365. doi: 10.1007/BF01969717. [DOI] [Google Scholar]

[CR293] 13.Hatinen A., Terasvirta M., Fakj J.E. Contact allergy to components in topical ophthalmologic preparations. Acta Ophthalmol. 1985;63:424–426. doi: 10.1111/j.1755-3768.1985.tb01557.x. [DOI] [PubMed] [Google Scholar]

[CR294] 14.Jay J.L. Clinical factors and diagnosis of atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthal. 1981;60:335–340. doi: 10.1136/bjo.65.5.335. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR295] 15.McGill J. Conjunctival cytokines in ocular allergy. Clin Exp Allergy. 2000;30:1355–1357. doi: 10.1046/j.1365-2222.2000.00974.x. [DOI] [PubMed] [Google Scholar]

[CR296] 16.Montan P.G., Biberfeld P.J., Scheynius A. IgE, IgE receptors and other immunocytochemical markers in atopic and nonatopic patients with vernal keratoconjunctivitis. Ophthalmology. 1995;102:725–732. doi: 10.1016/s0161-6420(95)30962-1. [DOI] [PubMed] [Google Scholar]

[CR297] 17.Neuhann T. Papillomatös-hyperplastische Konjunktivitis durch Kontaktlinsen. Mbl Augenheilkunde. 1983;8:46–50. doi: 10.1055/s-2008-1054706. [DOI] [PubMed] [Google Scholar]

[CR298] 18.Ring I., Dechant W., Seifert J., Lund O.-E., Grette J.-H., Stefani F.H., Brendel W. Immunosuppression with antilymphocyte globulin (ALG) in the treatment of ophthalmic disorders. Ophthal Res. 1978;10:82–97. doi: 10.1159/000264940. [DOI] [Google Scholar]

[CR299] 19.Silverstein A.M., O’Connor G.R., editors. Immunology and immunopathology of the eye. New York: Masson; 1979. [Google Scholar]

[CR300] 20.Solomon A., Pe’er J., Levi-Schaffer F. Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies. Curr Opin Allergy Clin Immunol. 2001;1:477–482. doi: 10.1097/01.all.0000011063.28808.cc. [DOI] [PubMed] [Google Scholar]

[CR301] 21.Theodore F.H., Schlossmann A. Ocular allergy. Baltimore: Williams & Wilkins; 1958. [Google Scholar]

[CR302] 22.Trocme S.D., Aldave A.J. The eye and the eosinophil. Surv Ophthalmol. 1994;39:241–252. doi: 10.1016/0039-6257(94)90197-X. [DOI] [PubMed] [Google Scholar]

[CR303] 1.Ackroyd J.F. Sedormid purpura: An immunological study of drug hypersensitivity. Progr Allergy. 1952;3:531. [Google Scholar]

[CR304] 2.Aster R.H. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med. 1995;332:1374–1376. doi: 10.1056/NEJM199505183322011. [DOI] [PubMed] [Google Scholar]

[CR305] 3.Belongia E.A., Hedberg C.W., Gleich G.J. An investigation into the cause of the eosinophilia myalgia syndrome associated with tryptophan use. N Engl J Med. 1990;323:357–365. doi: 10.1056/NEJM199008093230601. [DOI] [PubMed] [Google Scholar]

[CR306] 4.Berg P.A., Becker E.W. The lymphocyte transformation test-a debated method for the evaluation of drug allergic hepatic injury. J Hepatol. 1995;22:115–118. doi: 10.1016/0168-8278(95)80270-3. [DOI] [PubMed] [Google Scholar]

[CR307] 5.Brendel W., Ring J. Transplantationsimmunologie. In: Filipp G., editor. Allergologie. Munich: Banaschewski; 1980. p. 436. [Google Scholar]

[CR308] 6.Dukes M.N.G. Drug-induced hepatic injury. Amsterdam: Elsevier; 1998. [Google Scholar]

[CR309] 7.Greinacher A., Potzsch B., Amiral J., Dummel V., Eichner A., Mueller-Eckhardt C. Heparin in associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994;71:247–251. [PubMed] [Google Scholar]

[CR310] 8.Jäger L., Merk H.F. Arzneimittel-Allergie. Jena: Gustav Fischer; 1996. [Google Scholar]

[CR311] 9.Kelton J.G., Huang A.T., Mold N. The use of in vitro techniques to study drug-induced pancytopenia. N Engl J Med. 1979;301:621. doi: 10.1056/NEJM197909203011201. [DOI] [PubMed] [Google Scholar]

[CR312] 10.Landsteiner K. Wien Klin Wochenschr. 1901;14:1132. [PubMed] [Google Scholar]

[CR313] 11.Manns M. Autoantibodies and antigens in liver diseases-updated. J Hepatol. 1989;9:272–280. doi: 10.1016/0168-8278(89)90063-9. [DOI] [PubMed] [Google Scholar]

[CR314] 12.Maria V.A.J., Pinto L., Victorino R.M.M. Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol. 1994;21:151–158. doi: 10.1016/S0168-8278(05)80388-5. [DOI] [PubMed] [Google Scholar]

[CR315] 13.Mueller-Eckhardt C. Ex vivo drug antigens. Are drug-induced immunoreactions such as immunohemolytic anemia related to genetic control? In: Estabrook R.W., Lindenlaub E., Oesch F., de Weck A.L., editors. Toxicological and immunological aspects of drug metabolism and environmental chemicals. Stuttgart: Schattauer; 1988. pp. 329–342. [Google Scholar]

[CR316] 14.Mueller-Eckhart C., Kuenzlen E., Thilo-Korner D., Pralle H. High-dose intravenous immunoglobulin for post transfusion purpura. N Engl J Med. 1983;308:287. doi: 10.1056/NEJM198302033080526. [DOI] [PubMed] [Google Scholar]

[CR317] 15.Mueller-Eckhardt C., Salama A. Immunhämolytische Anämien durch Medikamente. Dtsch Ärztebl. 1987;84:232–234. [Google Scholar]

[CR318] 16.Neftel K.A., Wälti M., Spengler H., von Felten A., Weitzmann S.A., Bürgi H., de Weck A.L. Neutropenia after penicillins: toxic or immune-mediated? Klin Wochenschr. 1981;59:877. doi: 10.1007/BF01721921. [DOI] [PubMed] [Google Scholar]

[CR319] 17.Pessayre D. Mecanisme de hepatites medi-camenteuses Gastroenterol. Clin Biol. 1995;19:47–56. [PubMed] [Google Scholar]

[CR320] 18.Pihusch R. Die Heparin-induzierte Thrombozytopenie. Phlebologie. 1998;27:111–116. [Google Scholar]

[CR321] 19.Plötz G, et al. Hypereosinophilie-Syndrom. Hautarzt

[CR322] 20.Raif W., Schubothe H. Durch körperfremde Substanzen induzierte immunhämatologische Erkrankungen. Allergologie. 1979;2:192. [Google Scholar]

[CR323] 21.Raskob G.E., George J.N. Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice. Ann Intern Med. 1997;127:839–841. doi: 10.7326/0003-4819-127-9-199711010-00012. [DOI] [PubMed] [Google Scholar]

[CR324] 22.Salama A., Mueller-Eckhardt C. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med. 1985;313:469–474. doi: 10.1056/NEJM198508223130803. [DOI] [PubMed] [Google Scholar]

[CR325] 23.Salama A., Mueller-Eckhardt C. Humanemediated blood cell dyscrasias related to drugs. Semin Hematol. 1992;29:54–63. [PubMed] [Google Scholar]

[CR326] 24.Schiele F., Vuillemenot A., Kramarz P., Kieffer Y., Anguenot T., Bernard Y., Bassand J.P. Use of recombinant hirudin as antithrombotic treatment in patients with heparin induced thrombocytopenia. Ann J Hematol. 1995;50:20–25. doi: 10.1002/ajh.2830500105. [DOI] [PubMed] [Google Scholar]

[CR327] 25.Shulman N.R., Aster R.H., Leitner A., Hiller M.C. Immunoreactions involving platelets. V. Posttransfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. J Clin Invest. 1961;40:1597. doi: 10.1172/JCI104383. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR328] 26.Shulman N.R. Immunologic reactions to drugs. N Engl J Med. 1972;286:508–512. doi: 10.1056/NEJM197208242870810. [DOI] [PubMed] [Google Scholar]

[CR329] 27.Varga J., Uitto J., Jimenez S.A. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Int Med. 1992;116:140–147. doi: 10.7326/0003-4819-116-2-140. [DOI] [PubMed] [Google Scholar]

[CR330] 28.Wanamaker W.M., Wanamaker S.J., Celesia G.G., et al. Thrombocytopenia associated with long-term levodopa therapy. J Am Med Assoc. 1976;235:2217. doi: 10.1001/jama.235.20.2217. [DOI] [PubMed] [Google Scholar]

[CR331] 29.Zweiman B., Patten E. Immunohematologic diseases. J Am Med Assoc. 1982;248:2677–2682. doi: 10.1001/jama.248.20.2677. [DOI] [PubMed] [Google Scholar]

[CR332] 1.Becker E.L., Austen K.F. Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homcytotropic antibody-mediated histamine release and the first component of rat complement. J Exp Med. 1966;124:379–395. doi: 10.1084/jem.124.3.379. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR333] 2.Brostoff J., Challacombe S.J., editors. Food allergy and intolerance. London: Tindall; 1987. [Google Scholar]

[CR334] 3.Bruckbauer H.R., Ollert M., Ring J. Vaskulitiden der Haut. Bay Int. 1997;17:166–179. [Google Scholar]

[CR335] 4.Burden A.D., Tillman D.M., Foley P., Holme E. IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol. 1996;35:411–415. doi: 10.1016/S0190-9622(96)90606-4. [DOI] [PubMed] [Google Scholar]

[CR336] 5.Cochrane C.G., Koftler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16:185. doi: 10.1016/S0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]

[CR337] 6.Dixon F.J., Vasquez J.J., Weigle W.O., Cochrane C.G. Pathogenesis of serum sickness. Arch Pathol. 1958;65:18. [PubMed] [Google Scholar]

[CR338] 7.Eisenmann A., Ring J., von der Helm D., Meurer M., Braun-Falco O. Vasculitis allergica durch Nahrungsmittelallergie. Hautarzt. 1988;39:318–321. [PubMed] [Google Scholar]

[CR339] 8.Fauci A.S. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979;301:235. doi: 10.1056/NEJM197908023010503. [DOI] [PubMed] [Google Scholar]

[CR340] 9.Gross W.L., Schmitt W.H., Lotti T. ANCA-assoziierte Vaskulitiden. Hautarzt. 1995;46:511–524. doi: 10.1007/s001050050292. [DOI] [PubMed] [Google Scholar]

[CR341] 10.Hunt H.J., Valentine M.D., Sobotha A.K., Junginger J.W., Lichtenstein L.M. Serum sickness associated with nonvenom protein in mixed hymenoptera whole body extract. J Allergy Clin Immunol. 1976;57:246–254. [Google Scholar]

[CR342] 11.Jenette C.J., Milling D.M., Falk R.J. Vasculitis affecting the skin. Arch Dermatol. 1994;130:899–906. doi: 10.1001/archderm.130.7.899. [DOI] [PubMed] [Google Scholar]

[CR343] 12.Kohler P.F. Immune complexes and allergic disease. In: Middleton E., Ellis E.F., Reed C.E., editors. Allergy, principles and practice. 2nd edn. St. Louis: Mosby; 1983. pp. 167–199. [Google Scholar]

[CR344] 13.Meurer M. Urticarial vasculitis. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 148–151. [Google Scholar]

[CR345] 14.Morgan A.C., Jr, Rossen R., Twomey J.J. Naturally occurring circulating immune complexes: normal serum contains idiotype-anti-idotype complexes dissociable by certain IgG antiglobulins. J Immunol. 1979;122:1672. [PubMed] [Google Scholar]

[CR346] 15.Ollert, deleted in production

[CR347] 16.v Pirquet C., Schick B. Die Serumkrankheit. Leipzig: Deutike; 1905. [Google Scholar]

[CR348] 17.Ravetch J.V. Fc receptors: Rubor redux. Cell. 1994;78:533–560. doi: 10.1016/0092-8674(94)90521-5. [DOI] [PubMed] [Google Scholar]

[CR349] 18.Ring J., Seifert J., Lob G., Coulin K., Angstwurm H., Frick E., Brass B., Mertin I., Backmund H., Brendel W. Intensive immunosuppression in the treatment of multiple sclerosis. Lancet. 1974;II:1093. doi: 10.1016/S0140-6736(74)90866-6. [DOI] [PubMed] [Google Scholar]

[CR350] 19.Ring J., Seifert J., Seiler F., Brendel W. Improved compatibility of ALG therapy by application of aggregate free globulin. Int Arch Allergy Appl Immunol. 1976;52:227–234. doi: 10.1159/000231686. [DOI] [PubMed] [Google Scholar]

[CR351] 20.Ring J. Anaphylaktoide Reaktionen nach Infusion natürlicher und künstlicher Kolloide. Berlin Heidelberg New Yor: Springer; 1978. [Google Scholar]

[CR352] 21.Ruzicka T., Burg G. Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeico-satetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol. 1987;88:120–123. doi: 10.1111/1523-1747.ep12525265. [DOI] [PubMed] [Google Scholar]

[CR353] 22.Sais G., Vidaller A., Jucgla A., Gallardo F., Peyri J. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol. 1995;131:1399–1402. doi: 10.1001/archderm.131.12.1399. [DOI] [PubMed] [Google Scholar]

[CR354] 23.Scherer R., Wolff H.H. Vasculitis allergica. Allergologie. 1979;2:62. [Google Scholar]

[CR355] 24.Sedlacek H.H. Pathophysiological aspects of immune complex diseases. Klin Wochenschr. 1980;58:543–593. doi: 10.1007/BF01477164. [DOI] [PubMed] [Google Scholar]

[CR356] 25.Seifert J., Land W., Ring J., Lob G., Brendel W. Antigen-Eliminationstechnik. Fortschr Med. 1978;96:695–697. [PubMed] [Google Scholar]

[CR357] 26.Smedegard G., Revenas B., Arfors K.E. Anaphylaxis in the monkey: hemodynamics and blood flow distribution. Acta Physiol Scand. 1979;106:191–198. doi: 10.1111/j.1748-1716.1979.tb06389.x. [DOI] [PubMed] [Google Scholar]

[CR358] 27.Soter N.A., Austen K.F., Gigli I. Urticaria and arthralgias as manifestations of necrotizing angiitis (vasculitis) J Invest Dermatol. 1974;63:485–490. doi: 10.1111/1523-1747.ep12680443. [DOI] [PubMed] [Google Scholar]

[CR359] 28.Sylvestre D.L., Ravetch J.V. Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science. 1994;265:1095–1098. doi: 10.1126/science.8066448. [DOI] [PubMed] [Google Scholar]

[CR360] 29.Theissen U., Luger T.A., Schwarz T. Erfolgreiche topische Anwendung von Cyclosporin A bei Pyoderma gangraenosum. Hautarzt. 1996;47:132–135. doi: 10.1007/s001050050390. [DOI] [PubMed] [Google Scholar]

[CR361] 30.Theofilopoulos A.N., Dixon F.J. Detection of immune complexes; techniques and implications. Hosp Pract. 1980;15:107. doi: 10.1080/21548331.1980.11946602. [DOI] [PubMed] [Google Scholar]

[CR362] 31.van Furth R., Cohn Z.A., Hirsch J.G., et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull Wld Hlth Org. 1972;46:845. [PMC free article] [PubMed] [Google Scholar]

[CR363] 32.Wolff H.H., Scherer R. Allergic vasculitis. In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 140–147. [Google Scholar]

[CR364] 33.Zhang Y., Ramos B.F., Jakschik B.A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science. 1992;258:1957–1959. doi: 10.1126/science.1470922. [DOI] [PubMed] [Google Scholar]

[CR365] 1.Allen D.H., Basten A., Woolcock A.J. Studies of cell and humoral immunity in birdbreeders hypersensitivity pneumonitis. Am Rev Resp Dis. 1977;115:45. [Google Scholar]

[CR366] 2.Bäck O., Lindgren R., Wiman L.G. Nitrofurantoin induced pulmonary fibrosis and lupus syndrome. Lancet. 1974;I:930. doi: 10.1016/S0140-6736(74)90379-1. [DOI] [PubMed] [Google Scholar]

[CR367] 3.Bergmann K.C., Costabel U., Knape H., Kroidl R., Müller-Wening D., Repp H., Rust M., Schwarz H., Sennekamp J. Empfehlungen zur Diagno-sestellung einer exogen-allergischen Alveolitis. Allergologie. 1990;13:111. [Google Scholar]

[CR368] 4.Boyd G., McSharry C., McLeod K., Sriram S., Boyd F. Lymphocyte responses in pigeon breeders with extrinsic allergic alveolitis/hypersensitivity pneumonitis (EAA/HP) are predominantly T helper 2-type. Am J Resp Crit Care Med. 1999;159:A742. [Google Scholar]

[CR369] 5.Doerr W. Pneumokoniose durch Getreidestaub. Virchows Arch Pathol Anat. 1953;324:263. doi: 10.1007/BF00954507. [DOI] [PubMed] [Google Scholar]

[CR370] 6.Fink J.N. Hypersensitivity pneumonitis. Clinics in chest Medicine. 1992;13:303. [PubMed] [Google Scholar]

[CR371] 7.Fruhmann G. Pneumokoniosen durch organisches Material. Deutsches Ärzteblatt. 1988;85:3170. [Google Scholar]

[CR372] 8.Fuchs A., Liebetrau G. Die Vogelhalterlunge — eine Form der exogen allergischen Alveolitis. Z Klein Med. 1989;44:1407. [Google Scholar]

[CR373] 9.Heiner D.C., Snears J.W., Kniker W.T. Multiple precipitins to cow’s milk in chronic respiratory disease. Am J Dis Child. 1962;103:634. [PubMed] [Google Scholar]

[CR374] 10.Hinojosa M. Stipatosis or hypersensitivity pneumonitis caused by esparto (Stipa tenacissima) fibers. J Invest Allergol Clin Immunol. 2001;11:67–72. [PubMed] [Google Scholar]

[CR375] 11.Jelke G. Krank durch Fortschritt. Expositionelle Besonderheiten bei der exogen-allergischen Alveolitis. Allergologie. 1986;9:137. [Google Scholar]

[CR376] 12.Kroidl R.F., Nowak D., Seysen U. Exogen-allergische Alveolitis: Probleme und Fehler bei der Begutachtung. Allergologie. 1994;17:75. [Google Scholar]

[CR377] 13.Malmberg P., Rask-Andersen A. Organic dust toxic syndrome. Semin Resp Med. 1993;14:38. doi: 10.1055/s-2007-1006307. [DOI] [Google Scholar]

[CR378] 14.Marinkovich V.A. Hypersensitivity alveolitis. J Am Med Assoc. 1975;231:944. doi: 10.1001/jama.231.9.944. [DOI] [PubMed] [Google Scholar]

[CR379] 15.McCarthy D.S., Pepys J. Allergic bronchopulmonary aspergillosis. Clinical immunology: 1. Clinical features, 2. Skin, nasal and bronchial tests. Clin Allergy. 1971;1:261. doi: 10.1111/j.1365-2222.1971.tb00779.x. [DOI] [PubMed] [Google Scholar]

[CR380] 16.McSharry C., Banham S.W., Boyd G. Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy. 1985;15:487. doi: 10.1111/j.1365-2222.1985.tb02299.x. [DOI] [PubMed] [Google Scholar]

[CR381] 17.Molina C. Immunopathologie bronchopulmonaire. Paris: Masson; 1984. [Google Scholar]

[CR382] 18.Müller-Wening D., Repp H. Investigation on the protective value of breathing masks in farmer’s lung using an inhalation provocation test. Chest. 1989;95:100. doi: 10.1378/chest.95.1.100. [DOI] [PubMed] [Google Scholar]

[CR383] 19.Murray M.J., et al. Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin. N Engl J Med. 1965;273:1185. doi: 10.1056/NEJM196511252732204. [DOI] [PubMed] [Google Scholar]

[CR384] 20.Newman-Taylor A, Pickering CAC, Turner-Warwick M, Pepys J (1978) Respiratory allergy to a factor humidifier contaminant presenting as pyrexia of undetermined origin. Br Med J:II [DOI] [PMC free article] [PubMed]

[CR385] 21.Olenchock S.A., May J.J., Pratt D.S., et al. Presence of endotoxin in different agricultural environments. Am J Industr Med. 1990;18:279. doi: 10.1002/ajim.4700180307. [DOI] [PubMed] [Google Scholar]

[CR386] 22.Parkers W.R. Occupational lung disorders. London: Butterworth; 1994. [Google Scholar]

[CR387] 23.Patterson R. Studies of hypersensitivity lung disease with emphasis on a solid-phase radioimmunoassay as a potential diagnostic acid. J Allergy Clin Immunol. 1978;61:216. doi: 10.1016/0091-6749(78)90184-7. [DOI] [PubMed] [Google Scholar]

[CR388] 24.Pepys J. Farmer lung’s — a needle in a haystack, and Pandora’s box. Allergy Clin Immunol News. 1994;6:68. [Google Scholar]

[CR389] 25.Pepys I., Jenkins P., Festenstein G., Gregory P., Lacey M., Skinner F. Farmer’s lung. Thermophilic actinomycetes as a source of “farmer’s lung hay” antigen. Lancet. 1963;II:607. doi: 10.1016/S0140-6736(63)90398-2. [DOI] [PubMed] [Google Scholar]

[CR390] 26.Raulf M., Liebers V., Steppert C., Baur X. Increased gamma/delta positive T-cells in pneumonitis. Eur Respir J. 1994;7:140. doi: 10.1183/09031936.94.07010140. [DOI] [PubMed] [Google Scholar]

[CR391] 27.Rylander R., Malmberg P. Non-infectious fever: inhalation fever or toxic alveolitis? Br J Industr Med. 1992;49:296. doi: 10.1136/oem.49.4.296. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR392] 28.Salvaggio J.E., Buechner H.A., Seabury H. Bagassosis I. Precipitins against extracts of crude bagasse in the serum of patients with bagassosis. Ann Intern Med. 1966;64:748. doi: 10.7326/0003-4819-64-4-748. [DOI] [PubMed] [Google Scholar]

[CR393] 29.Sastre J., Ibanez M.D., Lopez M., Lehrer S.B. Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin Exp Allergy. 1990;20:13. doi: 10.1111/j.1365-2222.1990.tb02769.x. [DOI] [PubMed] [Google Scholar]

[CR394] 30.Schatz M., Patterson R. Immunopathogenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol. 1977;60:27. doi: 10.1016/0091-6749(77)90079-3. [DOI] [PubMed] [Google Scholar]

[CR395] 31.Schulz K.H., Felten G., Hausen B.M., Noster U. Allergy to spores of Pleurotus Florida. Lancet. 1974;I:625. doi: 10.1016/S0140-6736(74)92682-8. [DOI] [PubMed] [Google Scholar]

[CR396] 32.Schultze-Werninghaus G., Rust M. Asthma bronchiale und allergische Alveolitis durch Berufsallergene. Allergologie. 1988;II:437. [Google Scholar]

[CR397] 33.Seeliger H.P.R., Sühler H. Farmerlunge beim Tier. Berl Münch Tierärztl Wochenschr. 1975;88:163. [PubMed] [Google Scholar]

[CR398] 34.Sennekamp H.-J. Exogen allergische Alveolitis. Munich: Dustri; 1998. [Google Scholar]

[CR399] 35.Slavin R.G., Million L., Cherry J. Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment. J Allergy Clin Immunol. 1970;46:150. doi: 10.1016/0021-8707(70)90093-6. [DOI] [PubMed] [Google Scholar]

[CR400] 36.van Hage-Hamsten M., Johansson S.G.O., Höglund S., Tüll P., Wirén A., Zetterström O. Storage mite allergy is common in a farming population. Clin Allergy. 1985;15:555–564. doi: 10.1111/j.1365-2222.1985.tb02309.x. [DOI] [PubMed] [Google Scholar]

[CR401] 37.Vogelmeier C., Krombach F., Münzing S., et al. Activation of blood neutrophils in acute episodes of farmer’ lung. Am Rev Resp Dis. 1993;148:396. doi: 10.1164/ajrccm/148.2.396. [DOI] [PubMed] [Google Scholar]

[CR402] 38.von Essen S., Robbins R.A., Thompson A.B. Organic dust toxic syndrome. Clin Toxicol. 1990;28:389. doi: 10.3109/15563659009038584. [DOI] [PubMed] [Google Scholar]

[CR403] 39.Warren C.P.W. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax. 1977;32:567–569. doi: 10.1136/thx.32.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR404] 40.de Weck A.L., Gutersohn J., Bütikofer E. La maladie des laveurs de fromage (“Käsewascher-krankheit”): une forme particulière du syndrome du poumon de fermier. Schweiz Med Wochenschr. 1969;99:872. [PubMed] [Google Scholar]

[CR405] 41.Westphal O., Lüderitz O. Bacterial endotoxins. J Med Pharma Chem. 1961;4:497. doi: 10.1021/jm50019a008. [DOI] [PubMed] [Google Scholar]

[CR406] 42.Wild L.G., Lopez M. Hypersensitivity pneumonitis: A comprehensive review. J Invest Allergol Clin Immunol. 2001;11:3–15. [PubMed] [Google Scholar]

[CR407] 1.Ackermann A.B., Ragaz A. A plea to expunge the word eczema from the lexicon of dermatology and dermatopathology. Am J Dermatopathol. 1982;4:315–326. doi: 10.1007/BF00509073. [DOI] [PubMed] [Google Scholar]

[CR408] 2.von Amida A. Tetrabiblos. Basel: Froben; 1549. p. 730. [Google Scholar]

[CR409] 3.Akdis M., Klunker S., Schliz M., Blaser K., Akdis C.A. Expression cutaneous lymphocyte-associated antigen on human CD4+ and DC8+ Th2 cells. Eur J Immunol. 2000;30:3533–3541. doi: 10.1002/1521-4141(2000012)30:12<3533::AID-IMMU3533>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]

[CR410] 4.Bandmann H.J., Dohn W. Die Epicutantestung. 2nd edn. Munich: Bergmann; 1967. [Google Scholar]

[CR411] 5.Benezra C. Molecular recognition in allergic contact dermatitis. In: Ring J., Burg G., editors. New trends in allergy II. Berlin Heidelberg New York: Springer; 1986. pp. 218–224. [Google Scholar]

[CR412] 6.Bergstresser P.R., Tigelaar R.E., Dees J.H., Streilein J.W. Thy-1 antigen-bearing dendritic cells populate murine epidermis. J Invest Dermatol. 1983;81:286. doi: 10.1111/1523-1747.ep12518332. [DOI] [PubMed] [Google Scholar]

[CR413] 7.Bloch I. Der älteste Gebrauch des Wortes “Eczema”. Mh Prakt Dermatol. 1911;53:69–71. [Google Scholar]

[CR414] 8.Borelli S. Gewerbedermatosen, einschließlich Begutachtung. In: Korting G.W., editor. Dermatologie in Praxis und Klinik. Stuttgart: Thieme; 1980. [Google Scholar]

[CR415] 9.Braathen L.R., Thorsby E. Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T cell-responses. Br J Dermatol. 1983;108:139–146. doi: 10.1111/j.1365-2133.1983.tb00055.x. [DOI] [PubMed] [Google Scholar]

[CR416] 10.Brasch J., Geier J., Schnuch A. Differenzierte Kontaktallergenlisten dienen der Qualitätsverbesserung. Hautarzt. 1998;49:184–191. doi: 10.1007/s001050050725. [DOI] [PubMed] [Google Scholar]

[CR417] 11.Burg G., Przybilla B., Bogner J. Contact — allergy time. In: Ring J., Burg G., editors. New trends in allergy II. Berlin Heidelberg New York: Springer; 1986. pp. 230–239. [Google Scholar]

[CR418] 12.Bruynzeel DP (1983) Angry back or excited skin syndrome. Thesis, Amsterdam

[CR419] 13.Cavani A., Albanesi C., Traidl C., Sebastiani S., Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol. 2001;22:118–120. doi: 10.1016/S1471-4906(00)01815-9. [DOI] [PubMed] [Google Scholar]

[CR420] 14.Chase M.W. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med. 1946;61:257–259. doi: 10.3181/00379727-61-15294p. [DOI] [PubMed] [Google Scholar]

[CR421] 15.Cronin E. Contact dermatitis. Edinburgh: Churchill Livingstone; 1980. [Google Scholar]

[CR422] 16.De Groot A.C. Patch testing. Amsterdam: Elsevier; 1994. [Google Scholar]

[CR423] 17.Diepgen T.L., Coenraads P.J. The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health. 1999;72:496–506. doi: 10.1007/s004200050407. [DOI] [PubMed] [Google Scholar]

[CR424] 18.Enders F., Przybilla B., Ring J. Epikutantest mit einer Standardreihe. Hautarzt. 1988;39:779–786. [PubMed] [Google Scholar]

[CR425] 19.Enk A.H., Angeloni V.L., Udey M.C., Katz S.I. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol. 1993;150:3698–3703. [PubMed] [Google Scholar]

[CR426] 20.Faergemann J. Pityrosporum ovale-assoziierte Dermatosen. In: Braun-Falco O., Plewig G.K., Meurer M., editors. Fortschritte prakt. Derm Venereol. Berlin Heidelberg New York: Springer; 1993. pp. 234–237. [Google Scholar]

[CR427] 21.Fischer T., Bellberg K., Bruynzeel D.P., Ducombs G., Hannuksela M., Lachapelle I.M., Ring J., White I.R., Wilkinson J. European multicenter study of TRUE test. Contact Dermatol. 1988;19:91–97. doi: 10.1111/j.1600-0536.1988.tb05504.x. [DOI] [PubMed] [Google Scholar]

[CR428] 22.Foussereau J., Benezra C., Maibach H.I. Occupational contact dermatitis, clinical and chemical aspects. Copenhagen: Munksgaard; 1982. [Google Scholar]

[CR429] 23.Frosch P., Rustemeyer T., Schnuch A. Kontaktdermatitis, parts I and II. Hautarzt. 1996;47:874–882. doi: 10.1007/BF03355107. [DOI] [PubMed] [Google Scholar]

[CR430] 24.Fuchs T., Aberer W., editors. Kontakteczema. Deisenhofen: Dustri; 2004. [Google Scholar]

[CR431] 25.Gollhausen R., Ring J., Przybilla B. Der iterative Test zur Unterscheidung kontaktallergischer oder irritativer Epikutantestreaktionen. Allergologie. 1987;10:427. [Google Scholar]

[CR432] 26.Grabbe S., Kämpgen E., Schuler G. Dentritic cells: multi-lineal and multi-functional. Immunol Today. 2000;21:431–433. doi: 10.1016/S0167-5699(00)01694-7. [DOI] [PubMed] [Google Scholar]

[CR433] 27.Granstein R.D., Askari M. Cutaneous cells in activation of immunologic reactions: further characterization. J Invest Dermatol. 1986;87:141. [Google Scholar]

[CR434] 28.Halter S. Das vulgäre Eczema. In: Gottron A., Schönfeld W., editors. Dermatologie und Venerologie. Stuttgart: Thieme; 1959. [Google Scholar]

[CR435] 29.Happle R. Paraptisches Eczema. Hautarzt. 1994;45:1–3. doi: 10.1007/PL00013249. [DOI] [PubMed] [Google Scholar]

[CR436] 30.Hausen B., Vieluf I. Pflanzen-Allergene. Landsberg: Ecomed; 1998. Allergie-Pflanzen. [Google Scholar]

[CR437] 31.Hornstein O.P. Anmerkungen und Vorschläge zur Definition und Klassifikation der Eczemakrankheiten. Z Hautkr. 1986;61:1281–1296. [PubMed] [Google Scholar]

[CR438] 32.Hannuksela M., Salo H. The repeated open application test (ROAT) Contact Dermatol. 1986;14:211–227. doi: 10.1111/j.1600-0536.1986.tb01338.x. [DOI] [PubMed] [Google Scholar]

[CR439] 33.Jadassohn J. Verhandl Dtsch Derm Gesellschaft. 1895;5:103. [Google Scholar]

[CR440] 34.Kapsenberg M.L., Bos J.D., Wierenga E.A. Cells in allergic responses to haptens and proteins. Springer Semin Immunopathol. 1992;13:303–314. doi: 10.1007/BF00200530. [DOI] [PubMed] [Google Scholar]

[CR441] 35.Klaschka F. Hämatogenes Kontakteczema durch Nahrungsmittel. Allergologie. 1987;10:93–97. [Google Scholar]

[CR442] 36.Knop J., Malorny U., Macher E. Induction of T effector and T suppressor lymphocytes in vitro by haptenized bone marrow-derived macrophages. Cell Immunol. 1984;88:411–420. doi: 10.1016/0008-8749(84)90174-6. [DOI] [PubMed] [Google Scholar]

[CR443] 37.Kripke M.L., Munn C.G., Jeevan A., Tang M.M., Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol. 1990;145:2833–2842. [PubMed] [Google Scholar]

[CR444] 38.Langerhans P. Über die Nerven der menschlichen Haut. Virchows Arch A (Path Anat) 1868;44:325. doi: 10.1007/BF01959006. [DOI] [Google Scholar]

[CR445] 39.Lepoittevin J.-P., Benezra C., Sigman C.C., Baheri D., Fraginals R., Maibach H.I. Molecular aspects of allergic contact dermatitis. In: Rycroft R.J.G., Mennée T., Frosch P., editors. Textbook of contact dermatitis. Berlin Heidelberg New York: Springer; 1995. pp. 105–119. [Google Scholar]

[CR446] 40.Luderschmidt C., Heilgemair G., Ring J., Burg G. Polyvalente Kontaktallergie versus “Angry-back-Syndrom”. Allergologie. 1982;5:262–268. [Google Scholar]

[CR447] 41.Magnussen B., Kligman A.M. Usefulness of guinea pig tests for detection of contact sensitizers. In: Marzulli F.N., Maibach H.I., editors. Dermatotoxicology and pharmacology. London: Wiley; 1977. pp. 551–560. [Google Scholar]

[CR448] 42.Maibach H.I. The ESS, excited-skin-syndrome (alias the “angry-back”) In: Ring J., Burg G., editors. New trends in allergy. Berlin Heidelberg New York: Springer; 1981. pp. 206–216. [Google Scholar]

[CR449] 43.Miescher G. In: Handbuch der Haut-und Geschlechtskrankheiten. Marchionini A., editor. Berlin Heidelberg New York: Springer; 1962. p. 1. [Google Scholar]

[CR450] 44.Mitchell J.C. The angry back syndrome: eczema creates eczema. Contact Dermatol. 1975;1:193–194. doi: 10.1111/j.1600-0536.1975.tb05380.x. [DOI] [PubMed] [Google Scholar]

[CR451] 45.Nater J.P., De Groot A.C. Unwanted effects of cosmetics and drugs used in dermatology. 2nd edn. Amsterdam: Elsevier; 1983. [Google Scholar]

[CR452] 46.Odia S., Vocks E., Rakoski J., Ring J. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol. 1996;76:472–474. doi: 10.2340/0001555576472474. [DOI] [PubMed] [Google Scholar]

[CR453] 47.Rietschel R.L., Fouler J.F. Fisher’s contact dermatitis. 5th edn. Philadelphia: Lippincott-Williams; 2001. [Google Scholar]

[CR454] 48.Ring J (ed) (1990) Endogenous and exogenous eczema. Semin Dermatol 9:195–246 [PubMed]

[CR455] 49.Ring J. Zum Wandel des Eczema-Begreiffes: Klassisches versus atopisches Eczema. Z Hautkr. 1996;10:752–756. [Google Scholar]

[CR456] 50.Römpp H. Chemielexikon. 8th edn. Stuttgart: Franckh’sche Verlagshandlung; 1982. [Google Scholar]

[CR457] 51.Ross R., Gillitzer R., Kleinz J., Schwing H., Kleinert U., Förstermann A.B., Reske-Kunz Involvement of NO in contact hypersensitivity. Int Immunol. 1998;10:61–69. doi: 10.1093/intimm/10.1.61. [DOI] [PubMed] [Google Scholar]

[CR458] 52.Rycroft R.J.G., Menné T., Frosch P., editors. Textbook of contact dermatitis. Berlin Heidelberg New York: Springer; 1995. [Google Scholar]

[CR459] 53.Schäfer T, Böhler E, Ruhdorfer S, Weigl L, Wessner D, Filipiak B, Wichmann HE, Ring J (2004) Epidemiology of contact allergy in adults. Allergy (in press) [DOI] [PubMed]

[CR460] 54.Schnuch A., Geier J., Uter W., et al. National rates and regional differences in sensitization to allergens of the standard series. Contact Dermatitis. 1997;37:200–209. doi: 10.1111/j.1600-0536.1997.tb02435.x. [DOI] [PubMed] [Google Scholar]

[CR461] 55.Schnuch A., Aberer W., Agathos M., Brasch J., Frosch P.J., Fuchs T., Richter G. Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) zur Durchführung des Epikutantests mit Kontaktallergenen. Hautarzt. 2001;52:864–866. doi: 10.1007/s001050170048. [DOI] [PubMed] [Google Scholar]

[CR462] 56.Schulz K.H., Fuchs T. Manuale allergologicum. Deisenhofen: Dustri; 1993. Der Epikutantest; pp. 1–39. [Google Scholar]

[CR463] 57.Schuler G., Steinman R.M. Murine epidermal Langerhans cells mature into potent immuno-stimulatory dendritic cells in vitro. J Exp Med. 1985;161:526–546. doi: 10.1084/jem.161.3.526. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR464] 58.Schwanitz H.J. Das atopische Palmoplantareczema. Berlin Heidelberg New York: Springer; 1986. [Google Scholar]

[CR465] 59.Schwanitz H.J., Szliska C., editors. Berufsdermatosen. Munich: Dustri; 2001. [Google Scholar]

[CR466] 60.Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 1993;260:496–497. doi: 10.1126/science.8097337. [DOI] [PubMed] [Google Scholar]

[CR467] 61.Silberberg I., Baer R.I., Rosenthal S.A. The role of Langerhans cells in contact allergy. I. An ultrastructural study in actively induced contact dermatitis in guinea pigs. Acta Derm Venereol. 1974;54:321–331. [PubMed] [Google Scholar]

[CR468] 62.Stingl G. New aspects of Langerhans cell function. Int J Dermatol. 1980;19:189. doi: 10.1111/j.1365-4362.1980.tb00297.x. [DOI] [PubMed] [Google Scholar]

[CR469] 63.Török I. Eczema s betegsegek. Budapest: Medicina; 1989. [Google Scholar]

[CR470] 64.Traidl C., Merk H.F., Cavani A., Hunzelmann N. New insights into the pathomechanisms of contact dermatitis by the use of transgenic mouse models. Skin Pharmacol Appl Skin Physiol. 2000;13:300–312. doi: 10.1159/000029938. [DOI] [PubMed] [Google Scholar]

[CR471] 65.Unna P.G. Seborrhoeal eczema. J Cutan GU Dis. 1887;5:449–459. [Google Scholar]

[CR472] 66.Uter W., Schnuch A., Geier J., et al. Epidemiology of contact dermatitis. The information network of Department of Dermatology (IVDK) in Germany. Eur J Dermatol. 1998;8:36–40. [PubMed] [Google Scholar]

[CR473] 67.Willan . On cutaneous diseases. London: Johnson; 1808. [Google Scholar]

[CR474] 1.Abeck D., Schmidt T., Fesq H., Strom K., Mempel M., Brockow K., Ring J. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol. 2000;42:254–257. doi: 10.1016/S0190-9622(00)90134-8. [DOI] [PubMed] [Google Scholar]

[CR475] 2.Abeck D., Ring J., editors. Atopisches Eczema (Neurodermitis) im Kindesalter. Darmstadt: Steinkopff; 2002. [Google Scholar]

[CR476] 3.Akdis C.A., Akdis M., Trautmann A., Blaser K. Immune regulation in atopic dermatitis. Curr Opin Immunol. 2000;12:641–646. doi: 10.1016/S0952-7915(00)00156-4. [DOI] [PubMed] [Google Scholar]

[CR477] 4.Atherton D.J. Allergy and atopic eczema. Clin Exp Dermatol. 1981;6:317–325. doi: 10.1111/j.1365-2230.1981.tb02311.x. [DOI] [PubMed] [Google Scholar]

[CR478] 5.Besnier E. Premiere note et observations preliminaires pour servir d’introduction a l’etude des prurigos diathesiques (dermatites multiformes prurigineuses chroniques exacerbantes et paroxystiques, du type du prurigo de Hebra) Ann Derm Syph. 1892;3(3):634–648. [Google Scholar]

[CR479] 6.Bieber T. FceR1 on human Langerhans cells: a receptor in search of new functions. Immunol Today. 1994;15:52–53. doi: 10.1016/0167-5699(94)90132-5. [DOI] [PubMed] [Google Scholar]

[CR480] 7.Bleck O., Abeck D., Ring J., Hoppe U., Vietzke J., Wolber R., Brandt O., Schreiner V. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids on non-lesional skin of atopic eczema. J Invest Dermatol. 1999;113:894–900. doi: 10.1046/j.1523-1747.1999.00809.x. [DOI] [PubMed] [Google Scholar]

[CR481] 8.Boguniewicz M., Leung D.Y.M. Atopic dermatitis: A question of balance. Arch Dermatol. 1998;134:870–871. doi: 10.1001/archderm.134.7.870. [DOI] [PubMed] [Google Scholar]

[CR482] 9.Bos J.D., Van Leent E.J., Sillevis Smitt J.H. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol. 1998;7:132–138. doi: 10.1111/j.1600-0625.1998.tb00313.x. [DOI] [PubMed] [Google Scholar]

[CR483] 10.Borelli S., Schnyder U.W. Neurodermitis constitutionalis sive atopica, part II: Atiologie, Pathophysiologie, Pathogenese, Therapie. In: Miescher G., Storck H., editors. Entzündliche Dermatosen I. Handbuch der Haut-und Geschlechts-krankheiten. Berlin Heidelberg New York: Springer; 1962. pp. 254–319. [Google Scholar]

[CR484] 11.Braun-Falco O., Ring J. Zur Therapie des atopischen Eczemas. Hautarzt. 1984;35:447–454. [PubMed] [Google Scholar]

[CR485] 12.Bruynzeel-Koomen C., Van Wichen D.F., Toonstra J., Berrens L., Bruynzeel P.L.B. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res. 1986;278:199–205. doi: 10.1007/BF00412924. [DOI] [PubMed] [Google Scholar]

[CR486] 13.Carucci J.A., Washenik K., Weinstein A., Shupack J., Cohen D.E. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol. 1998;134:785–786. doi: 10.1001/archderm.134.7.785. [DOI] [PubMed] [Google Scholar]

[CR487] 14.Cooper K.D., Stevens S.R. T cells in atopic dermatitis. J Am Acad Dermatol. 2001;45:510–512. doi: 10.1067/mjd.2001.117025. [DOI] [PubMed] [Google Scholar]

[CR488] 15.Cookson W.O., Ubhi B., Lawrence R., Abecasis G.R., Whalley A.J., Cox H.E., et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet. 2001;27:372–373. doi: 10.1038/86867. [DOI] [PubMed] [Google Scholar]

[CR489] 16.Darsow U., Vieluf D., Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. J Am Acad Dermatol. 1999;40:187–193. doi: 10.1016/S0190-9622(99)70186-6. [DOI] [PubMed] [Google Scholar]

[CR490] 17.Darsow U., Drzezga A., Frisch M., Munz F., Weilke F., Bartenstein P., Schwaiger M., Ring J. Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol. 2000;115:1029–1033. doi: 10.1046/j.1523-1747.2000.00193.x. [DOI] [PubMed] [Google Scholar]

[CR491] 18.Fartasch M., Abeck D., Werfel T., Diepgen T., Schmid-Ott G., Ring J., Gieler U. Aktueller Stand des interdisziplinären Modellprojektes “Neurodermitis-Schulung für Kinder und Jugendliche”. Hautarzt. 2000;51:299–301. doi: 10.1007/s001050051122. [DOI] [PubMed] [Google Scholar]

[CR492] 19.Giustizieri M.L., Mascia F., Frezzolini A., De Pita O., Chinni L.M., Gianetti A., Girolomoni G., Pastore S. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol. 2001;107:871–877. doi: 10.1067/mai.2001.114707. [DOI] [PubMed] [Google Scholar]

[CR493] 20.Hanifin J.M. Atopic dermatitis. J Am Acad Dermatol. 1982;8:1–13. doi: 10.1016/S0190-9622(82)70001-5. [DOI] [PubMed] [Google Scholar]

[CR494] 21.Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;114:146–148. [Google Scholar]

[CR495] 22.Herzberg J. Wenig bekannte Formen der Neurodermitis. Hautarzt. 1973;24:407–501. [PubMed] [Google Scholar]

[CR496] 23.Imokawa G. Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol. 2001;45:S29–32. doi: 10.1067/mjd.2001.117020. [DOI] [PubMed] [Google Scholar]

[CR497] 24.Jakob T. Mechanismen der Aktivierung und Mobilisation dentritischer Zellen in der Haut. München: Habilitationsschrift, Technische Universität; 2002. [Google Scholar]

[CR498] 25.Jung T. Zytokindysregulation bei atopischer Dermatitis. Munich: Dustri; 2002. [Google Scholar]

[CR499] 26.Kissling S., Wüthrich B. Dermatitis in young adults: personal follow-up 20 years after diagnosis in childhood. Hautarzt. 1994;45:368–371. doi: 10.1007/s001050050085. [DOI] [PubMed] [Google Scholar]

[CR500] 27.Korting G.W. Zur Pathogenese des endogenen Eczemas. Stuttgart: Thieme; 1954. [Google Scholar]

[CR501] 28.Kowalzick L., Kleinheinz A., Weichenthal M., Neuber K., Köhler I., et al. Low dose versus medium dose UVA1 treatment in severe atopic eczema. Acta Derm Venereol. 1995;75:43–45. doi: 10.2340/00015555754345. [DOI] [PubMed] [Google Scholar]

PERMALINK

Allergic Diseases (and Differential Diagnoses)

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Allergic Diseases (and Differential Diagnoses)

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases